<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0064">
    <title>47 Acinetobacter, Chryseobacterium, Moraxella, Branhamella and Other Nonfermentative Gram-Negative Rods*</title>
    <sect1 id="ch0064s0001">
      <title>47 Acinetobacter, Chryseobacterium, Moraxella, Branhamella and Other Nonfermentative Gram-Negative Rods*</title>
      <anchor id="ch0064s000001a0001"/>
      <anchor id="ch0064s000000a0001"/>
      <anchor id="ch0064s000000a0002"/>
      <para role="chapterAuthor"><phrase role="center">PIET COOLS, ALEXANDR NEMEC, ANNE-MARIE VAN DEN ABEELE, AND PETER KÄMPFER</phrase>
      </para>
      <sect2 id="ch0064s0001s0001">
        <title>TAXONOMY</title>
        <anchor id="ch0064s000001a0002"/>
        <anchor id="ch0064s000000a0003"/>
        <para id="ch0064s000000p0001">The organisms covered in this chapter belong to a group of taxonomically and phylogenetically diverse, Gram-negative, nonfermentative rods and coccobacilli. Several of the genera discussed belong to the same family, i.e.,<emphasis>Acinetobacter, Moraxella, Oligella</emphasis>, and <emphasis>Psychrobacter</emphasis> belong to the family <emphasis>Moraxellaceae</emphasis> (<emphasis>Gammaproteobacteria</emphasis>) (<link linkend="ch0064s000000li0001">1</link>) and <emphasis>Balneatrix, Bergeyella, Chryseobacterium, Elizabethkingia, Empedobacter, Myroides</emphasis>, and <emphasis>Sphingobacterium</emphasis> belong to the family <emphasis>Flavobacteriaceae</emphasis> (<emphasis>Bacteroidetes</emphasis>) (<link linkend="ch0064s000000li0002">2</link>), although their phylogenetic placement in higher taxonomic ranks is still open (<link linkend="ch0064s000000li0003">3</link>). The genus <emphasis>Weeksella</emphasis> belongs to the family <emphasis>Weeksellaceae</emphasis> (<link linkend="ch0064s000000li0003">3</link>).</para>
      </sect2>
      <sect2 id="ch0064s0001s0002">
        <title>DESCRIPTION OF THE AGENTS</title>
        <anchor id="ch0064s000001a0003"/>
        <anchor id="ch0064s000000a0004"/>
        <para id="ch0064s000000p0002">The species discussed in this chapter all share the common phenotypic features of being catalase positive but failing to acidify the butt of Kligler iron agar (KIA) or triple sugar iron (TSI) agar or of fermentative media, indicating their inability to metabolize carbohydrates by the fermentative pathway. These organisms grow significantly better under aerobic than under anaerobic conditions, and many, i.e., those species that can use only oxygen as the final electron acceptor in the respiratory pathway, fail to grow anaerobically at all.</para>
      </sect2>
      <sect2 id="ch0064s0001s0003">
        <title>EPIDEMIOLOGY AND TRANSMISSION</title>
        <anchor id="ch0064s000001a0004"/>
        <anchor id="ch0064s000000a0005"/>
        <para id="ch0064s000000p0003">Most of the organisms described in this chapter are found in the environment, i.e., soil and water. For methylobacteria, tap water has been implicated as a possible agent of transmission in hospital environments, and methods for monitoring water systems for methylobacteria have been described previously (<link linkend="ch0064s000000li0004">4</link>). No person-to-person spread has been documented for the species covered in this chapter, except for <emphasis>Acinetobacter</emphasis> species and <emphasis>Branhamella catarrhalis</emphasis>.</para>
      </sect2>
      <sect2 id="ch0064s0001s0004">
        <title>CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0064s000001a0005"/>
        <anchor id="ch0064s000000a0006"/>
        <para id="ch0064s000000p0004">For almost all species in this chapter, case reports, e.g., of meningitis and endocarditis, can be found, and their clinical importance is mostly restricted to that of opportunistic pathogens. However,<emphasis>Elizabethkingia meningoseptica, Elizabethkingia anophelis, Moraxella lacunata</emphasis> (eye infections), <emphasis>B. catarrhalis</emphasis> (respiratory tract infections), and species of the <emphasis>Acinetobacter calcoaceticus</emphasis>-<emphasis>Acinetobacter baumannii</emphasis> complex are of clinical importance. For some species, scarcity of reported cases can be attributed either to the intrinsic lower virulence of the bacterium or to under-reporting due to isolation and identification difficulties. Broad implementation of proteomic and genomic techniques in clinical laboratories could alter this situation.</para>
        <para id="ch0064s000000p0005"><emphasis>A. baumannii</emphasis> ventilator-associated pneumonia and bloodstream infections are known to be associated with a high degree of mortality and morbidity (<link linkend="ch0064s000000li0005">5</link>). Particular manifestations of <emphasis>A. baumannii</emphasis> are its implication in severely war-wounded soldiers (<link linkend="ch0064s000000li0006">6</link>) and in victims of natural disasters (<link linkend="ch0064s000000li0007">7</link>). Although severe infections with <emphasis>A. baumannii</emphasis> have been documented, colonization is much more frequent than infection, and differentiation between these conditions can be difficult. Although uncommon, community-acquired infections with <emphasis>A. baumannii</emphasis> occur. In particular, community-acquired pneumonia with <emphasis>A. baumannii</emphasis> has been reported from tropical areas, such as Southeast Asia and tropical Australia (<link linkend="ch0064s000000li0008">8</link>–<link linkend="ch0064s000000li0010">10</link>).</para>
        <para id="ch0064s000000p0006">The clinical role of<emphasis>Acinetobacter pittii</emphasis> and <emphasis>Acinetobacter nosocomialis</emphasis> resembles that of <emphasis>A. baumannii</emphasis>, although, compared to these two species, <emphasis>A. baumannii</emphasis> is more often associated with multidrug resistance and epidemic spread in hospitals and possibly also with higher mortality among patients with systemic infections (<link linkend="ch0064s000000li0009">9</link>).</para>
        <para id="ch0064s000000p0007">Other<emphasis>Acinetobacter</emphasis> species occasionally associated with human infections are listed in <anchor id="ch0064s000000a0007"/><link linkend="ch0064s000000a0010">Table 1</link>. <emphasis>A. johnsonii, A. lwoffii</emphasis>, and <emphasis>A. radioresistens</emphasis> seem to be common inhabitants of human skin (<link linkend="ch0064s000000li0011">11</link>). Several species, <emphasis>A. ursingii</emphasis> in particular, have been found to cause bloodstream infections in hospitalized patients (<link linkend="ch0064s000000li0012">12</link>–<link linkend="ch0064s000000li0014">14</link>), while <emphasis>A. junii</emphasis> and <emphasis>A. soli</emphasis> have been implicated in outbreaks of neonatal infections and <emphasis>A. parvus</emphasis> can be isolated from blood cultures (<link linkend="ch0064s000000li0015">15</link>, <link linkend="ch0064s000000li0016">16</link>). Many infections with these species are related to intravascular catheters or have other iatrogenic origins (<link linkend="ch0064s000000li0012">12</link>, <link linkend="ch0064s000000li0017">17</link>); their course is generally benign. For various other <emphasis>Acinetobacter</emphasis> species, although they are occasionally recovered from clinical specimens, a possible role in infection has not been documented.</para>
        <anchor id="ch0064s000000a0008"/>
        <beginpage pagenum="912"/>
        <anchor id="ch0064s000000a0009"/>
        <beginpage pagenum="913"/>
        <table id="ch0064s000000t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0064s000000a0010"/><link linkend="ch0064s000000a0007">TABLE 1</link></phrase></emphasis> Oxidase-negative, indole-negative, nonfermentative, Gram-negative rods: the genus <emphasis>Acinetobacter</emphasis><superscript><emphasis><anchor id="ch0064s000000a0011"/><link linkend="ch0064s000000a0018">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="29">
            <tbody>
              <row>
                <entry><phrase role="center">Characteristic</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. baumannii</emphasis> (25)<superscript><emphasis><anchor id="ch0064s000000a0012"/><link linkend="ch0064s000000a0019">b</link></emphasis>,<emphasis><anchor id="ch0064s000000a0013"/><link linkend="ch0064s000000a0020">c</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. calcoaceticus</emphasis> (11)<superscript><emphasis><link linkend="ch0064s000000a0020">c</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. lactucae</emphasis> (6)<superscript><emphasis><link linkend="ch0064s000000a0020">c</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. nosocomialis</emphasis> (20)<superscript><emphasis><link linkend="ch0064s000000a0020">c</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. pittii</emphasis> (20)<superscript><emphasis><link linkend="ch0064s000000a0020">c</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. seifertii</emphasis> (16)<superscript><emphasis><link linkend="ch0064s000000a0020">c</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. beijerinckii</emphasis> (15)<superscript><emphasis><anchor id="ch0064s000000a0014"/><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. bereziniae</emphasis> (16)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. colistiniresistens</emphasis> (24)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. courvalinii</emphasis> (9)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. dispersus</emphasis> (9)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. guillouiae</emphasis> (17)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. gyllenbergii</emphasis> (9)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. haemolyticus</emphasis> (16)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. indicus</emphasis> (2)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. johnsonii</emphasis> (30)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. junii</emphasis> (14)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. lwoffii</emphasis> (37)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. modestus</emphasis> (7)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. parvus</emphasis> (10)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. proteolyticus</emphasis> (6)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. pseudolwoffii</emphasis> (15)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. radioresistens</emphasis> (12)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. schindleri</emphasis> (22)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. soli</emphasis> (5)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. ursingii</emphasis> (29)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. variabilis</emphasis> (16)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>A. vivianii</emphasis> (9)<superscript><emphasis><link linkend="ch0064s000000a0021">d</link></emphasis></superscript></phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Growth at:</phrase>
                </entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left">44°C</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">50</phrase>
                </entry>
                <entry><phrase role="center">95</phrase>
                </entry>
                <entry><phrase role="center">10</phrase>
                </entry>
                <entry><phrase role="center">13</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">–<superscript><emphasis><anchor id="ch0064s000000a0015"/><link linkend="ch0064s000000a0022">e</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">31<superscript><emphasis><anchor id="ch0064s000000a0016"/><link linkend="ch0064s000000a0023">f</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">41°C</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">9</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">94</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">50<superscript><emphasis><link linkend="ch0064s000000a0023">f</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">94</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">93</phrase>
                </entry>
                <entry><phrase role="center">11<superscript><emphasis><link linkend="ch0064s000000a0023">f</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">80</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">37°C</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">91</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100<superscript><emphasis><anchor id="ch0064s000000a0017"/><link linkend="ch0064s000000a0024">g</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">82</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">10<superscript><emphasis><link linkend="ch0064s000000a0024">g</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">10<superscript><emphasis><link linkend="ch0064s000000a0023">f</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">90</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Acidification of <phrase role="small">D</phrase>-glucose</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">91</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">95</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">88</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">75</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">19</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">13</phrase>
                </entry>
                <entry><phrase role="center">89</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Gelatinase</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">13</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">94</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Hemolysis of sheep blood agar</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">89</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">60<superscript><emphasis><link linkend="ch0064s000000a0023">f</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">50</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">60</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Assimilation of:</phrase>
                </entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left"><emphasis>trans</emphasis>-Aconitate</phrase>
                </entry>
                <entry><phrase role="center">92</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">60</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">38</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">44</phrase>
                </entry>
                <entry><phrase role="center">11</phrase>
                </entry>
                <entry><phrase role="center">12</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">63</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">5</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">6</phrase>
                </entry>
                <entry><phrase role="center">56</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Adipate</phrase>
                </entry>
                <entry><phrase role="center">88</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">95</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">63</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">63</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">22</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">76</phrase>
                </entry>
                <entry><phrase role="center">14</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">67</phrase>
                </entry>
                <entry><phrase role="center">40</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">41</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">69</phrase>
                </entry>
                <entry><phrase role="center">89</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">β-Alanine</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">91</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">85</phrase>
                </entry>
                <entry><phrase role="center">90</phrase>
                </entry>
                <entry><phrase role="center">88</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">17</phrase>
                </entry>
                <entry><phrase role="center">89</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">94</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">4-Aminobutyrate</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">88</phrase>
                </entry>
                <entry><phrase role="center">–<superscript><emphasis><link linkend="ch0064s000000a0022">e</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">83</phrase>
                </entry>
                <entry><phrase role="center">86</phrase>
                </entry>
                <entry><phrase role="center">84</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">–<superscript><emphasis><link linkend="ch0064s000000a0022">e</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">19</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><phrase role="small">L</phrase>-Arginine</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">94</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">83</phrase>
                </entry>
                <entry><phrase role="center">93</phrase>
                </entry>
                <entry><phrase role="center">5</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">83</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">19</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><phrase role="small">L</phrase>-Aspartate</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">11</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">31</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">83</phrase>
                </entry>
                <entry><phrase role="center">21</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">97<superscript><emphasis><link linkend="ch0064s000000a0023">f</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">11</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Azelate</phrase>
                </entry>
                <entry><phrase role="center">88</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">95</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">63</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">63</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">22</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">50</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">67</phrase>
                </entry>
                <entry><phrase role="center">80</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">64</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">81</phrase>
                </entry>
                <entry><phrase role="center">89</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Citrate (Simmons)</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">91</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">75</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">90</phrase>
                </entry>
                <entry><phrase role="center">79</phrase>
                </entry>
                <entry><phrase role="center">8</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">59<superscript><emphasis><link linkend="ch0064s000000a0023">f</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">25</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Ethanol</phrase>
                </entry>
                <entry><phrase role="center">96</phrase>
                </entry>
                <entry><phrase role="center">91</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">17</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">11</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">22</phrase>
                </entry>
                <entry><phrase role="center">94</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">93</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">73</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">95</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><phrase role="small">D</phrase>-Glucose</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Glutarate</phrase>
                </entry>
                <entry><phrase role="center">96</phrase>
                </entry>
                <entry><phrase role="center">91</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">95</phrase>
                </entry>
                <entry><phrase role="center">90</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">–<superscript><emphasis><link linkend="ch0064s000000a0022">e</link></emphasis></superscript></phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">33</phrase>
                </entry>
                <entry><phrase role="center">13</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">95</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">97</phrase>
                </entry>
                <entry><phrase role="center">19</phrase>
                </entry>
                <entry><phrase role="center">89</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><phrase role="small">L</phrase>-Histidine</phrase>
                </entry>
                <entry><phrase role="center">96</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">94</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">94</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">94</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">93</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left"><phrase role="small">DL</phrase>-Lactate</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">96</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">93</phrase>
                </entry>
                <entry><phrase role="center">84</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">40</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">6</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Malonate</phrase>
                </entry>
                <entry><phrase role="center">88</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">20</phrase>
                </entry>
                <entry><phrase role="center">95</phrase>
                </entry>
                <entry><phrase role="center">75</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">8</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">22</phrase>
                </entry>
                <entry><phrase role="center">18</phrase>
                </entry>
                <entry><phrase role="center">78</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">73</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">8</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">67</phrase>
                </entry>
                <entry><phrase role="center">7</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Phenylacetate</phrase>
                </entry>
                <entry><phrase role="center">84</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">85</phrase>
                </entry>
                <entry><phrase role="center">75</phrase>
                </entry>
                <entry><phrase role="center">88</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">25</phrase>
                </entry>
                <entry><phrase role="center">96</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">89</phrase>
                </entry>
                <entry><phrase role="center">65</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">81</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">83</phrase>
                </entry>
                <entry><phrase role="center">80</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">75</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Putrescine</phrase>
                </entry>
                <entry><phrase role="center">96</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">95</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">81</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">92</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">78</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0018"/><link linkend="ch0064s000000a0011">a</link></emphasis></superscript>Listed are only the species found in humans. All data were obtained in the Laboratory of Bacterial Genetics in Prague (A. Nemec) and are taken from previous studies (<link linkend="ch0064s000000li0076">76</link>, <link linkend="ch0064s000000li0080">80</link>). The numbers are percentages of strains positive in a given test.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0019"/><link linkend="ch0064s000000a0012">b</link></emphasis></superscript>Numerals in parentheses after species names are numbers of strains tested.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0020"/><link linkend="ch0064s000000a0013">c</link></emphasis></superscript>Species of the <emphasis>A. calcoaceticus-A. baumannii</emphasis> complex (71–73).</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0021"/><link linkend="ch0064s000000a0014">d</link></emphasis></superscript>Species of the hemolytic clade (<link linkend="ch0064s000000li0057">57</link>).</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0022"/><link linkend="ch0064s000000a0015">e</link></emphasis></superscript>Unreproducible or delayed growth of most strains.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0023"/><link linkend="ch0064s000000a0016">f</link></emphasis></superscript>Weak growth of most strains with positive reactions.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0024"/><link linkend="ch0064s000000a0017">g</link></emphasis></superscript>Growth tested at 38°C instead of 37°C.</para>
        <para id="ch0064s000000p0008"><emphasis>B. catharrhalis</emphasis> is a human mucosal pathogen, and the molecular mechanisms involved in its metabolism and pathogenesis, including cellular adherence, target cell invasion, and modulation of the host’s immune response, have been reviewed (<link linkend="ch0064s000000li0018">18</link>). <emphasis>Moraxella</emphasis> species are agents of infections (conjunctivitis, keratitis, meningitis, septicemia, endocarditis, arthritis, and otolaryngologic infections) (<link linkend="ch0064s000000li0019">19</link>–<link linkend="ch0064s000000li0024">24</link>). <emphasis>B. catarrhalis</emphasis> has been reported to cause sinusitis, upper respiratory tract infections, and otitis media by contiguous spread of the organisms from a colonizing focus in the respiratory tract (<link linkend="ch0064s000000li0019">19</link>, <link linkend="ch0064s000000li0025">25</link>). However, isolation of <emphasis>B. catarrhalis</emphasis> from the upper respiratory tract (i.e., a throat culture) of children with otitis media or sinusitis does not provide evidence that the isolate is the cause of these infections, because <emphasis>B. catarrhalis</emphasis> is frequently present as a commensal of the upper respiratory tract in children (<link linkend="ch0064s000000li0021">21</link>, <link linkend="ch0064s000000li0025">25</link>). Isolates from sinus aspirates and middle ear specimens obtained by tympanocentesis should be identified and reported.</para>
        <para id="ch0064s000000p0009"><emphasis>B. catarrhalis</emphasis> has now been assigned a clear pathogenic role in lower respiratory tract infections (although little is known about its pathogenesis), particularly in adults with chronic obstructive pulmonary disease (COPD) (<link linkend="ch0064s000000li0026">26</link>, <link linkend="ch0064s000000li0027">27</link>). This conclusion results from observations that <emphasis>B. catarrhalis</emphasis> is not a frequent commensal of the upper respiratory tract in adults (<link linkend="ch0064s000000li0026">26</link>), and that examination of Gram-stained smears of sputum specimens from patients with exacerbations of bronchitis and pneumonia due to <emphasis>B. catarrhalis</emphasis> usually reveals an abundance of leukocytes, the presence of many Gram-negative diplococci as the exclusive or predominant bacterial cell type, and the presence of intracellular Gram-negative diplococci. Such specimens may yield <emphasis>B. catarrhalis</emphasis> in virtually pure culture, and the organism should be identified and reported. In immunocompromised hosts, <emphasis>B. catarrhalis</emphasis> can cause a variety of severe infections including pneumonia, endocarditis, septicemia, and meningitis (<link linkend="ch0064s000000li0027">27</link>).</para>
        <para id="ch0064s000000p0010"><emphasis>Moraxella</emphasis> species normally exist, similar to <emphasis>B. catarrhalis</emphasis>, as part of the human upper respiratory tract microbiota and rarely cause invasive human disease. <emphasis>M. nonliquefaciens</emphasis> (<link linkend="ch0064s000000li0006">6</link>, <link linkend="ch0064s000000li0028">28</link>) is an unusual organism to be isolated from cerebrospinal fluid (CSF) and there exists only one case report of <emphasis>M. nonliquefaciens</emphasis> neonatal meningitis. There are only a handful of case reports implicating the organism as a cause of endocarditis, bacteremia, septic arthritis, and endophthalmitis. A fatal endocarditis case caused by <emphasis>M. nonliquefaciens</emphasis> has been reported (<link linkend="ch0064s000000li0029">29</link>). History of acute sinusitis has been associated with significant depletion in relative abundance of taxa, including <emphasis>Faecalibacterium prausnitzii</emphasis> and <emphasis>Akkermansia</emphasis> spp., and enrichment of <emphasis>Moraxella nonliquefaciens.</emphasis> Enrichment of <emphasis>M. nonliquefaciens</emphasis> was also a characteristic of baseline nasopharyngeal samples of children who subsequently developed acute sinusitis over the 1-year study period (<link linkend="ch0064s000000li0030">30</link>). These findings were confirmed by profiling of bacterial communities in upper respiratory tracts (<link linkend="ch0064s000000li0031">31</link>). Identification to the species level based on routine laboratory techniques has been challenging, with final identification often made through 16S rRNA gene sequencing and/or matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) (<link linkend="ch0064s000000li0032">32</link>). <emphasis>M. osloensis</emphasis> (<link linkend="ch0064s000000li0033">33</link>, <link linkend="ch0064s000000li0034">34</link>) is also part of the normal human upper respiratory tract microbiome. In rare cases, the organism is detected as a pathogen in nonrespiratory clinical samples, mostly in an immunocompromised population. <emphasis>M. osloensis</emphasis> was cultured in blood cultures from bacteremic adults and children (<link linkend="ch0064s000000li0035">35</link>, <link linkend="ch0064s000000li0036">36</link>) and from peritonitis (<link linkend="ch0064s000000li0037">37</link>) in patients on peritoneal dialysis. Besides <emphasis>M. nonliquefaciens, M. osloensis</emphasis> has been isolated in a wide variety of ocular infections (<link linkend="ch0064s000000li0038">38</link>), ranging from conjunctivitis and overt keratitis to endophthalmitis. <emphasis>M. lacunata</emphasis> has been associated with infective endocarditis and eye infections (<link linkend="ch0064s000000li0024">24</link>, <link linkend="ch0064s000000li0039">39</link>, <link linkend="ch0064s000000li0040">40</link>). <emphasis>M. canis</emphasis> has been isolated from dog bite wounds (<link linkend="ch0064s000000li0041">41</link>) and debilitated patients (<link linkend="ch0064s000000li0021">21</link>).</para>
      </sect2>
      <sect2 id="ch0064s0001s0005">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0064s000001a0006"/>
        <anchor id="ch0064s000000a0025"/>
        <para id="ch0064s000000p0011">Standard methods for collection, transport, and storage of specimens as detailed in<ulink url="ch0027#ch0027s0001">chapters 12</ulink> and <ulink url="ch0034#ch0034s0001">18</ulink> of this <emphasis>Manual</emphasis> are satisfactory for this group of organisms. The only fastidious species handled in this chapter are <emphasis>Asaia</emphasis> species, <emphasis>Granulibacter bethesdensis, Methylobacterium</emphasis> species, and most <emphasis>Moraxella</emphasis> species; these should be cultured on media containing blood.</para>
      </sect2>
      <sect2 id="ch0064s0001s0006">
        <title>DIRECT EXAMINATION</title>
        <anchor id="ch0064s000001a0007"/>
        <anchor id="ch0064s000000a0026"/>
        <para id="ch0064s000000p0012">No characteristics can help to recognize the species dealt with in this chapter by means of direct microscopic examination. On Gram stain, organisms appear as Gram-negative rods, coccobacilli, or diplococci. Neither direct antigen tests nor molecular genetic tests to use directly on clinical materials have been developed.</para>
      </sect2>
      <sect2 id="ch0064s0001s0007">
        <title>ISOLATION PROCEDURES</title>
        <anchor id="ch0064s000001a0008"/>
        <anchor id="ch0064s000000a0027"/>
        <para id="ch0064s000000p0013">Initial incubation should be at 35 to 37°C, although some strains, among them many of the pink-pigmented species, grow better at or below 30°C and may be detected only on plates left at room temperature. In such cases, all tests should be carried out at room temperature. In fact, some of the commercial kits, such as the API 20NE, are designed to be incubated at 30°C.</para>
        <para id="ch0064s000000p0014">Growth on certain selective primary media, e.g., MacConkey agar, is variable and may be influenced by lot-to-lot variations in the composition of media. Gram-negative, nonfermentative bacteria (GNF) that grow on MacConkey agar generally form colorless colonies, although some form lavender or purple colonies due to uptake of crystal violet contained in the agar medium. Selective media have been described for<emphasis>Acinetobacter</emphasis> species (<link linkend="ch0064s000000li0042">42</link>) and for <emphasis>Moraxella</emphasis> species (<link linkend="ch0064s000000li0043">43</link>).</para>
      </sect2>
      <sect2 id="ch0064s0001s0008">
        <title>IDENTIFICATION</title>
        <anchor id="ch0064s000001a0009"/>
        <anchor id="ch0064s000000a0028"/>
        <para id="ch0064s000000p0015"><anchor id="ch0064s000000a0029"/><link linkend="ch0064s000000a0032">Figure 1</link> provides an overview of identification, in the form of a key to the five large groups that can be distinguished among the species described in this chapter. This key is based only on colony color (pink or not), the presence or absence of oxidase, the production of indole, and benzyl arginine aminopeptidase (trypsin) activity.</para>
        <para id="ch0064s000000p0016"><link linkend="ch0064s000000a0032">Figure 1</link> refers to <link linkend="ch0064s000000a0010">Tables 1</link> through <anchor id="ch0064s000000a0030"/><link linkend="ch0064s000000a0121">5</link>, which provide further keys to identify the species of these five groups based on biochemical reactions. Results for enzymatic reactions can be read within hours or up to 2 days of incubation, whereas results of carbon source assimilation tests (<emphasis>Acinetobacter</emphasis> species) and acid production from carbohydrates are read after up to 6 and 7 days, respectively.</para>
        <para id="ch0064s000000p0017">For each group of closely related species, we present their taxonomic history (explaining the use of other names in the past and the taxonomic changes introduced since the previous edition), address the clinical importance of the species, and describe the phenotypic data that are useful to differentiate this group from other groups and to differentiate the species within this group. When relevant, antibiotic susceptibility characteristics and treatment options are discussed immediately; otherwise, they are discussed at the end of each section for the five large groups in this chapter.</para>
        <anchor id="ch0064s000000a0031"/>
        <beginpage pagenum="914"/>
        <figure id="ch0064s000000f0001"><title><phrase role="figureLabel"><anchor id="ch0064s000000a0032"/><link linkend="ch0064s000000a0029">FIGURE 1</link></phrase> Identification of miscellaneous GNF. The organisms covered in this chapter belong to a group of taxonomically diverse, Gram-negative, nonfermentative rods and coccobacilli. They all share the common phenotypic features of failing to acidify the butt of KIA or TSI agar or of oxidative-fermentative media, indicating their inability to metabolize carbohydrates by the fermentative pathway. These characteristics are shared with those of the species of the emended genus <emphasis>Pseudomonas</emphasis> (<ulink url="ch0060#ch0060s0001">chapter 43</ulink>) and those of the species of genera that previously were named as <emphasis>Pseudomonas</emphasis> (<ulink url="ch0061#ch0061s0001">chapter 44</ulink>). <emphasis>G. bethesdensis</emphasis> grows slowly and poorly on SBA. <emphasis>A. parvus</emphasis> forms small colonies as well, but these are already visible after 24 h of incubation.</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0064f06.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0064s000000p0018">Although several of the genera discussed in this chapter comprise many more species than the ones addressed here, we focus on those species that can be isolated from clinical samples.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0064s0002">
      <title>Classical Biochemical Identification Schemes Presented in This Chapter</title>
      <anchor id="ch0064s000002a0001"/>
      <anchor id="ch0064s000000a0033"/>
      <para id="ch0064s000000p0019">For all the species in this chapter, except those of the genus<emphasis>Acinetobacter</emphasis>, the biochemical tests listed have been carried out by Georges Wauters according to standardized protocols described in detail in <ulink url="ch0048#ch0048s0001">chapter 32</ulink> of this <emphasis>Manual.</emphasis> The limited number of tests that have been used to discriminate between the species dealt with in this chapter have been selected because they can be carried out easily and quickly, because they mostly yield uniform results per group or species, and because they are highly discriminatory. For the genus <emphasis>Acinetobacter</emphasis>, data based on standardized physiological and metabolic tests were provided by one of us (see footnotes to <link linkend="ch0064s000000a0010">Table 1</link>).</para>
    </sect1>
    <sect1 id="ch0064s0003">
      <title>Automated, Commercially Available, Phenotypic Identification Systems</title>
      <anchor id="ch0064s000003a0001"/>
      <anchor id="ch0064s000000a0034"/>
      <para id="ch0064s000000p0020">Traditional diagnostic systems, e.g., those based on oxidation-fermentation media, aerobic low-peptone media, or buffered single substrates, have now been replaced in many laboratories by commercial kits or automated systems such as VITEK 2 (bioMérieux, Marcy l’Étoile, France) and Phoenix (BD Diagnostic Systems, Sparks, MD) and by the widely used matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). The ability of commercial kits to identify this group of GNF is variable and often results in identification to the genus or group level only, necessitating the use of supplemental biochemical testing for species identification. O’Hara and Miller (<link linkend="ch0064s000000li0044">44</link>), using the VITEK 2 ID-GNB identification card, reported that of 103 glucose-fermenting and nonfermenting, nonenteric strains, 88 (85.4%) were correctly identified at probability levels ranging from excellent to good and that 10 (9.7%) were correctly identified at a low level of discrimination, for a total of 95.1% accuracy within this group. Bosshard et al. (<link linkend="ch0064s000000li0045">45</link>) compared 16S rRNA gene sequencing for the identification of clinically relevant isolates of GNF (non-<emphasis>Pseudomonas aeruginosa</emphasis>) with two commercially available identification systems (API 20NE and VITEK 2 fluorescent card; bioMérieux). By 16S rRNA gene sequence analysis, 92% of the isolates were assigned to species level and 8% to genus level. Using API 20NE, 54% of the isolates were assigned to species level, 7% were assigned to genus level, and 39% of the isolates could not be discriminated at any taxonomic level. The respective numbers for VITEK 2 were 53%, 1%, and 46%. Fifteen percent and 43% of the isolates corresponded to species not included in the API 20NE and VITEK 2 databases, respectively. Altogether, commercial identification systems can be useful for identification of organisms commonly found in clinical specimens, like <emphasis>Enterobacteriaceae.</emphasis> However, for rare organisms the performance of these systems can be poor.</para>
      <anchor id="ch0064s000000a0035"/>
      <beginpage pagenum="915"/>
      <table id="ch0064s000000t0002"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0064s000000a0036"/><link linkend="ch0064s000000a0079">TABLE 2</link></phrase></emphasis> Oxidase-positive, indole-negative, trypsin-negative, coccoid GNF<superscript><emphasis><anchor id="ch0064s000000a0037"/><link linkend="ch0064s000000a0039">a</link></emphasis></superscript>
</title>
        
        <tgroup cols="18">
          <tbody>
            <row>
              <entry><phrase role="center">Characteristic</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Haematobacter massiliensis</emphasis> (10)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Haematobacter missouriensis</emphasis> (3)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Moraxella atlantae</emphasis> (7)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Moraxella canis</emphasis> (5)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Branhamella catarrhalis</emphasis> (7)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Moraxella lacunata</emphasis> (5)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Moraxella lincolnii</emphasis> (2)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Moraxella nonliquefaciens</emphasis> (16)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Moraxella osloensis</emphasis> (28)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Oligella ureolytica</emphasis> (3)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Oligella urethralis</emphasis> (7)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Paracoccus yeei</emphasis> (14)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Psychrobacter faecalis</emphasis> (19)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Psychrobacter phenylpyruvicus</emphasis><superscript><emphasis><anchor id="ch0064s000000a0038"/><link linkend="ch0064s000000a0040">b</link></emphasis></superscript> (5)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Psychrobacter pulmonis</emphasis> (8)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Psychrobacter sanguinis</emphasis><superscript><emphasis><link linkend="ch0064s000000a0040">b</link></emphasis></superscript> (15)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Wohlfahrtiimonas chitiniclastica</emphasis> (3)</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Motility (flagella)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">67 (Pt)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Growth on MacConkey agar</phrase>
              </entry>
              <entry><phrase role="center">90</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">60</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">50</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">57</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">(50)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Alkalinizaton of acetate</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">60</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">87</phrase>
              </entry>
              <entry><phrase role="center">(100<superscript>w</superscript>)</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Susceptibility to desferrioxamine</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">71</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Acidification of:</phrase>
              </entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><phrase role="left">Glucose</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Mannitol</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">66</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">(50)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Xylose</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">(100<superscript>w</superscript>)</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Ethylene glycol</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">20</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">87</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Gelatinase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Tween 80 esterase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">4</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Tributyrate esterase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Alkaline phosphatase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">80</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">79</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Phenylalanine deaminase</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100<superscript>w</superscript></phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">10</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">33</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Pyrrolidonyl aminopeptidase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Urease</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Nitrate reductase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">80</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">18</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">20</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">33</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Nitrite reductase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">20</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Arginine dihydrolase</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0039"/><link linkend="ch0064s000000a0037">a</link></emphasis></superscript>Numbers in parentheses after organism names are numbers of strains tested. Values are percentages; those in parentheses represent delayed positivity. Abbreviations: Pt, peritrichous; w, weakly positive.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0040"/><link linkend="ch0064s000000a0038">b</link></emphasis></superscript>Growth markedly promoted by Tween 80. <emphasis>P. phenylpyruvicus</emphasis> grows in 12% NaCl tryptic soy broth supplemented with 0.1% Tween 80, in contrast to <emphasis>P. sanguinis.</emphasis></para>
    </sect1>
    <sect1 id="ch0064s0004">
      <title>Chemotaxonomic Methods</title>
      <anchor id="ch0064s000004a0001"/>
      <anchor id="ch0064s000000a0041"/>
      <para id="ch0064s000000p0021">The fatty acid profiles for the most common species of GNF have been published (<link linkend="ch0064s000000li0046">46</link>).</para>
    </sect1>
    <sect1 id="ch0064s0005">
      <title>Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry</title>
      <anchor id="ch0064s000005a0001"/>
      <anchor id="ch0064s000000a0042"/>
      <para id="ch0064s000000p0022">Different commercial platforms for MALDI-TOF MS are available, such as the MALDI BioTyper (Bruker Daltonics) and VITEK MS (bioMérieux), and although the initial cost of mass spectrometry equipment and maintenance costs are relatively high, the additional identification costs per isolate are minimal. MALDI-TOF MS is an established technique for identification of the species covered in this chapter, and most difficulties in obtaining a correct identification are due to missing spectra of newly described species. These problems can be overcome by creating new databases or by adding missing spectra (<link linkend="ch0064s000000li0047">47</link>, <link linkend="ch0064s000000li0048">48</link>).</para>
    </sect1>
    <sect1 id="ch0064s0006">
      <title>Nucleic Acid Amplification Tests and Sequence-Based Methods</title>
      <anchor id="ch0064s000006a0001"/>
      <anchor id="ch0064s000000a0043"/>
      <para id="ch0064s000000p0023">Sanger sequencing-based on rRNA (16S, 16S-23S spacer, or 23S) and housekeeping genes, such as those encoding the RNA polymerase subunit B (<emphasis>rpoB</emphasis>), the gyrase subunit B (<emphasis>gyrB</emphasis>), or the recombination A protein (<emphasis>recA</emphasis>), have become standard techniques to identify bacteria in general (<link linkend="ch0064s000000li0049">49</link>) and have contributed to the better delineation of several of these groups and the discovery and description of new species. Because these are generally applicable methods, their application for species of this chapter is not outlined in detail. However, for some species multilocus sequence type (MLST) schemes are available (<ulink url="https://pubmlst.org/data/">https://pubmlst.org/data/</ulink>) and also several genomes are available from the EzCloud homepage (<link linkend="ch0064s000000li0050">50</link>) (<ulink url="http://www.ezbiocloud.net/taxonomy">http://www.ezbiocloud.net/taxonomy</ulink>). It is important to note that genome data listed at that homepage are checked by the provider of the EzCloud database with respect to the reliability of the assignment to the given taxa.</para>
      <anchor id="ch0064s000000a0044"/>
      <beginpage pagenum="916"/>
      <anchor id="ch0064s000000a0045"/>
      <beginpage pagenum="917"/>
      <table id="ch0064s000000t0003"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0064s000000a0046"/><link linkend="ch0064s000000a0093">TABLE 3</link></phrase></emphasis> Oxidase-positive, indole-negative, trypsin-positive GNF<superscript><emphasis><anchor id="ch0064s000000a0047"/><link linkend="ch0064s000000a0051">a</link></emphasis></superscript>
</title>
        
        <tgroup cols="23">
          <tbody>
            <row>
              <entry><phrase role="center">Characteristic</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Alishewanella fetalis</emphasis> (1)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Inquilinus limosus</emphasis> (3)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Myroides odoratimimus</emphasis> (21)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Myroides injenensis</emphasis> (2)<superscript><emphasis><anchor id="ch0064s000000a0048"/><link linkend="ch0064s000000a0053">e</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Myroides odoratus</emphasis> (4)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Ochrobactrum anthropi</emphasis> (29)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Ochrobactrum grignonense</emphasis> (2)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Ochrobactrum haematophilum</emphasis> (3)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Ochrobactrum intermedium</emphasis> (9)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Ochrobactrum pseudintermedium</emphasis> (1)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Ochrobactrum pseudogrignonense</emphasis> (2)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Pannonibacter phragmitetus</emphasis> (7)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Pseudochrobactrum asaccharolyticum</emphasis> (3)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Rhizobium radiobacter</emphasis> (22)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Shewanella algae</emphasis><superscript><emphasis><anchor id="ch0064s000000a0049"/><link linkend="ch0064s000000a0052">b</link></emphasis></superscript> (10)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Shewanella putrefaciens</emphasis><superscript><emphasis><link linkend="ch0064s000000a0052">b</link></emphasis></superscript> (2)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Sphingobacterium cellulitidis</emphasis> (2)<superscript><emphasis><anchor id="ch0064s000000a0050"/><link linkend="ch0064s000000a0054">f</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Sphingobacterium hotanense</emphasis> (1)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Sphingobacterium multivorum</emphasis> (7)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Sphingobacterium spiritivorum</emphasis> (4)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Sphingobacterium thalpophilum</emphasis> (3)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Sphingomonas</emphasis> spp. (15)</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Motility</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">33</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">66</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Flagella</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">P, 1</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">Pt, L</phrase>
              </entry>
              <entry><phrase role="center">Pt, L</phrase>
              </entry>
              <entry><phrase role="center">Pt, L</phrase>
              </entry>
              <entry><phrase role="center">Pt, L</phrase>
              </entry>
              <entry><phrase role="center">Pt, L</phrase>
              </entry>
              <entry><phrase role="center">Pt, L</phrase>
              </entry>
              <entry><phrase role="center">Pt, L</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">Pt, L</phrase>
              </entry>
              <entry><phrase role="center">P, 1</phrase>
              </entry>
              <entry><phrase role="center">P, 1</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">P, 1</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Production of flexirubin pigments</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">95</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Growth on MacConkey agar</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">(100)</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">75</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">(50)</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Growth at 41°C</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Growth at 45°C</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Acidification of:</phrase>
              </entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><phrase role="left">Glucose</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">(100)</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">50</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">87 (13)</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Mannitol</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">59</phrase>
              </entry>
              <entry><phrase role="center">50</phrase>
              </entry>
              <entry><phrase role="center">33</phrase>
              </entry>
              <entry><phrase role="center">33</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">50</phrase>
              </entry>
              <entry><phrase role="center">28</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Xylose</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">(100)</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">87</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Ethylene glycol</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">86</phrase>
              </entry>
              <entry><phrase role="center">86</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">93</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Esculin hydrolysis</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Gelatinase</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Urease</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">(34)</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">(44)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">(100)</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">(100)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Nitrate reductase</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">7</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Nitrite reductase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">64</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">β-Galactosidase (ONPG<superscript><emphasis><link linkend="ch0064s000000a0053">e</link></emphasis></superscript>)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">75</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Pyrrolinodyl aminopeptidase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">27</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Production of H<subscript>2</subscript>S (on KIA)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Alkaline phosphatase</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Requirement for NaCl</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Phenylalanine deaminase</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Tributyrine esterase (&lt;1 h)</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Susceptibility to:</phrase>
              </entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><phrase role="left">Colistin</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">50</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">73</phrase>
              </entry>
              <entry><phrase role="center">60</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100<superscript><emphasis><link linkend="ch0064s000000a0054">f</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">7</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Desferrioxamine</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">33</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">18</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">7</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Netilmicin</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">66</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Tetracyline</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100<superscript><emphasis><link linkend="ch0064s000000a0054">f</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0051"/><link linkend="ch0064s000000a0047">a</link></emphasis></superscript>Numbers in parentheses after organism names are numbers of strains tested. Values are percentages; those in parentheses represent delayed positivity. Abbreviations: L, lateral; ND, no data; P, polar; Pt, peritrichous.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0052"/><link linkend="ch0064s000000a0049">b</link></emphasis></superscript>Data from reference <link linkend="ch0064s000000li0206">206</link>.</para>
      <para role="table-footnote"><superscript><emphasis>c</emphasis></superscript>Both <emphasis>Shewanella</emphasis> species are ornithine decarboxylase positive.</para>
      <para role="table-footnote"><superscript><emphasis>d</emphasis></superscript>Data from reference <link linkend="ch0064s000000li0248">248</link>.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0053"/><link linkend="ch0064s000000a0048">e</link></emphasis></superscript>ONPG, <emphasis>o</emphasis>-nitrophenyl-β-<phrase role="small">D</phrase>-galactopyranoside.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0054"/><link linkend="ch0064s000000a0050">f</link></emphasis></superscript>Only the type strain was tested.</para>
      <table id="ch0064s000000t0004"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0064s000000a0055"/><link linkend="ch0064s000000a0104">TABLE 4</link></phrase></emphasis> Oxidase-positive, indole-positive GNF<superscript><emphasis><anchor id="ch0064s000000a0056"/><link linkend="ch0064s000000a0060">a</link></emphasis></superscript>
</title>
        
        <tgroup cols="14">
          <tbody>
            <row>
              <entry><phrase role="center">Characteristic</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Balneatrix alpica</emphasis> (1)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Bergeyella zoohelcum</emphasis> (10)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Chryseobacterium anthropi</emphasis><superscript><emphasis><anchor id="ch0064s000000a0057"/><link linkend="ch0064s000000a0061">b</link></emphasis></superscript> (11)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Chryseobacterium gleum</emphasis> (11)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Chryseobacterium hominis</emphasis><superscript><emphasis><link linkend="ch0064s000000a0061">b</link></emphasis></superscript> (14)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Chryseobacterium indologenes</emphasis> (15)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Chryseobacterium treverense</emphasis><superscript><emphasis><link linkend="ch0064s000000a0061">b</link></emphasis></superscript> (5)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Elizabethkingia meningoseptica</emphasis> (17)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Elizabethkingia anophelis</emphasis><superscript><emphasis>f</emphasis></superscript> (1)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Empedobacter brevis</emphasis> (7)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Empedobacter falsenii</emphasis> (53)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Sphingobacterium mizutaii</emphasis> (5)</phrase>
              </entry>
              <entry><phrase role="left"><emphasis>Weeksella virosa</emphasis> (10)</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Motility</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Beta-hemolysis (after 3 days on SBA)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Production of flexirubin pigments</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">74</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Production of other pigments</phrase>
              </entry>
              <entry><phrase role="center">PY</phrase>
              </entry>
              <entry><phrase role="center">—</phrase>
              </entry>
              <entry><phrase role="center">—/PS</phrase>
              </entry>
              <entry><phrase role="center">—</phrase>
              </entry>
              <entry><phrase role="center">—/PY</phrase>
              </entry>
              <entry><phrase role="center">—</phrase>
              </entry>
              <entry><phrase role="center">PY</phrase>
              </entry>
              <entry><phrase role="center">—/PY/PS</phrase>
              </entry>
              <entry><phrase role="center">PY</phrase>
              </entry>
              <entry><phrase role="center">PY</phrase>
              </entry>
              <entry><phrase role="center">—/PY</phrase>
              </entry>
              <entry><phrase role="center">PY</phrase>
              </entry>
              <entry><phrase role="center">—</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Growth on MacConkey agar</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">67</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">83</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Growth at 41°C</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">47</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Acidification of:</phrase>
              </entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><phrase role="left">Glucose</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Mannitol</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Xylose</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">27</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left"><phrase role="small">L</phrase>-Arabinose</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">80</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Maltose</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Sucrose</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">28</phrase>
              </entry>
              <entry><phrase role="center">20</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Ethylene glycol</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">47</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Esculin hydrolysis</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">20</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">53</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Gelatinase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">53/(47)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Urease</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">73</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0<superscript><emphasis><anchor id="ch0064s000000a0058"/><link linkend="ch0064s000000a0062">d</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Nitrate reductase</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">73</phrase>
              </entry>
              <entry><phrase role="center">65</phrase>
              </entry>
              <entry><phrase role="center">26</phrase>
              </entry>
              <entry><phrase role="center">60</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Nitrite reductase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">54</phrase>
              </entry>
              <entry><phrase role="center">65</phrase>
              </entry>
              <entry><phrase role="center">13</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">88</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">34</phrase>
              </entry>
              <entry><phrase role="center">80</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">β-Galactosidase (ONPG<superscript><emphasis><anchor id="ch0064s000000a0059"/><link linkend="ch0064s000000a0063">e</link></emphasis></superscript>)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">19</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Benzyl-arginine aminopeptidase (trypsin)</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">80</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Pyrrolidonyl aminopeptidase</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">91</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">80</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Susceptibility to:</phrase>
              </entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><phrase role="left">Colistin/polymyxin</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">14</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="left">Desferrioxamine</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">73</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">15</phrase>
              </entry>
              <entry><phrase role="center">0</phrase>
              </entry>
              <entry><phrase role="center">100</phrase>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0060"/><link linkend="ch0064s000000a0056">a</link></emphasis></superscript>Numbers in parentheses after organism names are numbers of strains tested. Values are percentages; those in parentheses represent delayed positivity. ND, no data; —, none; PS, pale salmon-pink; PY, pale yellow.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0061"/><link linkend="ch0064s000000a0057">b</link></emphasis></superscript>Alkalinization of acetate is positive for <emphasis>C. anthropi</emphasis> and <emphasis>C. hominis</emphasis> and negative for <emphasis>C. treverense.</emphasis></para>
      <para role="table-footnote"><superscript><emphasis>c</emphasis></superscript>Data from reference <link linkend="ch0064s000000li0333">333</link>.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0062"/><link linkend="ch0064s000000a0058">d</link></emphasis></superscript><emphasis>E. miricola</emphasis> is urease positive (data from reference <link linkend="ch0064s000000li0258">258</link>).</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0063"/><link linkend="ch0064s000000a0059">e</link></emphasis></superscript>ONPG, <emphasis>o</emphasis>-nitrophenyl-β-<phrase role="small">D</phrase>-galactopyranoside.</para>
      <para id="ch0064s000000p0024">Other sequence-based methods, based on DNA array hybridization, have been used for some species of these groups (<link linkend="ch0064s000000li0051">51</link>). DNA sequence-based fingerprinting methods like amplified ribosomal DNA (rRNA gene) restriction analysis (ARDRA) (<link linkend="ch0064s000000li0052">52</link>, <link linkend="ch0064s000000li0053">53</link>) and tDNA PCR (<link linkend="ch0064s000000li0054">54</link>, <link linkend="ch0064s000000li0055">55</link>) have been applied for the identification of species of several groups as well. These fingerprinting approaches are also generally applicable, but they require reference fingerprint libraries and are often poorly exchangeable between different electrophoresis platforms and laboratories.</para>
      <para id="ch0064s000000p0025">Next-generation sequencing (NGS) allows the sequencing of the whole genome of numerous bacteria in a single run. Because the whole genome of isolates is sequenced, a single protocol can be used for many applications such as identification, typing (whole-genome MLST), and detection of resistance and virulence markers. The NGS approach was found to be superior to both MLST and PFGE for the strain typing of<emphasis>A. baumannii</emphasis> and contributed to the understanding of the transmission dynamics of multidrug-resistant <emphasis>A. baumannii</emphasis> outbreaks (<link linkend="ch0064s000000li0056">56</link>).</para>
      <sect2 id="ch0064s0006s0001">
        <title>IDENTIFICATION OF THE FIVE GENOTYPIC GROUPS</title>
        <anchor id="ch0064s000006a0002"/>
        <anchor id="ch0064s000000a0064"/>
      </sect2>
    </sect1>
    <sect1 id="ch0064s0007">
      <title>Oxidase-Negative GNF</title>
      <anchor id="ch0064s000007a0001"/>
      <anchor id="ch0064s000000a0065"/>
      <sect2 id="ch0064s0007s0001">
        <title>Acinetobacter</title>
        <anchor id="ch0064s000007a0002"/>
        <anchor id="ch0064s000000a0066"/>
        <para id="ch0064s000000p0026">Members of the genus<emphasis>Acinetobacter</emphasis> are strictly aerobic, oxidase-negative, catalase-positive, coccobacillary bacteria. They are Gram negative but may be difficult to decolorize. Most strains do not reduce nitrate to nitrite in a laboratory test, owing to the lack of a dissimilative nitrate reductase. Tween 80 esterase activity is frequently present, while hemolysis and gelatinase production and oxidation of <phrase role="small">D</phrase>-glucose vary. Individual cell sizes are 0.9 to 1.6 μm in diameter and 1.5 to 2.5 μm in length. In the stationary phase, the cells are usually coccoid and occur in pairs. Most strains grow at between 20 and 35°C. Medically relevant species commonly grow well at 37°C, although some of them (<emphasis>Acinetobacter guillouiae</emphasis> and <emphasis>A. johnsonii</emphasis>) show reduced or no <emphasis>in vitro</emphasis> growth at this temperature.</para>
        <anchor id="ch0064s000000a0067"/>
        <beginpage pagenum="918"/>
        <para id="ch0064s000000p0027">The name<emphasis>Acinetobacter</emphasis> (from the Greek <emphasis>akineto</emphasis>, “nonmotile”) reflects the fact that these bacteria do not have flagella and, consequently, lack swimming motility. However, twitching motility, a form of surface translocation, on soft agar can occur and some strains can spread rapidly over certain surfaces. Acinetobacters can form a pellicle on the surface of fluid media. They grow well on complex media, including blood agar, nutrient agar, and mostly on MacConkey agar. After 24 h of incubation at 30°C, colonies are 1 to 2 mm in diameter (except for <emphasis>A. parvus</emphasis>, with markedly smaller colonies), colorless to beige, domed, and smooth to mucoid (<anchor id="ch0064s000000a0068"/><link linkend="ch0064s000000a0071">Fig. 2</link>). Many strains can use a wide variety of organic compounds as single sources of carbon and energy. Selective enrichment can be obtained in mineral media with acetate as the carbon source and ammonium salt as the nitrogen source with shaking incubation at 30°C. General features of <emphasis>Acinetobacter</emphasis> have been reviewed in detail (<link linkend="ch0064s000000li0057">57</link>, <link linkend="ch0064s000000li0058">58</link>).</para>
        <para id="ch0064s000000p0028">Members of the genus<emphasis>Acinetobacter</emphasis> are widespread in nature and have been found in soil, water, sewage, and food, as well as in human and animal specimens. Some of the <emphasis>Acinetobacter</emphasis> species have been predominantly cultured from humans (e.g., <emphasis>A. baumannii, A. colistiniresistens, A. nosocomialis</emphasis>, and <emphasis>A. ursingii</emphasis>), while others inhabit diverse ecosystems (e.g., <emphasis>A. calcoaceticus, A. dispersus, A. guillouiae</emphasis>, and <emphasis>A. johnsonii</emphasis>) or are confined to specific niches such as floral nectar (<link linkend="ch0064s000000li0059">59</link>).</para>
        <para id="ch0064s000000p0029">The ecology of most clinically relevant<emphasis>Acinetobacter</emphasis> species is poorly understood. <emphasis>A. baumannii, A. nosocomialis</emphasis>, and <emphasis>A. ursingii</emphasis> have been mainly recovered from clinical specimens in hospitals. Human skin carrier rates of <emphasis>A. baumannii</emphasis> outside hospitals are low (<link linkend="ch0064s000000li0011">11</link>); higher rates have been found in tropical areas (<link linkend="ch0064s000000li0060">60</link>). <emphasis>A. baumannii</emphasis>, including multidrug-resistant strains, has been isolated from sick animals (<link linkend="ch0064s000000li0061">61</link>) and from hospitalized horses (<link linkend="ch0064s000000li0062">62</link>), but a non-human reservoir has not been found. <emphasis>A. baumannii</emphasis> is, due to its role as a prominent health care-related pathogen, the species for which the epidemiology has been studied most intensively. Epidemic strains of this species can survive in the hospital environment, as they have been found on equipment and on environmental surfaces and materials (<link linkend="ch0064s000000li0063">63</link>), usually in the vicinity of colonized patients. Multiple sites of the skin and mucosae of patients can be colonized, and colonization may last days to weeks (<link linkend="ch0064s000000li0064">64</link>).</para>
      </sect2>
      <sect2 id="ch0064s0007s0002">
        <title>Species Diversity</title>
        <anchor id="ch0064s000007a0003"/>
        <anchor id="ch0064s000000a0069"/>
        <para id="ch0064s000000p0030">In April 2022, the genus<emphasis>Acinetobacter</emphasis> comprised 74 species with correct, validly published names and several provisional taxa (<ulink url="http://www.bacterio.net/acinetobacter.html">http://www.bacterio.net/acinetobacter.html</ulink>; apps.szu.cz/anemec/Classification.pdf). A comprehensive review of the genus systematics has now been published (<link linkend="ch0064s000000li0057">57</link>). Previous studies have shown that nearly all <emphasis>Acinetobacter</emphasis> isolates from colonized or infected patients belong to one of the validly named or provisional species (<link linkend="ch0064s000000li0013">13</link>, <link linkend="ch0064s000000li0014">14</link>, <link linkend="ch0064s000000li0065">65</link>). This indicates that the species diversity of acinetobacters found in the human body environment is well covered by the current classification. Twenty-eight validly named species found in human clinical specimens are listed in <link linkend="ch0064s000000a0010">Table 1</link>.</para>
        <para id="ch0064s000000p0031">Recently published core genome-based phylogenies revealed a deep and complex evolution of the genus, with many distant phylogroups and singletons (<link linkend="ch0064s000000li0057">57</link>, <link linkend="ch0064s000000li0066">66</link>). These studies showed that medically relevant <emphasis>Acinetobacter</emphasis> species are not distributed randomly across different lineages but are members of only a few clades. The medically most important clade corresponds to the <emphasis>A. calcoaceticus-A. baumannii</emphasis> complex (<link linkend="ch0064s000000li0067">67</link>), which includes six species with correct binomial names (<link linkend="ch0064s000000a0010">Table 1</link>). <emphasis>A. baumannii</emphasis> (<link linkend="ch0064s000000li0069">69</link>) is clinically and epidemiologically the most significant species of the genus and includes the vast majority of epidemic and multidrug-resistant <emphasis>Acinetobacter</emphasis> strains (<link linkend="ch0064s000000li0007">7</link>, <link linkend="ch0064s000000li0068">68</link>, <link linkend="ch0064s000000li0069">69</link>). A comprehensive account of the processes playing a role in <emphasis>A. baumannii</emphasis> pathogenesis has recently been published (<link linkend="ch0064s000000li0070">70</link>). <emphasis>A. pittii</emphasis> (<link linkend="ch0064s000000li0067">67</link>) is, along with <emphasis>A. baumannii</emphasis>, the species most frequently isolated from clinical specimens in hospitals in non-epidemic situations (<link linkend="ch0064s000000li0071">71</link>, <link linkend="ch0064s000000li0072">72</link>), predominates in specimens from ambulatory patients (A. Nemec, unpublished), and occurs in soil and water. Less frequently isolated from clinical specimens are <emphasis>A. nosocomialis</emphasis> (<link linkend="ch0064s000000li0067">67</link>), <emphasis>A. seifertii</emphasis> (<link linkend="ch0064s000000li0073">73</link>), and <emphasis>A. lactucae</emphasis> (<link linkend="ch0064s000000li0074">74</link>), which is synonymous with <emphasis>A. dijkshoorniae</emphasis> (<link linkend="ch0064s000000li0075">75</link>, <link linkend="ch0064s000000li0076">76</link>), whereas <emphasis>A. calcoaceticus</emphasis> (<link linkend="ch0064s000000li0077">77</link>) is primarily a soil organism and is only rarely found in humans (<link linkend="ch0064s000000li0067">67</link>). The latest addition to the <emphasis>A. calcoaceticus-A. baumannii</emphasis> complex is the valid publication of <emphasis>A. geminorum</emphasis>, proposed for a single clinical strain (<link linkend="ch0064s000000li0078">78</link>). However, the <emphasis>A. geminorum</emphasis> strain is closely related to (and possibly conspecific with) <emphasis>A. pittii</emphasis>, having whole-genome average nucleotide identity against reference <emphasis>A. pittii</emphasis> strains as high as 95% (<link linkend="ch0064s000000li0057">57</link>).</para>
        <para id="ch0064s000000p0032">The largest well-separated clade of the genus, termed “hemolytic clade” (<link linkend="ch0064s000000li0079">79</link>), encompasses 14 species with correct binomial names, which nearly all show a strong ability to lyse sheep erythrocytes in ordinary agar media and can display gelatinase activity (<link linkend="ch0064s000000li0057">57</link>). In contrast, species outside this clade are neither hemolytic nor proteolytic except for a few species with weakly hemolytic strains. Most of the hemolytic clade species have been isolated from humans, and these are marked in <link linkend="ch0064s000000a0010">Table 1</link>. The clinically most relevant species are <emphasis>A. haemolyticus</emphasis> and <emphasis>A. junii</emphasis> (<link linkend="ch0064s000000li0077">77</link>). <emphasis>A. colistiniresistens</emphasis> (<link linkend="ch0064s000000li0080">80</link>) is unique in its intrinsic high-level resistance to polymyxin antibiotics, while <emphasis>A. parvus</emphasis> (<link linkend="ch0064s000000li0081">81</link>) is the metabolically least active member of the clade, which forms tiny colonies on agar media (<link linkend="ch0064s000000a0071">Fig. 2</link>) and has the smallest genome of the hemolytic clade species (<link linkend="ch0064s000000li0057">57</link>).</para>
        <anchor id="ch0064s000000a0070"/>
        <beginpage pagenum="919"/>
        <figure id="ch0064s000000f0002"><title><phrase role="figureLabel"><anchor id="ch0064s000000a0071"/><link linkend="ch0064s000000a0068">FIGURE 2</link></phrase> Differences in the size of the colonies formed by different <emphasis>Acinetobacter</emphasis> species isolated from human clinical specimens. The strains were grown on TSA (Oxoid) at 30°C for 24 h. (a) <emphasis>A. parvus</emphasis> NIPH 384<superscript>T</superscript>; (b) <emphasis>A. ursingii</emphasis> NIPH 137<superscript>T</superscript>; (c) <emphasis>A. schindleri</emphasis> NIPH 1034<superscript>T</superscript>; (d) <emphasis>A. baumannii</emphasis> ATCC 19606<superscript>T</superscript>.</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0064f07.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0064s000000p0033"><emphasis>A. lwoffii, A. pseudolwoffii</emphasis> (<link linkend="ch0064s000000li0082">82</link>), <emphasis>A. schindleri</emphasis> (<link linkend="ch0064s000000li0083">83</link>), and <emphasis>A. variabilis</emphasis> (<link linkend="ch0064s000000li0084">84</link>) form another clade, being all catabolically versatile and occurring in humans, animals, and soil and water ecosystems. <emphasis>A. lwoffii</emphasis> is commonly isolated from specimens of ambulatory patients with questionable or no clinical relevance (A. Nemec, unpublished), whereas <emphasis>A. schindleri</emphasis> was associated with health care-related infections (<link linkend="ch0064s000000li0012">12</link>). The remaining species listed in <link linkend="ch0064s000000a0010">Table 1</link> are phylogenetically distant from the aforementioned clades and from each other except for <emphasis>A. bereziniae</emphasis> and <emphasis>A. guillouiae</emphasis> (<link linkend="ch0064s000000li0085">85</link>), which are ecologically different but phylogenetically related and phenotypically similar; whereas <emphasis>A. bereziniae</emphasis> has been found almost exclusively in humans, <emphasis>A. guillouiae</emphasis> is widely distributed in soil and water ecosystems and only rarely isolated from human specimens (<link linkend="ch0064s000000li0086">86</link>). The phylogenetically distinct <emphasis>A. ursingii</emphasis> is a clinically important species, being typically involved in health care-related bloodstream infections and associated with the use of intravascular catheters (<link linkend="ch0064s000000li0083">83</link>, <link linkend="ch0064s000000li0087">87</link>).</para>
      </sect2>
      <sect2 id="ch0064s0007s0003">
        <title>Species Identification</title>
        <anchor id="ch0064s000007a0004"/>
        <anchor id="ch0064s000000a0072"/>
        <para id="ch0064s000000p0034">Identification of<emphasis>Acinetobacter</emphasis> species by commercial identification systems based on biochemical and physiological properties (e.g., VITEK 2, Phoenix, and API 20NE) is problematic. This stems from the small number of taxonomically relevant characters included in these systems and/or from the insufficient quality of reference data in the identification matrices. <emphasis>A. baumannii</emphasis> and the other species of the <emphasis>A. calcoaceticus-A. baumannii</emphasis> complex are generally not differentiated by these systems, while non-glucose-oxidizing species (e.g., <emphasis>A. ursingii</emphasis> and <emphasis>A. schindleri</emphasis>) can be misidentified (<link linkend="ch0064s000000li0012">12</link>). The comparison of VITEK 2 and Phoenix for the ability to identify 76 isolates of 16 clinical <emphasis>Acinetobacter</emphasis> species showed that only 19 and 5 isolates were correctly identified by VITEK 2 and Phoenix, respectively (M. Vaneechoutte, unpublished data). In general, routine diagnostic systems such as VITEK 2, Phoenix, or API 20NE are reliable for genus-level allocation but not for identification at the species level.</para>
        <para id="ch0064s000000p0035">More reliable phenotypic identification of<emphasis>Acinetobacter</emphasis> species can be achieved using physiological and metabolic (mainly carbon source assimilation) tests based on the modified system of Bouvet and Grimont (<link linkend="ch0064s000000li0088">88</link>). <link linkend="ch0064s000000a0010">Table 1</link> presents a subset of the system aimed to differentiate species of medical relevance. The data were adopted from the recently published comprehensive overviews of the phenotypes of all known <emphasis>Acinetobacter</emphasis> species (<link linkend="ch0064s000000li0057">57</link>), which is available in a regularly updated form at apps.szu.cz/anemec/Phenotype.pdf. Assimilation tests were carried out using a basal liquid medium supplemented with 0.1% (wt/vol) carbon source (<link linkend="ch0064s000000li0088">88</link>). Growth was evaluated after 6 days of culture at 30°C by means of visual comparison between inoculated tubes containing carbon sources and control tubes containing only inoculated basal medium. However, the species of the <emphasis>A. calcoaceticus-A. baumannii</emphasis> complex are not clearly distinguished from each other by this approach. In addition, the need for in-house preparation of most of the tests precludes the use of this scheme in routine diagnostics.</para>
        <para id="ch0064s000000p0036">MALDI-TOF MS is currently the most rapid and reliable methodological platform for routine identification of<emphasis>Acinetobacter</emphasis> species (<link linkend="ch0064s000000li0089">89</link>). Although the efficacy of diagnostic systems based on MALDI-TOF MS can be hampered by the taxonomic incompleteness of identification databases, this can be addressed by adding the mass spectra of missing species. Notably, the 2020 update of the Bruker Daltonics reference library has been extended to include 59 <emphasis>Acinetobacter</emphasis> species with correct binomial names, including all the species listed in <link linkend="ch0064s000000a0010">Table 1</link>. Identification accuracy is high especially for strains belonging to taxonomically and phylogenetically well-separated species, e.g., <emphasis>A. johnsonii, A. radioresistens</emphasis>, and <emphasis>A. ursingii</emphasis> (<link linkend="ch0064s000000li0090">90</link>). Differentiation between closely related species such as those of the <emphasis>A. calcoaceticus-A. baumannii</emphasis> complex or hemolytic clade can be ambiguous, but this is partially solvable by using an alternative MALDI matrix solution (<link linkend="ch0064s000000li0091">91</link>).</para>
        <para id="ch0064s000000p0037">More accurate identification of<emphasis>Acinetobacter</emphasis> species can be achieved by genotypic methods, especially with those based on sequencing of particular genes. Common targets for this purpose are the <emphasis>rpoB</emphasis> gene (<link linkend="ch0064s000000li0088">88</link>), so far the best-studied single-gene taxonomic marker for <emphasis>Acinetobacter</emphasis>, or the 16S rRNA gene, although the latter approach suffers from low resolution capacity to differentiate between phylogenetically related species (<link linkend="ch0064s000000li0057">57</link>). Rapid identification of <emphasis>A. baumannii</emphasis> is possible using PCR detection of the <emphasis>bla</emphasis><subscript>OXA-51</subscript>-like gene, which is intrinsic to this species (<link linkend="ch0064s000000li0092">92</link>), even though in extremely rare strains this approach can be complicated by insertions of mobile elements in the gene or the presence of bla<subscript>OXA-51</subscript>-like genes on plasmids in non-<emphasis>A. baumannii</emphasis> strains.</para>
        <para id="ch0064s000000p0038">The most precise identification is achievable via genome-wide comparative analysis. This is facilitated by the public availability of genome sequences for the type strains of all validly named species (<link linkend="ch0064s000000li0057">57</link>) (apps.szu.cz/anemec/Genomes.pdf) and websites that enable the determination of genome-based taxonomic parameters such as average nucleotide identity (<ulink url="http://jspecies.ribohost.com/jspeciesws">http://jspecies.ribohost.com/jspeciesws</ulink>) or digital DNA–DNA hybridization (<ulink url="http://ggdc.dsmz.de">http://ggdc.dsmz.de</ulink>). It is of practical and economical value that draft genomes with approximately only 20% coverage render stable average nucleotide identity values when compared with complete genomes.</para>
      </sect2>
      <sect2 id="ch0064s0007s0004">
        <title>Genotyping and Epidemiology</title>
        <anchor id="ch0064s000007a0005"/>
        <anchor id="ch0064s000000a0073"/>
        <para id="ch0064s000000p0039">A number of molecular methods have been described for differentiation between isolates of the same species and for the study of the epidemiology of acinetobacters, in particular that of<emphasis>A. baumannii.</emphasis> Of these, macrorestriction analysis with pulsed-field gel electrophoresis (<link linkend="ch0064s000000li0093">93</link>) has historically been a useful method, although its resolution can be hampered by the concurrent occurrence of genotypically closely related but epidemiologically distinct strains. Improved resolution can be achieved by typing based on the variable number of tandem repeats (<link linkend="ch0064s000000li0094">94</link>) or CRISPR-based subtyping (<link linkend="ch0064s000000li0095">95</link>). Sequence analysis of the <emphasis>bla</emphasis><subscript>OXA-51</subscript>-like gene has been proposed as another useful typing method, based on the correlation between particular <emphasis>bla</emphasis><subscript>OXA-51</subscript>-like enzymes and epidemic clones of <emphasis>A. baumannii</emphasis> (<link linkend="ch0064s000000li0096">96</link>). With the growing availability of whole-genome sequencing, a number of studies focused on their use for analysis of hospital outbreaks. Genome-wide analysis has been shown to be superior to conventional typing techniques at the levels of species identification, population structure analysis, and intrahospital outbreak investigation (<link linkend="ch0064s000000li0097">97</link>, <link linkend="ch0064s000000li0098">98</link>).</para>
        <para id="ch0064s000000p0040">Multilocus sequence typing (MLST) remains the standard for global and long-term epidemiological and population studies. Two MLST schemes, proposed by Bartual et al. (<link linkend="ch0064s000000li0099">99</link>) and Diancourt et al. (<link linkend="ch0064s000000li0100">100</link>) (<ulink url="https://pubmlst.org/abaumannii">https://pubmlst.org/abaumannii</ulink>), are currently used for <emphasis>A. baumannii.</emphasis> Both schemes are based on the internal fragments of seven housekeeping genes, and they share three genes. The two schemes yield compatible results, although a higher resolution has been reported for the former (<link linkend="ch0064s000000li0101">101</link>). A MLST scheme based on the core genome (cgMLST) has been proposed for <emphasis>A. baumannii</emphasis> by Higgins et al. (<link linkend="ch0064s000000li0102">102</link>). The scheme is highly discriminatory and can identify separate outbreaks caused by <emphasis>A. baumannii</emphasis> strains belonging to the same conventional MLST type (<link linkend="ch0064s000000li0103">103</link>).</para>
        <anchor id="ch0064s000000a0074"/>
        <beginpage pagenum="920"/>
        <para id="ch0064s000000p0041">Resistance to multiple antimicrobials and the occurrence of hospital outbreaks have been associated with several international lineages of<emphasis>A. baumannii</emphasis>, particularly with the so-called European (also termed international or global) clones I and II (<link linkend="ch0064s000000li0100">100</link>, <link linkend="ch0064s000000li0104">104</link>, <link linkend="ch0064s000000li0105">105</link>). The earliest known strain of clone I was isolated in 1977 (<link linkend="ch0064s000000li0106">106</link>), and this lineage prevailed among outbreak and multidrug-resistant <emphasis>Acinetobacter</emphasis> strains in some European countries in the 1980s and 1990s (<link linkend="ch0064s000000li0107">107</link>). Currently, strains belonging to or related to clone II dominate in the global population of multidrug-resistant <emphasis>A. baumannii</emphasis>, although clone I and other lineages can be common or even prevail in some regions (<link linkend="ch0064s000000li0101">101</link>, <link linkend="ch0064s000000li0108">108</link>–<link linkend="ch0064s000000li0112">112</link>). Allocation of isolates to international lineages or the identification of novel clones can be achieved by both MLST schemes. Clones I and II correspond, respectively, to MLST-based clonal complexes CC1 and CC2 in the scheme of Diancourt et al. (<link linkend="ch0064s000000li0100">100</link>) and to CC109 and CC92 in that of Bartual et al. (<link linkend="ch0064s000000li0099">99</link>), according to Karah et al. (<link linkend="ch0064s000000li0101">101</link>).</para>
      </sect2>
      <sect2 id="ch0064s0007s0005">
        <title>Antimicrobial Susceptibilities</title>
        <anchor id="ch0064s000007a0006"/>
        <anchor id="ch0064s000000a0075"/>
        <para id="ch0064s000000p0042"><emphasis>A. baumannii</emphasis> has an extraordinary capacity to acquire or develop resistance to all antibiotics used in the treatment of <emphasis>Acinetobacter</emphasis> infections (<link linkend="ch0064s000000li0068">68</link>, <link linkend="ch0064s000000li0104">104</link>). With the growing proportion of <emphasis>A. baumannii</emphasis> strains resistant to carbapenems, a last therapeutic option is disappearing, although these strains often remain susceptible to colistin and/or tigecycline. Even though multidrug resistance is mainly confined to <emphasis>A. baumannii</emphasis>, strains of other clinically relevant species, such as <emphasis>A. pittii, A. nosocomialis</emphasis>, and <emphasis>A. ursingii</emphasis>, and <emphasis>A. bereziniae</emphasis> can also be resistant to multiple antibiotics, including carbapenems (<link linkend="ch0064s000000li0113">113</link>–<link linkend="ch0064s000000li0116">116</link>). Resistance mechanisms in <emphasis>A. baumannii</emphasis> comprise all general strategies, including enzymatic breakdown, modification of target sites, active efflux, and decreased influx of antibiotics. The known resistance mechanisms have been reviewed previously (<link linkend="ch0064s000000li0069">69</link>). Recent genomic studies have also shed light on the genetic organization of resistance determinants in multidrug-resistant <emphasis>A. baumannii.</emphasis> Large clusters of horizontally transferred genes, conferring resistance to multiple antibiotics and interspersed with mobile genetic elements (resistance islands), were found to be integrated at a specific genomic site in a number of strains (<link linkend="ch0064s000000li0107">107</link>). Despite the high intraclonal variability of the resistance islands, these structures seem to have evolved independently in the two main <emphasis>A. baumannii</emphasis> clones (<link linkend="ch0064s000000li0117">117</link>, <link linkend="ch0064s000000li0118">118</link>).</para>
        <para id="ch0064s000000p0043"><emphasis>In vitro</emphasis> determination of antimicrobial susceptibility can be achieved by disk diffusion, agar dilution, broth microdilution, or Etest. The panel of tested antibiotics should cover the spectrum of agents with potential activity against <emphasis>A. baumannii</emphasis>, including third- or fourth-generation cephalosporins, sulbactam, antipseudomonal penicillins combined with β-lactamase inhibitors, carbapenems, aminoglycosides, fluoroquinolones, polymyxins, and tetracyclines (<link linkend="ch0064s000000li0119">119</link>). Of note, susceptibility to colistin should not be tested by disk diffusion due to poor diffusion of this compound in agar. Etest and broth microdilution for determination of the MIC for this drug have been compared and showed a good concordance in the MIC range of 0.25 to 1 mg/liter (<link linkend="ch0064s000000li0120">120</link>).</para>
      </sect2>
      <sect2 id="ch0064s0007s0006">
        <title>Granulibacter bethesdensis</title>
        <anchor id="ch0064s000007a0007"/>
        <anchor id="ch0064s000000a0076"/>
        <para id="ch0064s000000p0044"><emphasis>G. bethesdensis</emphasis> (<emphasis>Acetobacteraceae, Alphaproteobacteria</emphasis>) (<link linkend="ch0064s000000li0121">121</link>) is a Gram-negative, strictly aerobic, coccobacillary to rod-shaped bacterium, the only species of a sublineage within the acetic acid bacteria in the family <emphasis>Acetobacteraceae.</emphasis> This fastidious organism grows poorly and slowly on sheep blood agar (SBA) at an optimum temperature of 35 to 37°C and an optimum pH of 5.0 to 6.5. It produces a yellow pigment, oxidizes lactate (and, weakly, acetate) to carbon dioxide and water, acidifies ethanol, and can use methanol as a sole carbon source, all characteristics that distinguish it from other acetic acid bacteria. The DNA base composition is 59.1 mol% G+C. It was isolated first from three patients with chronic granulomatous disease (<link linkend="ch0064s000000li0121">121</link>) and more recently from additional patients with the same disease, including cases leading to fatal meningitis (<link linkend="ch0064s000000li0122">122</link>) or fulminant sepsis (<link linkend="ch0064s000000li0123">123</link>). The serological reactivity (<link linkend="ch0064s000000li0124">124</link>) and the molecular mechanisms (<link linkend="ch0064s000000li0124">124</link>, <link linkend="ch0064s000000li0125">125</link>) have been studied in detail.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0064s0008">
      <title>Oxidase-Positive, Indole-Negative, Trypsin-Negative GNF</title>
      <anchor id="ch0064s000008a0001"/>
      <anchor id="ch0064s000000a0077"/>
      <sect2 id="ch0064s0008s0001">
        <title>Haematobacter</title>
        <anchor id="ch0064s000008a0002"/>
        <anchor id="ch0064s000000a0078"/>
        <para id="ch0064s000000p0045">Three<emphasis>Haematobacter</emphasis> species (<emphasis>Rhodobacteraceae, Alphaproteobacteria</emphasis>) have been described, i.e., <emphasis>H. massiliensis</emphasis> (formerly <emphasis>Rhodobacter massiliensis</emphasis>), <emphasis>H. missouriensis</emphasis>, and <emphasis>Haematobacter</emphasis> genomic species 1 (<anchor id="ch0064s000000a0079"/><link linkend="ch0064s000000a0036">Table 2</link>) (<link linkend="ch0064s000000li0126">126</link>). The genus description is based on data of 12 strains received at the Centers for Disease Control and Prevention (CDC), isolated from patients with septicemia. From 2007 on, only one aortic valve endocarditis caused by a <emphasis>Haematobacter</emphasis>-like organism and one mitral valve endocarditis caused by <emphasis>H. massiliensis</emphasis> have been reported (<link linkend="ch0064s000000li0127">127</link>, <link linkend="ch0064s000000li0128">128</link>).</para>
        <para id="ch0064s000000p0046">Cells grow after 2 to 5 days on blood and chocolate agar as nonhemolytic, convex, smooth to mucoid, glistening colonies. On Gram stain, organisms appear predominantly as long serpentine Gram-negative rods with filaments. The species cannot easily be differentiated phenotypically, and even the 16S rRNA gene sequences are closely related.<emphasis>Haematobacter</emphasis> species were described as asaccharolytic, but when low-peptone phenol red agar is used (see <ulink url="ch0048#ch0048s0001">chapter 32</ulink>), <emphasis>H. missouriensis</emphasis> is clearly saccharolytic, producing acid from glucose and xylose and sometimes from mannitol, whereas <emphasis>H. massiliensis</emphasis> strains do not acidify carbohydrates. Acid is produced from ethylene glycol by all species. All the species are strongly urease and phenylalanine deaminase positive. Arginine dihydrolase is also positive but sometimes delayed. Asaccharolytic <emphasis>Haematobacter</emphasis> strains resemble <emphasis>Psychrobacter phenylpyruvicus</emphasis> but can be differentiated by the lack of tributyrine esterase, the lack of growth improvement by Tween 80, and the presence of arginine dihydrolase. Differences from <emphasis>Psychrobacter faecalis, Psychrobacter pulmonis</emphasis>, and related species are the lack of tributyrine and Tween 80 esterase, the lack of nitrate reductase, and a positive arginine dihydrolase test.</para>
        <para id="ch0064s000000p0047"><emphasis>Haematobacter</emphasis> strains have low MICs for amoxicillin, fluoroquinolones, aminoglycosides, and carbapenems but variable MICs for cephalosporins, monobactams, and piperacillin.</para>
      </sect2>
      <sect2 id="ch0064s0008s0002">
        <title>Moraxella/Branhamella</title>
        <anchor id="ch0064s000008a0003"/>
        <anchor id="ch0064s000000a0080"/>
        <para id="ch0064s000000p0048">The genus<emphasis>Moraxella</emphasis> comprises ~20 species that have been validly named. The genus <emphasis>Branhamella</emphasis> comprises a single species, <emphasis>B. catarrhalis</emphasis>, of which <emphasis>Moraxella catarrhalis</emphasis> is a homotypic synonym. <emphasis>B. catarrhalis, M. osloensis, M. nonliquefaciens</emphasis>, and <emphasis>M. lincolnii</emphasis> are part of the normal microbiota of the human upper respiratory tract. Animal species include <emphasis>M. bovis</emphasis>, isolated from healthy cattle and other animals, including horses; <emphasis>M. boevrei</emphasis> and <emphasis>M. caprae</emphasis> (goats); <emphasis>M. canis</emphasis> (dogs, cats, and camels); <emphasis>M. caviae</emphasis> (guinea pigs); <emphasis>M. cuniculi</emphasis> (rabbits); <emphasis>M. ovis</emphasis> and <emphasis>M. oblonga</emphasis> (sheep); and <emphasis>M. plurianimalum</emphasis> and <emphasis>M. porcinum</emphasis> (pigs and sheep) (<link linkend="ch0064s000000li0129">129</link>).</para>
        <anchor id="ch0064s000000a0081"/>
        <beginpage pagenum="921"/>
        <para id="ch0064s000000p0049"><emphasis>B. catarrhalis</emphasis> and <emphasis>M. canis</emphasis> grow well on SBA and even on tryptic soy agar (TSA), and their colonies may reach &gt;1 mm in diameter after 24 h of incubation. Colonies of <emphasis>B. catarrhalis</emphasis> grow well on both blood and chocolate agars, and some strains also grow well on modified Thayer-Martin and other selective media. Colonies are generally gray to white, opaque, and smooth and measure about 1 to 3 mm after 24 h of incubation. Characteristically, the colonies are very consistent and may be nudged intact across the plate with a bacteriological loop like a “hockey puck” and can be removed from the agar entirely. Most <emphasis>M. canis</emphasis> colonies resemble those of the <emphasis>Enterobacteriaceae</emphasis> (large, smooth colonies) and may produce a brown pigment when grown on starch-containing Mueller-Hinton agar (<link linkend="ch0064s000000li0041">41</link>). Some strains may also produce very slimy colonies resembling colonies of <emphasis>Klebsiella pneumoniae</emphasis> (<link linkend="ch0064s000000li0041">41</link>). <emphasis>M. nonliquefaciens</emphasis> forms smooth, translucent to semiopaque colonies 0.1 to 0.5 mm in diameter after 24 h and 1 mm in diameter after 48 h of growth on SBA plates. Occasionally, these colonies spread and pit the agar. Colony morphologies of <emphasis>M. lincolnii</emphasis> (<link linkend="ch0064s000000li0130">130</link>), <emphasis>M. osloensis</emphasis>, and <emphasis>Psychrobacter phenylpyruvicus</emphasis> (formerly <emphasis>Moraxella phenylpyruvica</emphasis>) are similar, but pitting is rare. On the other hand, pitting is common with <emphasis>M. lacunata</emphasis>, whose colonies are smaller and form dark haloes on chocolate agar. Rod-shaped <emphasis>Moraxella</emphasis> species, especially <emphasis>M. atlantae</emphasis> and <emphasis>M. lincolnii</emphasis>, are more fastidious and display smaller colonies on SBA, &lt;1 mm in diameter after 24 h. Colonies of <emphasis>M. atlantae</emphasis> are small (usually 0.5 mm in diameter) and show pitting and spreading. The growth of <emphasis>M. atlantae</emphasis> is stimulated by bile salts, which explains its growth on MacConkey agar. <emphasis>M. nonliquefaciens</emphasis> and <emphasis>M. osloensis</emphasis> produce colonies that are somewhat larger than those of <emphasis>M. atlantae</emphasis> and that are rarely pitting. Colonies of <emphasis>M. nonliquefaciens</emphasis> may be mucoid. A selective medium, acetazolamide agar, inhibiting growth of neisseriae when incubated in ambient atmosphere, has been described for <emphasis>B. catarrhalis</emphasis> (<link linkend="ch0064s000000li0043">43</link>) and can be used for other <emphasis>Moraxella</emphasis> species as well.</para>
        <para id="ch0064s000000p0050"><emphasis>Moraxella</emphasis> species are coccoid or coccobacillary organisms (plump rods), occurring predominantly in pairs and sometimes in short chains, that tend to resist decolorization in the Gram stain (<link linkend="ch0064s000000li0131">131</link>). <emphasis>M. canis</emphasis> and <emphasis>B. catarrhalis</emphasis> are <emphasis>Neisseria</emphasis>-like diplococci, and they can easily be distinguished from other moraxellae or other coccoid species by performing a Gram stain on cells cultured in the vicinity of a penicillin disk: cells of <emphasis>M. canis</emphasis> and <emphasis>B. catarrhalis</emphasis> remain spherical diplococci of 0.5 to 1.5 μm in diameter, although of irregular size, whereas coccobacilli show obviously rod-shaped and filamentous cells.</para>
        <para id="ch0064s000000p0051"><emphasis>Moraxella</emphasis> species and <emphasis>B. catarrhalis</emphasis> are asaccharolytic and strongly oxidase positive. <emphasis>B. catarrhalis</emphasis> and <emphasis>M. canis</emphasis> are also strongly catalase positive, and most strains reduce nitrate and nitrite. <emphasis>B. catarrhalis</emphasis> and <emphasis>M. canis</emphasis> may be easily distinguished from the commensal <emphasis>Neisseria</emphasis> species, which are also frequently isolated from respiratory clinical specimens, by the ability of the former to produce DNase and butyrate esterase (tributyrine test). Rapid butyrate esterase tests have been described (<link linkend="ch0064s000000li0132">132</link>), and the indoxyl-butyrate hydrolysis spot test is commercially available (Remel, Inc., Lenexa, KS). Butyrate esterase is, however, also present in some other <emphasis>Moraxella</emphasis> species. <emphasis>M. canis</emphasis> acidifies ethylene glycol and alkalinizes acetate, in contrast to <emphasis>B. catarrhalis.</emphasis> There are few biochemical differences between <emphasis>B. catarrhalis</emphasis> and <emphasis>M. nonliquefaciens</emphasis>, which are differentiated from each other mainly on the basis of morphological characteristics and by nitrite reductase and DNase activity of <emphasis>B. catarrhalis</emphasis>.</para>
        <para id="ch0064s000000p0052"><emphasis>M. atlantae</emphasis> is the only <emphasis>Moraxella</emphasis> species to be positive for pyrrolidonyl aminopeptidase (<link linkend="ch0064s000000li0133">133</link>). <emphasis>M. lacunata</emphasis> is the only proteolytic species with gelatinase activity. Using the plate method (see <ulink url="ch0048#ch0048s0001">chapter 32</ulink>), gelatin hydrolysis occurs usually within 2 to 4 days. A more rapid and almost equally specific test to differentiate <emphasis>M. lacunata</emphasis> from other moraxellae is the detection of Tween 80 esterase activity, which is often positive within 2 days, whereas all other species, except for very rare <emphasis>M. osloensis</emphasis> strains, remain negative. This species should also be distinguished from <emphasis>Psychrobacter</emphasis> species, which are also Tween 80 esterase positive, but <emphasis>P. phenylpyruvicus</emphasis> and <emphasis>P. sanguinis</emphasis> are urease positive and other <emphasis>Psychrobacter</emphasis> species exhibit luxuriant growth on plain agar, like TSA, even at 25°C.</para>
        <para id="ch0064s000000p0053"><emphasis>M. lincolnii</emphasis> is biochemically quite inactive.</para>
        <para id="ch0064s000000p0054"><emphasis>M. osloensis</emphasis> alkalinizes acetate, acidifies ethylene glycol, and is resistant to desferrioxamine (250-μg disk). <emphasis>M. nonliquefaciens</emphasis> has opposite properties to those of <emphasis>M. osloensis</emphasis> and is, in addition, always nitrate reductase positive.</para>
        <para id="ch0064s000000p0055">Most<emphasis>Moraxella</emphasis> species are susceptible to penicillin and its derivatives, cephalosporins, tetracyclines, quinolones, and aminoglycosides (<link linkend="ch0064s000000li0134">134</link>, <link linkend="ch0064s000000li0135">135</link>). Production of β-lactamase has been only rarely reported for <emphasis>Moraxella</emphasis> species; for <emphasis>B. catarrhalis</emphasis>, &gt;95% of the isolates produce an inducible, cell-associated β-lactamase (<link linkend="ch0064s000000li0043">43</link>, <link linkend="ch0064s000000li0136">136</link>). Isolates of <emphasis>B. catarrhalis</emphasis> are generally susceptible to amoxicillin-clavulanate, expanded-spectrum and broad-spectrum cephalosporins (i.e., cefuroxime, cefotaxime, ceftriaxone, cefpodoxime, ceftibuten, and the oral agents cefixime and cefaclor), macrolides (e.g., azithromycin, clarithromycin, and erythromycin), tetracyclines, rifampin, and fluoroquinolones. However, macrolide-resistant <emphasis>B. catarrhalis</emphasis> isolates have been reported (<link linkend="ch0064s000000li0137">137</link>, <link linkend="ch0064s000000li0138">138</link>).</para>
      </sect2>
      <sect2 id="ch0064s0008s0003">
        <title>Oligella</title>
        <anchor id="ch0064s000008a0004"/>
        <anchor id="ch0064s000000a0082"/>
        <para id="ch0064s000000p0056">The genus<emphasis>Oligella</emphasis> comprises two species, <emphasis>O. ureolytica</emphasis> (formerly CDC group IVe) and <emphasis>O. urethralis</emphasis> (formerly <emphasis>Moraxella urethralis</emphasis> and CDC group M-4) (<link linkend="ch0064s000000li0139">139</link>). Both species have been mainly isolated from the human genitourinary tract as a commensal organism. However, case reports in patients with underlying immunosuppressive conditions have been described. Most of these infections take place in the urinary tract (<link linkend="ch0064s000000li0140">140</link>). Extra-genitourinary infections with isolates from blood, lymph nodes, and protected bronchial samples have been reported (<link linkend="ch0064s000000li0141">141</link>–<link linkend="ch0064s000000li0146">146</link>).</para>
        <para id="ch0064s000000p0057">Colonies of<emphasis>O. urethralis</emphasis> are smaller than those of <emphasis>M. osloensis</emphasis> and are opaque to whitish. Colonies of <emphasis>O. ureolytica</emphasis> are slow growing on blood agar, appearing as pinpoint colonies after 24 h but large colonies after 3 days of incubation. Colonies are white and opaque, with entire borders, and are nonhemolytic.</para>
        <para id="ch0064s000000p0058"><emphasis>O. ureolytica</emphasis> and <emphasis>O. urethralis</emphasis> are small, asaccharolytic coccobacilli that rapidly acidify ethylene glycol and are susceptible to desferrioxamine. Most strains of <emphasis>O. ureolytica</emphasis> are motile by peritrichous flagella, and all are strongly urease positive (with the urease reaction often turning positive within minutes after inoculation) and reduce nitrate. <emphasis>O. urethralis</emphasis> strains are nonmotile and urease and nitrate reductase negative, but they reduce nitrite and are weakly phenylalanine deaminase positive. <emphasis>Bordetella bronchiseptica</emphasis> and <emphasis>Cupriavidus pauculus</emphasis> are also rapidly urease positive but are desferrioxamine resistant.</para>
        <anchor id="ch0064s000000a0083"/>
        <beginpage pagenum="922"/>
        <para id="ch0064s000000p0059"><emphasis>O. urethralis</emphasis> and <emphasis>M. osloensis</emphasis> have biochemical similarities, e.g., accumulation of poly-β-hydroxybutyric acid and failure to hydrolyze urea, but can be differentiated on the basis of nitrite reduction and alkalinization of formate, itaconate, proline, and threonine, all positive for <emphasis>O. urethralis</emphasis> (<link linkend="ch0064s000000li0147">147</link>). Moreover, <emphasis>O. urethralis</emphasis> is susceptible to desferrioxamine, and tributyrate esterase is negative, in contrast to <emphasis>M. osloensis</emphasis>.</para>
        <para id="ch0064s000000p0060">MALDI-TOF MS offers reliable genus identification and species differentiation (<link linkend="ch0064s000000li0148">148</link>–<link linkend="ch0064s000000li0150">150</link>).</para>
        <para id="ch0064s000000p0061"><emphasis>O. urethralis</emphasis> strains are generally susceptible to most antibiotics, including penicillin, aminoglycosides, and trimethoprim-sulfamethoxazole, but production of penicillinases and cephalosporinases has been observed. Acquired resistance to fluoroquinolones is frequently noted. <emphasis>O. ureolytica</emphasis> strains are generally resistant to ampicillin, chloramphenicol, erythromycin, penicillin G, tetracycline, and trimethoprim-sulfamethoxazole (<link linkend="ch0064s000000li0151">151</link>, <link linkend="ch0064s000000li0152">152</link>).</para>
      </sect2>
      <sect2 id="ch0064s0008s0004">
        <title>Paracoccus</title>
        <anchor id="ch0064s000008a0005"/>
        <anchor id="ch0064s000000a0084"/>
        <para id="ch0064s000000p0062">The genus<emphasis>Paracoccus</emphasis> (<emphasis>Rhodobacteraceae, Alphaproteobacteria</emphasis>) includes &gt;95 validly named species. Originally, <emphasis>P. yeei</emphasis> seemed unique in the genus, presenting as an environmental opportunistic pathogen of clinical importance. The bacterium has been isolated from human wound infections (<link linkend="ch0064s000000li0153">153</link>), endophtalmitis, and keratitis. Case reports of bloodstream infections with bacteremia, but without serious clinical sepsis, and peritonitis related to peritoneal dialysis have been described (<link linkend="ch0064s000000li0154">154</link>, <link linkend="ch0064s000000li0155">155</link>).</para>
        <para id="ch0064s000000p0063"><emphasis>P. yeei</emphasis> organisms are coccoid cells, showing many diplococci and a few very short rods. The O-shaped or doughnut-shaped cells (<anchor id="ch0064s000000a0085"/><link linkend="ch0064s000000a0086">Fig. 3</link>) upon Gram stain examination, due to the presence of vacuolated or peripherally stained cells, are highly characteristic. Colonies on blood agar are large and mucoid with a pale yellow pigmentation. The species is saccharolytic and urease positive. Antibiotic susceptibility testing to a broad range of antibiotic classes showed no specific resistant phenotypes.</para>
        <figure id="ch0064s000000f0003"><title><phrase role="figureLabel"><anchor id="ch0064s000000a0086"/><link linkend="ch0064s000000a0085">FIGURE 3</link></phrase> Gram stain of <emphasis>P. yeei</emphasis>, showing characteristic doughnut-shaped morphology.</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0064f08.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0064s000000p0064">In 2015, four strains isolated from blood of four unrelated patients were assigned to a novel species within the genus and named<emphasis>Paracoccus sanguinis</emphasis> (<link linkend="ch0064s000000li0156">156</link>). Organisms present as Gram-negative rods in pairs or chains. Colonies on chocolate and SBA are pale yellow, moist, circular, and convex. Acid production from most carbohydrates is absent. Recently, <emphasis>P. sanguinis</emphasis> was isolated from the blood of a premature newborn with breathing difficulties and an abnormal chest X-ray (<link linkend="ch0064s000000li0157">157</link>). MALDI-TOF MS was not able to identify the isolate, but 16S rRNA gene sequencing showed high similarity with the type strain. However, the pathogenic potential of this species needs further confirmation.</para>
      </sect2>
      <sect2 id="ch0064s0008s0005">
        <title>Psychrobacter</title>
        <anchor id="ch0064s000008a0006"/>
        <anchor id="ch0064s000000a0087"/>
        <para id="ch0064s000000p0065">The genus<emphasis>Psychrobacter</emphasis> comprises &gt;50 species, of which most belong to the marine and Antarctic environment or are isolated from poikilothermic animals. Only a subset of <emphasis>Psychrobacter</emphasis> spp. are considered medically relevant opportunistic pathogens. A limited number of published case reports describe a variety of clinical manifestations that include bacteremia, meningitis, surgical wound infections, and ocular infections. Apart from <emphasis>Psychrobacter phenylpyruvicus</emphasis> (formerly <emphasis>M. phenylpyruvica</emphasis>), the <emphasis>Psychrobacter</emphasis> strains isolated from clinical material were considered until recently as belonging to the species <emphasis>Psychrobacter immobilis</emphasis>, originally isolated from poultry. In 2012 (<link linkend="ch0064s000000li0157">157</link>), it was shown that almost all the strains formerly identified as <emphasis>P. immobilis</emphasis> belong in fact to the species <emphasis>P. faecalis</emphasis> and <emphasis>P. pulmonis</emphasis>, isolated first from pigeons and lambs, respectively (<link linkend="ch0064s000000li0158">158</link>, <link linkend="ch0064s000000li0159">159</link>). <emphasis>P. immobilis</emphasis> is rarely, if at all, isolated from humans.</para>
        <para id="ch0064s000000p0066"><emphasis>P. faecalis</emphasis> and <emphasis>P. pulmonis</emphasis> are coccoid Gram-negative rods growing on TSA with large, creamy colonies. <emphasis>P. faecalis</emphasis> is saccharolytic and acidifies glucose and xylose, while <emphasis>P. pulmonis</emphasis> is asaccharolytic. Both species produce acid from ethylene glycol. They are Tween 80 esterase, tributyrate esterase, and nitrate reductase positive and, unlike the type strain of <emphasis>P. immobilis</emphasis>, urease negative and nitrite reductase positive. Colonies may resemble those of <emphasis>Haematobacter</emphasis>, but the latter lack nitrate reductase, Tween 80 esterase, and tributyrin esterase and are strongly urease positive, arginine dihydrolase positive, and phenylalanine deaminase positive.</para>
        <para id="ch0064s000000p0067"><emphasis>P. phenylpyruvicus</emphasis> and <emphasis>P. sanguinis</emphasis> are phenotypically very similar, although genetically clearly distinct. <emphasis>P. sanguinis</emphasis> (<link linkend="ch0064s000000li0160">160</link>, <link linkend="ch0064s000000li0161">161</link>) seems to occur more frequently in clinical samples than <emphasis>P. phenylpyruvicus</emphasis> and has been isolated from blood and cases of meningitis (<link linkend="ch0064s000000li0160">160</link>–<link linkend="ch0064s000000li0163">163</link>). The majority of older <emphasis>P. phenylpyruvicus</emphasis> collection strains are in fact <emphasis>P. sanguinis.</emphasis> A salient feature is the dramatic effect of Tween 80 in promoting growth of both species, resulting in colonies 2 to 3 times larger on Tween 80 agar compared to blood agar. Since these species grow very poorly or not at all on usual media, like TSA, supplementation with 0.1% Tween 80 is recommended when blood agar cannot be used, as for susceptibility testing to desferrioxamine or for testing growth abilities in broth at different temperatures.</para>
        <para id="ch0064s000000p0068"><emphasis>P. phenylpyruvicus</emphasis> grows in 12% NaCl tryptic soy broth supplemented with 0.1% Tween 80, while <emphasis>P. sanguinis</emphasis> does not. Phenylalanine deaminase is always positive in <emphasis>P. phenylpyruvicus</emphasis> but only in one-third of <emphasis>P. sanguinis</emphasis> strains.</para>
        <para id="ch0064s000000p0069">In 2017,<emphasis>Psychrobacter piechaudii</emphasis>, a new species with human pathogenic potential within the genus, was described, based on data of four human strains (<link linkend="ch0064s000000li0164">164</link>). Cells are Gram-negative coccobacilli arranged in pairs, with some cells resistant to decolorization. Small, convex, translucent, nonhemolytic, nonpigmented colonies on SBA and pinpoint colony morphology with pitting on chocolate agar are observed. Growth occurs at 0 to 37°C, with up to 10% NaCl tolerance for most strains. Cells are not able to reduce nitrate to nitrite, Tween 80 esterase is present, and urease activity varies. <emphasis>P. sanguinis</emphasis> and <emphasis>P. phenylpyruvicus</emphasis> are among the closest phylogenetic relatives. In 2021 (<link linkend="ch0064s000000li0165">165</link>), in a premature infant with hydrocephalus and multiple cerebrospinal fuid (CSF) shunt operations, <emphasis>P. piechaudii</emphasis> health care-related ventriculo-meningitis was described. MALDI-TOF MS only produced reliable results to genus specification; sequencing of the full 16S rRNA gene achieved species identification.</para>
        <anchor id="ch0064s000000a0088"/>
        <beginpage pagenum="923"/>
        <para id="ch0064s000000p0070">Most<emphasis>Psychrobacter</emphasis> species are resistant to penicillin but susceptible to most other antibiotics (<link linkend="ch0064s000000li0166">166</link>).</para>
      </sect2>
      <sect2 id="ch0064s0008s0006">
        <title>Wohlfahrtiimonas chitiniclastica</title>
        <anchor id="ch0064s000008a0007"/>
        <anchor id="ch0064s000000a0089"/>
        <para id="ch0064s000000p0071">The genus<emphasis>Wohlfahrtiimonas</emphasis> comprises three species. <emphasis>W. chitiniclastica</emphasis> and <emphasis>Wohlfahrtiimonas larvae</emphasis> were isolated from larvae of different fly vectors in tropical, subtropical, and moderate climates. <emphasis>Wohlfahrtiimonas populi</emphasis>, from the diseased bark of the Populus tree, has no documented human pathogenic potential. <emphasis>W. chitiniclastica</emphasis> was decribed in 2008 and is closely related to the “Gilardi rod group 1” also isolated from wounds and blood (<link linkend="ch0064s000000li0167">167</link>, <link linkend="ch0064s000000li0168">168</link>). The type strain of <emphasis>W. chitiniclastica</emphasis> was originally classified as “Gilardi rod group 1.”</para>
        <para id="ch0064s000000p0072"><emphasis>W. chitiniclastica</emphasis> and <emphasis>W. larvae</emphasis> may be associated with human accidental myiasis. In these cases of wound infections, cellulitis, and osteomyelitis, other microbial species are frequently detected along with <emphasis>Wohlfahrtiimonas</emphasis>, making it difficult to estimate the intrinsic pathogenic potential of the bacterium. However, as well as polymicrobial bacteremia or sepsis (<link linkend="ch0064s000000li0167">167</link>, <link linkend="ch0064s000000li0169">169</link>), several case reports of monomicrobial <emphasis>W. chitiniclastica</emphasis> bacteremia and clinical sepsis have been described (<link linkend="ch0064s000000li0170">170</link>–<link linkend="ch0064s000000li0172">172</link>).</para>
        <para id="ch0064s000000p0073">The organisms are short, coccoid rods, growing on current selective and nonselective media with flat, slightly spreading colonies. Some carbohydrates, like glucose, xylose, and fructose, are weakly and slowly acidified.<emphasis>W. chitiniclastica</emphasis> exhibits a very strong phenylalanine deaminase reaction, and a strong chitinase activity is present. <emphasis>Wohlfahrtiimonas</emphasis> spp. are resistant to penicillin and susceptible to broad-spectrum β-lactam penicllins, cephalosporins, carbapenems, trimethoprim/sulfamethoxazole, and quinolones (<link linkend="ch0064s000000li0173">173</link>).</para>
      </sect2>
      <sect2 id="ch0064s0008s0007">
        <title>Ignatzschineria</title>
        <anchor id="ch0064s000008a0008"/>
        <anchor id="ch0064s000000a0090"/>
        <para id="ch0064s000000p0074">The genus<emphasis>Ignatzschineria</emphasis>, first described in 2001, now comprises several species with animal or human pathogenic potential. WGS analysis suggests that <emphasis>Ignatzschineria larvae</emphasis> and <emphasis>Ignatzschineria ureiclastica</emphasis> are strongly related or identical (sub)species within the genus (<link linkend="ch0064s000000li0174">174</link>). Both bacteria exhibit a strong chitinase activity, as in <emphasis>W. chitiniclastica</emphasis>, which is, however, urease negative. <emphasis>Ignatzschineria indica</emphasis> forms a separate species within the genus. <emphasis>Ignatzschineria</emphasis> spp. are accidental zoonotic pathogens, carried by fly larvae. They have been isolated from maggot-infested wounds and abscesses, in some cases with concomitant bacteremia (<link linkend="ch0064s000000li0175">175</link>, <link linkend="ch0064s000000li0176">176</link>). The organisms are short, straight rods that grow on blood agar and MacConkey agar after 1 to 2 days as small, convex, nonpigmented, and translucent colonies. Automated biochemical instruments and MALDI-TOF MS may produce no identification or an incorrect identification. Genotypic methods, 16S rRNA gene sequencing, and WGS are required to achieve genus and species identification, respectively. Antibiotic susceptibility profiles may vary between species, but overall susceptibility to β-lactam antibiotics is conserved.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0064s0009">
      <title>Oxidase-Positive, Indole-Negative, Trypsin-Positive GNF</title>
      <anchor id="ch0064s000009a0001"/>
      <anchor id="ch0064s000000a0091"/>
      <sect2 id="ch0064s0009s0001">
        <title>Alishewanella</title>
        <anchor id="ch0064s000009a0002"/>
        <anchor id="ch0064s000000a0092"/>
        <para id="ch0064s000000p0075">The genus<emphasis>Alishewanella</emphasis> harbors seven species. Cells are Gram-negative, motile or nonmotile rods, oxidase and catalase positive, and negative for arginine dihydrolase and indole (<link linkend="ch0064s000000li0177">177</link>). <emphasis>Alishewanella</emphasis> has been identified as part of the blood microbiome in patients with type 2 diabetes mellitus (<link linkend="ch0064s000000li0177">177</link>). <emphasis>Alishewanella fetalis</emphasis> has been isolated from a clinical sample, i.e., from a human fetus at autopsy, but its association with clinical infection is unknown (<link linkend="ch0064s000000li0178">178</link>).</para>
        <para id="ch0064s000000p0076"><emphasis>A. fetalis</emphasis> (<anchor id="ch0064s000000a0093"/><link linkend="ch0064s000000a0046">Table 3</link>) grows at temperatures between 25 and 41°C, with optimum growth at 37°C. <emphasis>A. fetalis</emphasis> can withstand NaCl concentrations of up to 8% but not 10%, which helps to differentiate this species from <emphasis>Shewanella algae</emphasis>, which can grow in 10% NaCl (<link linkend="ch0064s000000li0178">178</link>). Also, in contrast to <emphasis>Shewanella</emphasis> species, it does not produce H<subscript>2</subscript>S in the butt of TSI and KIA. The type strain, tested by Georges Wauters, acidifies glucose and does not hydrolyze esculin.</para>
      </sect2>
      <sect2 id="ch0064s0009s0002">
        <title>Inquilinus limosus</title>
        <anchor id="ch0064s000009a0003"/>
        <anchor id="ch0064s000000a0094"/>
        <para id="ch0064s000000p0077"><emphasis>I. limosus</emphasis>, one of the two species in the genus <emphasis>Inquilinus</emphasis>, is a rod-shaped, Gram-negative bacterium that measures 1.5 to 2 μm in width by 3.5 μm in length and grows at 35 and 41°C but poorly at 25°C. Colonies are nonpigmented and very mucoid and grow on ordinary media such as TSA. Some strains are motile by one or two polar flagella, but motility is difficult to demonstrate due to the mucoid character of the colonies. In contrast to the original description (<link linkend="ch0064s000000li0179">179</link>), the species is saccharolytic, acidifying glucose, mannitol, xylose, and other carbohydrates. In contrast, ethylene glycol is not acidified. β-Galactosidase, pyrrolidonyl aminopeptidase, and trypsin are positive, but alkaline phosphatase is negative. Esculin is hydrolyzed. All strains are positive for catalase, β-glucosidase, proline aminopeptidase, and pyrrolidonyl aminopeptidase and negative for lysine, arginine, ornithine, denitrification, and indole production (<link linkend="ch0064s000000li0179">179</link>).</para>
        <para id="ch0064s000000p0078"><emphasis>I. limosus</emphasis> can be distinguished from <emphasis>Sphingobacterium</emphasis> species by its lack of alkaline phosphatase activity and by its acidification of mannitol. <emphasis>Sphingobacterium spiritivorum</emphasis> also produces acid from mannitol but acidifies ethylene glycol, unlike <emphasis>Inquilinus. I. limosus</emphasis> differs from <emphasis>Rhizobium radiobacter</emphasis> and <emphasis>Pannonibacter phragmitetus</emphasis> by the absence of acid production from ethylene glycol (positive in most of the <emphasis>P. phragmitetus</emphasis> strains) and by the lack of nitrate reductase activity.</para>
        <para id="ch0064s000000p0079">Identifying this species can be challenging because it is not contained in the databases of commercial identification kits such as API 20NE and its mucoid appearance may lead to confusion with mucoid<emphasis>P. aeruginosa</emphasis> strains (<link linkend="ch0064s000000li0180">180</link>). However, MALDI-TOF MS appears to identify the species correctly (<link linkend="ch0064s000000li0181">181</link>, <link linkend="ch0064s000000li0182">182</link>). Isolates can be recovered on colistin-containing <emphasis>Burkholderia cepacia</emphasis> selective media but are inhibited on <emphasis>B. cepacia</emphasis> selective agar, which also contains gentamicin (<link linkend="ch0064s000000li0183">183</link>).</para>
        <para id="ch0064s000000p0080">All isolates are reported to be resistant to penicillins and cephalosporins, kanamycin, tobramycin, colistin, doxycycline, and trimethoprim-sulfamethoxazole and susceptible to imipenem, gentamicin, and ciprofloxacin (<link linkend="ch0064s000000li0180">180</link>, <link linkend="ch0064s000000li0183">183</link>).</para>
        <para id="ch0064s000000p0081"><emphasis>I. limosus</emphasis> has been isolated from soil samples and from respiratory secretions of cystic fibrosis patients (<link linkend="ch0064s000000li0180">180</link>, <link linkend="ch0064s000000li0181">181</link>, <link linkend="ch0064s000000li0184">184</link>–<link linkend="ch0064s000000li0187">187</link>). The clinical impact of chronic colonization with <emphasis>I. limosus</emphasis> remains unclear. Chiron et al. (<link linkend="ch0064s000000li0183">183</link>) reported that for one patient, <emphasis>I. limosus</emphasis> was the only potential pathogen recovered from the sputum, and acquisition of this bacterium was followed by a worsening of the patient’s lung function. Lenhart and coworkers reported that lung function and nutrition status at time of detection, lung function decline, and pulmonary exacerbation rates in <emphasis>Inquilinus</emphasis> cases were similar to those in patients with chronic <emphasis>P. aeruginosa</emphasis> infection (<link linkend="ch0064s000000li0188">188</link>).</para>
        <anchor id="ch0064s000000a0095"/>
        <beginpage pagenum="924"/>
      </sect2>
      <sect2 id="ch0064s0009s0003">
        <title>Myroides odoratimimus and Myroides odoratus</title>
        <anchor id="ch0064s000009a0004"/>
        <anchor id="ch0064s000000a0096"/>
        <para id="ch0064s000000p0082">The genus<emphasis>Myroides</emphasis> includes 16 species. <emphasis>Myroides odoratimimus</emphasis> (<link linkend="ch0064s000000li0189">189</link>), <emphasis>Myroides odoratus</emphasis> (formerly <emphasis>Flavobacterium odoratum</emphasis> (<link linkend="ch0064s000000li0190">190</link>), and <emphasis>Myroides injenensis</emphasis> have been isolated from clinical samples and have some clinical importance. Cells are thin, middle-sized (0.5 μm in diameter and 1 to 2 μm long), nonmotile rods, and both species display a gliding motility. The spreading colonies develop a typical fruity smell, similar to the odor of <emphasis>Alcaligenes faecalis.</emphasis> The yellow pigment, although less pronounced than that of some <emphasis>Chryseobacterium</emphasis> species, is of the flexirubin type.</para>
        <para id="ch0064s000000p0083"><emphasis>Myroides</emphasis> species grow on most media, including MacConkey agar. Growth occurs at 18 to 37°C, but usually not at 41°C. <emphasis>Myroides</emphasis> species are asaccharolytic, urease positive, and nitrate reductase negative, but nitrite is reduced. <emphasis>M. odoratus</emphasis> can be differentiated by its susceptibility to desferrioxamine, while <emphasis>M. odoratimimus</emphasis> is resistant. The species also differ by their cellular fatty acid patterns, with <emphasis>M. odoratimimus</emphasis> having significant amounts of C13:0<emphasis>i</emphasis> and C15:0 (<link linkend="ch0064s000000li0189">189</link>). MALDI-TOF MS, but not VITEK 2, has been shown to efficiently distinguish between <emphasis>M. odoratimimus</emphasis> and <emphasis>M. odoratus</emphasis> (<link linkend="ch0064s000000li0190">190</link>).</para>
        <para id="ch0064s000000p0084"><emphasis>M. odoratus</emphasis> has been reported mostly from urine but has also been found in wounds, sputum, blood, and ear specimens and identified as causes of septic shock, pericardial effusion, necrotizing fasciitis, and cellulitis (<link linkend="ch0064s000000li0191">191</link>–<link linkend="ch0064s000000li0195">195</link>). <emphasis>M. odoratimimus</emphasis> has been described in case reports of fulminant erysipelas and sepsis, in health care-related outbreaks of urinary tract infection, in a soft tissue infection following a pig bite, in health care-related catheter-related infections, and in empyema in a patient with liver abscess (<link linkend="ch0064s000000li0196">196</link>–<link linkend="ch0064s000000li0203">203</link>). <emphasis>Myroides</emphasis> bacteremia has been reported in 48 cases in the U.S (<link linkend="ch0064s000000li0204">204</link>). Most strains are resistant to penicillins, cephalosporins, aminoglycosides, aztreonam, and carbapenems (<link linkend="ch0064s000000li0192">192</link>, <link linkend="ch0064s000000li0205">205</link>). A genomic analysis of a multidrug-resistant strain has been reported (<link linkend="ch0064s000000li0206">206</link>).</para>
        <para id="ch0064s000000p0085"><emphasis>M. injenensis</emphasis> was isolated from a patient admitted to the emergency room with fever and abruptly reduced drainage from the left kidney (<link linkend="ch0064s000000li0207">207</link>) and showed a high level of resistance to multiple antibiotic agents (<link linkend="ch0064s000000li0208">208</link>). <emphasis>M. injenensis</emphasis> was also reported in a case of bacteremia and severe cellulitis in a patient with cirrhosis (<link linkend="ch0064s000000li0209">209</link>).</para>
      </sect2>
      <sect2 id="ch0064s0009s0004">
        <title>Ochrobactrum anthropi and Ochrobactrum intermedium</title>
        <anchor id="ch0064s000009a0005"/>
        <anchor id="ch0064s000000a0097"/>
        <para id="ch0064s000000p0086"><emphasis>Ochrobactrum, Pseudochrobactrum, Rhizobium</emphasis>, and <emphasis>Pannonibacter</emphasis> have many morphological and biochemical characteristics in common, and therefore additional characteristics for these taxa are provided in <link linkend="ch0064s000000a0046">Table 3</link>.</para>
        <para id="ch0064s000000p0087">In 2020 it was proposed to reassign members of the<emphasis>Ochrobactrum</emphasis> genus to the <emphasis>Brucella</emphasis> genus. Moreno and colleagues (<link linkend="ch0064s000000li0210">210</link>) opposed the unification of <emphasis>Brucella</emphasis> and <emphasis>Ochrobactrum</emphasis> due to the differences in epidemiology, pathogenicity, virulence, diagnosis, and treatment between the two genera. For this reason, the editors of this <emphasis>Manual</emphasis> prefer to maintain the separation of these organisms into two groups. The <emphasis role="strong">Ochrobactrum</emphasis> species are discussed in this chapter. The reader is referred to <ulink url="ch0068#ch0068s0001">chapter 51</ulink>, “<emphasis>Brucella</emphasis>,” for additional discussion.</para>
        <para id="ch0064s000000p0088">The genus<emphasis>Ochrobactrum</emphasis> comprises at present 19 species. Two species, i.e., <emphasis>O. anthropi</emphasis> (<link linkend="ch0064s000000li0211">211</link>) and <emphasis>O. intermedium</emphasis> (<link linkend="ch0064s000000li0212">212</link>), are currently isolated from humans. <emphasis>O. haematophilum</emphasis> (<link linkend="ch0064s000000li0213">213</link>), <emphasis>O. pseudogrignonense</emphasis> (<link linkend="ch0064s000000li0213">213</link>), and <emphasis>O. pseudintermedium</emphasis> (<link linkend="ch0064s000000li0214">214</link>) have been recovered from clinical samples. <emphasis>O. anthropi</emphasis> (<link linkend="ch0064s000000li0211">211</link>) comprises the so-called urease-positive <emphasis>Achromobacter</emphasis> species, formerly designated CDC group Vd (biotypes 1 and 2), and <emphasis>Achromobacter</emphasis> groups A, C, and D.</para>
        <para id="ch0064s000000p0089">Colonies on SBA are small, ~1 mm after overnight incubation, but grow large and creamy after 2 days and appear smooth, circular, and clearly delineated.<emphasis>Ochrobactrum</emphasis> species are Gram-negative rods, approximately 0.6–1.2 to 2 μm in length, and motile by peritrichous flagella, although most cells have only one or two very long lateral flagella.</para>
        <para id="ch0064s000000p0090"><emphasis>Ochrobactrum</emphasis> species are strongly trypsin and pyrrolidonyl aminopeptidase positive and are saccharolytic, with rapid acidification of glucose and xylose. Acidification of mannitol is irregular and often delayed positive. Ethylene glycol is acidified. Urease is positive in most species; phenylalanine deaminase is always positive. Nitrate reduction and nitrite reduction are positive, except in <emphasis>O. haematophilum. O. intermedium</emphasis> can be distinguished from <emphasis>O. anthropi</emphasis> by colistin resistance and growth at 41°C. Urease is often negative or delayed in this species. <emphasis>O. pseudintermedium</emphasis> is the only species growing at 45°C. Resistance to colistin, tetracycline, and aminoglycosides may have diagnostic value for distinction between <emphasis>O. intermedium</emphasis> and <emphasis>O. pseudintermedium.</emphasis> Among aminoglycosides, netilmicin provides the most clear-cut results. Comparative phylogenomics of the family <emphasis>Brucellaceae</emphasis> reveals a path to virulence (<link linkend="ch0064s000000li0215">215</link>).</para>
        <para id="ch0064s000000p0091"><emphasis>O. anthropi</emphasis> has been isolated from various environmental and human sources, predominantly from patients with catheter-related bacteremia (<link linkend="ch0064s000000li0211">211</link>, <link linkend="ch0064s000000li0216">216</link>), bloodstream infections, and a few other infections (case reports of neonatal sepsis, pneumonia, osteomyelitis, and endocarditis) (<link linkend="ch0064s000000li0217">217</link>–<link linkend="ch0064s000000li0221">221</link>). One hospital outbreak in transplant patients has been described (<link linkend="ch0064s000000li0222">222</link>). A few cases of <emphasis>O. intermedium</emphasis> infections have been reported (see, e.g., reference <link linkend="ch0064s000000li0223">223</link>), but because of the close phenotypic similarity of <emphasis>O. anthropi</emphasis> and <emphasis>O. intermedium</emphasis>, it is possible that certain infections considered to be caused by <emphasis>O. anthropi</emphasis> were actually caused by <emphasis>O. intermedium</emphasis> (<link linkend="ch0064s000000li0224">224</link>). A case report of an <emphasis>O. anthropi</emphasis> bacteremia in a pediatric patient with malignant tumor has been described (<link linkend="ch0064s000000li0225">225</link>). Several virulence factors have been detected in <emphasis>O. intermedium</emphasis> (<link linkend="ch0064s000000li0226">226</link>).</para>
        <para id="ch0064s000000p0092"><emphasis>O. anthropi</emphasis> strains are usually resistant to β-lactams, such as broad-spectrum penicillins, broad-spectrum cephalosporins, aztreonam, and amoxicillin-clavulanate, but are usually susceptible to aminoglycosides, fluoroquinolones, imipenem, tetracycline, and trimethoprim-sulfamethoxazole (<link linkend="ch0064s000000li0216">216</link>).</para>
      </sect2>
      <sect2 id="ch0064s0009s0005">
        <title>Pannonibacter</title>
        <anchor id="ch0064s000009a0006"/>
        <anchor id="ch0064s000000a0098"/>
        <para id="ch0064s000000p0093">The genus<emphasis>Pannonibacter</emphasis>, member of the family <emphasis>Stappiaceae</emphasis> (<emphasis>Alphaproteobacteria</emphasis>), currently comprises three species, <emphasis>P. carbonis, P. phragmitetus</emphasis>, and <emphasis>P. indicus</emphasis>, an environmental species. <emphasis>P. phragmitetus</emphasis> has been shown to be identical to the strains formerly designated <emphasis>Achromobacter</emphasis> groups B and E (<link linkend="ch0064s000000li0227">227</link>). The species resembles most strongly <emphasis>Rhizobium radiobacter</emphasis>, but saccharolytic activity is somewhat weaker and not as extended. Unlike <emphasis>Rhizobium</emphasis> and <emphasis>Pseudochrobactrum</emphasis>, which all have a strong phenylalanine deaminase activity, <emphasis>P. phragmitetus</emphasis> does not produce phenylpyruvic acid from phenylalanine. Another easy and reliable differential test is the hydrolysis of tributyrin, which is positive within 30 min for <emphasis>P. phragmitetus</emphasis>, whereas <emphasis>R. radiobacter</emphasis> strains are only positive after several hours of overnight incubation or remain negative. <emphasis>Pseudochrobactrum</emphasis> species do not hydrolyze tributyrin. Moreover, <emphasis>P. phragmitetus</emphasis> grows at 41°C while <emphasis>R. radiobacter</emphasis> does not.</para>
        <anchor id="ch0064s000000a0099"/>
        <beginpage pagenum="925"/>
        <para id="ch0064s000000p0094">Cases of septicemia and a liver abcess due to<emphasis>P. phragmitetus</emphasis> have been reported (<link linkend="ch0064s000000li0228">228</link>, <link linkend="ch0064s000000li0229">229</link>).</para>
      </sect2>
      <sect2 id="ch0064s0009s0006">
        <title>Pseudochrobactrum</title>
        <anchor id="ch0064s000009a0007"/>
        <anchor id="ch0064s000000a0100"/>
        <para id="ch0064s000000p0095">The genus<emphasis>Pseudochrobactrum</emphasis> was described in 2006 (<link linkend="ch0064s000000li0230">230</link>) and comprises six species, among them <emphasis>P. saccharolyticum</emphasis> and <emphasis>P. asaccharolyticum.</emphasis> The type strain of <emphasis>P. asaccharolyticum</emphasis> was isolated from a knee aspirate (<link linkend="ch0064s000000li0230">230</link>). Two more human strains were isolated from Belgian clinical samples: a wound and an eye swab. <emphasis>P. asaccharolyticum</emphasis> slowly acidifies glucose and xylose, while <emphasis>P. saccharolyticum</emphasis> is more saccharolytic. Both species are susceptible to desferrioxamine and do not produce urease. Nitrate reduction and nitrite reduction are negative. The clinical significance of <emphasis>Pseudochrobactrum</emphasis> species remains to be assessed.</para>
      </sect2>
      <sect2 id="ch0064s0009s0007">
        <title>Rhizobium</title>
        <anchor id="ch0064s000009a0008"/>
        <anchor id="ch0064s000000a0101"/>
        <para id="ch0064s000000p0096">The genus<emphasis>Rhizobium</emphasis> harbours 84 species. Only <emphasis>R. radiobacter</emphasis> and <emphasis>Rhizobium pusense</emphasis> are clinically important (<link linkend="ch0064s000000li0231">231</link>).</para>
        <para id="ch0064s000000p0097">Colonies of<emphasis>R. radiobacter</emphasis> and <emphasis>R. pusense</emphasis> are circular, convex, smooth, and nonpigmented to light beige on SBA, with a diameter of 2 mm at 48 h. Colonies may appear wet and become extremely mucoid and pink on MacConkey agar with prolonged incubation. Cells measure 0.6 to 1.0 by 1.5 to 3.0 μm and occur singly and in pairs.</para>
        <para id="ch0064s000000p0098"><emphasis>R. radiobacter</emphasis> grows optimally at 25 to 28°C and grows at 35°C as well, but not at 41°C. <emphasis>R. pusense</emphasis> is phenotypically very similar to <emphasis>R. radiobacter</emphasis>, but can be separated by the sequencing of the 16S rRNA and <emphasis>atpD</emphasis> genes (<link linkend="ch0064s000000li0231">231</link>).</para>
        <para id="ch0064s000000p0099"><emphasis>R. radiobacter</emphasis> has broad saccharolytic activity, including mannitol and raffinose.</para>
        <para id="ch0064s000000p0100"><emphasis>R. radiobacter</emphasis> (which may have also been falsely identified as <emphasis>R. pusense</emphasis>) has been most frequently isolated from blood, followed by peritoneal dialysate, urine, and ascitic fluid (<link linkend="ch0064s000000li0232">232</link>), and from cases of endocarditis (<link linkend="ch0064s000000li0233">233</link>) and keratitis (<link linkend="ch0064s000000li0234">234</link>). The species has also been isolated from the airways of patients with cystic fibrosis. The few cases are from patients with transcutaneous catheters or implanted biomedical prostheses, and effective treatment often requires removal of the device. Most strains are susceptible to broad-spectrum cephalosporins, carbapenems, tetracyclines, and gentamicin but not to tobramycin (<link linkend="ch0064s000000li0232">232</link>, <link linkend="ch0064s000000li0235">235</link>). Testing of individual isolates is recommended for clinically significant cases.</para>
      </sect2>
      <sect2 id="ch0064s0009s0008">
        <title>Shewanella</title>
        <anchor id="ch0064s000009a0009"/>
        <anchor id="ch0064s000000a0102"/>
        <para id="ch0064s000000p0101">The organisms formerly called<emphasis>Pseudomonas putrefaciens, Alteromonas putrefaciens, Achromobacter putrefaciens</emphasis>, and CDC group Ib have been placed in the genus <emphasis>Shewanella</emphasis>, which comprises more than 70 species. <emphasis>S. putrefaciens</emphasis> was described with two CDC biotypes. CDC biotype 1 was later described as <emphasis>S. putrefaciens sensu stricto</emphasis>, whereas CDC biotype 2 was subsequently assigned to a new species, <emphasis>S. alga</emphasis> (<link linkend="ch0064s000000li0236">236</link>), later corrected to <emphasis>S. algae</emphasis>.</para>
        <para id="ch0064s000000p0102">Colonies of<emphasis>Shewanella</emphasis> species on SBA are convex, circular, smooth, and occasionally mucoid, produce a brown to tan soluble pigment, and cause green discoloration of the medium. Cells are long, short, or filamentous, reminiscent of <emphasis>Myroides.</emphasis> Motility is due to a single polar flagellum.</para>
        <para id="ch0064s000000p0103">Most strains of both<emphasis>S. putrefaciens</emphasis> and <emphasis>S. algae</emphasis> species produce H<subscript>2</subscript>S in KIA and TSI agar, a unique feature among clinically relevant GNF. Both are also ornithine decarboxylase positive and have strong alkaline phosphatase, strong trypsin, and strong pyrrolidonyl aminopeptidase activities. <emphasis>S. algae</emphasis> is halophilic and asaccharolytic and requires NaCl for growth, with growth occurring on TSA plus 0.5% NaCl. <emphasis>S. putrefaciens</emphasis> does not require NaCl for growth and is saccharolytic, producing acid from maltose and sucrose and irregularly and weakly from glucose.</para>
        <para id="ch0064s000000p0104">Khashe and Janda (<link linkend="ch0064s000000li0237">237</link>) have reported that <emphasis>S. algae</emphasis> is the predominant human clinical isolate (77%), while <emphasis>S. putrefaciens</emphasis> represents most non-human isolates (89%). Although infrequently isolated in the clinical laboratory, <emphasis>S. putrefaciens</emphasis> and <emphasis>S. algae</emphasis> have been recovered from a wide variety of clinical specimens and are associated with a broad range of human infections (<link linkend="ch0064s000000li0238">238</link>), including skin and soft tissue infections, otitis media, ocular infection, osteomyelitis, peritonitis, and septicemia. <emphasis>S. algae</emphasis> has been described as an emerging pathogen implicated in acute cholangitis (<link linkend="ch0064s000000li0239">239</link>). The habitat for <emphasis>S. algae</emphasis> is saline, whereas <emphasis>S. putrefaciens</emphasis> has been isolated mostly from fish, poultry, and meats as well as from freshwater and marine samples. A review on the clinical relevance of <emphasis>Shewanella algae</emphasis> has been published (<link linkend="ch0064s000000li0240">240</link>).</para>
        <para id="ch0064s000000p0105"><emphasis>Shewanella</emphasis> species are generally susceptible to most antimicrobial agents effective against Gram-negative rods, except penicillin and cephalothin (<link linkend="ch0064s000000li0166">166</link>, <link linkend="ch0064s000000li0235">235</link>). The mean MICs of <emphasis>S. algae</emphasis> for penicillin, ampicillin, and tetracycline are higher than the corresponding MICs of <emphasis>S. putrefaciens</emphasis> (<link linkend="ch0064s000000li0237">237</link>).</para>
      </sect2>
      <sect2 id="ch0064s0009s0009">
        <title>Sphingobacterium, Indole-Negative Species</title>
        <anchor id="ch0064s000009a0010"/>
        <anchor id="ch0064s000000a0103"/>
        <para id="ch0064s000000p0106">In July 2022, a total of 65 species were described as belonging to the genus<emphasis>Sphingobacterium.</emphasis> Based on 16S rRNA gene sequence data, the indole-producing <emphasis>Sphingobacterium mizutaii</emphasis> also belongs to this genus, and as a consequence, the description of the genus <emphasis>Sphingobacterium</emphasis> as indole negative was emended to indole variable (<link linkend="ch0064s000000li0241">241</link>). <emphasis>S. mizutaii</emphasis> is dealt with among the indole-positive GNF in <anchor id="ch0064s000000a0104"/><link linkend="ch0064s000000a0055">Table 4</link>.</para>
        <para id="ch0064s000000p0107">The species of the genus<emphasis>Sphingobacterium</emphasis> encountered in clinical samples include <emphasis>S. multivorum</emphasis> (formerly <emphasis>Flavobacterium multivorum</emphasis> and CDC group IIk-2), <emphasis>S. spiritivorum</emphasis> (including the species formerly designated as <emphasis>Flavobacterium spiritivorum, Flavobacterium yabuuchiae</emphasis>, and CDC group IIk-3), <emphasis>S. thalpophilum, S. hotanense, S. cellulitidis</emphasis>, and <emphasis>S. mizutaii</emphasis> (<link linkend="ch0064s000000li0242">242</link>, <link linkend="ch0064s000000li0243">243</link>).</para>
        <para id="ch0064s000000p0108">Colonies are yellowish.<emphasis>Sphingobacterium</emphasis> species are middle-sized, nonmotile, Gram-negative rods. All species are strongly saccharolytic; i.e., glucose, xylose, and other sugars are acidified. No acid is produced from mannitol, except by <emphasis>S. spiritivorum</emphasis>, which is also the only species to produce acid from ethylene glycol. <emphasis>S. thalpophilum</emphasis> can be distinguished from other <emphasis>Sphingobacterium</emphasis> species by its nitrate reductase and its growth at 41°C.</para>
        <para id="ch0064s000000p0109"><emphasis>S. multivorum</emphasis> and <emphasis>S. spiritivorum</emphasis> can be distinguished from <emphasis>Sphingomonas paucimobilis</emphasis> (formerly CDC group IIk-1) because they are nonmotile, urease positive, and resistant to polymyxin. Many strains of other <emphasis>Sphingomonas</emphasis> species are also colistin resistant.</para>
        <para id="ch0064s000000p0110"><emphasis>S. multivorum</emphasis> is the most common human species. It has been isolated from various clinical specimens, and the rare associations with serious infections (sepsis, peritonitis, end-stage renal disease, and necrotizing fasciitis) occurred usually in severely comorbid patients (<link linkend="ch0064s000000li0244">244</link>–<link linkend="ch0064s000000li0247">247</link>). Blood and urine have been the most common sources for the isolation of <emphasis>S. spiritivorum</emphasis> (<link linkend="ch0064s000000li0248">248</link>). <emphasis>S. thalpophilum</emphasis> has been recovered from wounds, blood, eyes, abscesses, and an abdominal incision (<link linkend="ch0064s000000li0046">46</link>). <emphasis>S. hotanense</emphasis> has been involved in a bacteremia case (<link linkend="ch0064s000000li0247">247</link>), and <emphasis>S. cellulitidis</emphasis> has been isolated from various clinical samples (<link linkend="ch0064s000000li0249">249</link>).</para>
        <anchor id="ch0064s000000a0105"/>
        <beginpage pagenum="926"/>
        <para id="ch0064s000000p0111"><emphasis>Sphingobacterium</emphasis> species are generally resistant to aminoglycosides and polymyxin B while susceptible <emphasis>in vitro</emphasis> to the quinolones and trimethoprim-sulfamethoxazole. Susceptibility to β-lactam antibiotics is variable, requiring testing of individual isolates (<link linkend="ch0064s000000li0134">134</link>).</para>
      </sect2>
      <sect2 id="ch0064s0009s0010">
        <title>Sphingomonas</title>
        <anchor id="ch0064s000009a0011"/>
        <anchor id="ch0064s000000a0106"/>
        <para id="ch0064s000000p0112">The genus<emphasis>Sphingomonas</emphasis> contains 146 species, of which only <emphasis>S. paucimobilis</emphasis> and <emphasis>S. parapaucimobilis</emphasis> are thought to be clinically important.</para>
        <para id="ch0064s000000p0113"><emphasis>Sphingomonas</emphasis> colonies are slow growing on blood agar medium, with small colonies appearing after 24 h of incubation. Growth occurs at 37°C but not at 41°C, with optimum growth at 30°C. Almost all strains produce a yellow, insoluble pigment, different from flexirubin pigments, as can be established by the KOH test (<link linkend="ch0064s000000li0002">2</link>). Few strains are nonpigmented or develop a pale yellow color after several days. Older colonies demonstrate a deep yellow (mustard-color) pigment.</para>
        <para id="ch0064s000000p0114"><emphasis>Sphingomonas</emphasis> species are medium to long, motile rods with a single polar flagellum. Motility occurs at 18 to 22°C but not at 37°C. However, few cells are actively motile in broth culture, thus making motility a difficult characteristic to demonstrate.</para>
        <para id="ch0064s000000p0115">Oxidase is only weakly positive or even absent. All the strains are saccharolytic, but some acidify glucose only weakly and slowly. Urease is always negative, and nitrate reduction is only very rarely positive. Esculin is hydrolyzed, and β-galactosidase and alkaline phosphatase are positive. The yellow pigment of some strains may hamper a correct reading of the yellow color shift when nitrophenyl compounds of the latter substrates are used.</para>
        <para id="ch0064s000000p0116">Members of this genus are known as decomposers of aromatic compounds and are being developed for use in bioremediation.<emphasis>Sphingomonas</emphasis> species are widely distributed in the environment, including water.</para>
        <para id="ch0064s000000p0117"><emphasis>S. paucimobilis</emphasis> has been isolated from a variety of clinical specimens, including blood, CSF, peritoneal fluid, urine, wounds, and vaginal and cervix swabs, as well as from the hospital environment (<link linkend="ch0064s000000li0250">250</link>–<link linkend="ch0064s000000li0254">254</link>). <emphasis>S. parapaucimobilis</emphasis> clinical isolates have been obtained from sputum, urine, and the vagina (<link linkend="ch0064s000000li0255">255</link>). A peritonitis case has been reported associated with <emphasis>S. koreensis</emphasis> (<link linkend="ch0064s000000li0256">256</link>).</para>
        <para id="ch0064s000000p0118">Most strains are resistant to colistin, but all are susceptible to vancomycin, which is exceptional for Gram-negative, nonfermenting rods. This is elsewhere only found in<emphasis>Chryseobacterium</emphasis> and related genera like <emphasis>Elizabethkingia</emphasis> and <emphasis>Empedobacter.</emphasis> Most <emphasis>Sphingomonas</emphasis> strains are susceptible to tetracycline, chloramphenicol, trimethoprim-sulfamethoxazole, and aminoglycosides. Susceptibility to other antimicrobial agents, including fluoroquinolones, varies (<link linkend="ch0064s000000li0166">166</link>, <link linkend="ch0064s000000li0250">250</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0064s0010">
      <title>Oxidase-Positive, Indole-Positive GNF</title>
      <anchor id="ch0064s000010a0001"/>
      <anchor id="ch0064s000000a0107"/>
      <para id="ch0064s000000p0119">The natural habitats of most oxidase-positive, indole-positive GNF (<link linkend="ch0064s000000a0055">Table 4</link>) are soil, plants, and food and water sources, including those in hospitals. Clinically relevant species include <emphasis>Balneatrix alpica, Bergeyella zoohelcum, Chryseobacterium</emphasis> species, <emphasis>Elizabethkingia meningoseptica, Elizabethkingia anopheles, Elizabethkingia miricola, Empedobacter brevis, Empedobacter falsenii</emphasis> (formerly <emphasis>Wautersiella falsenii</emphasis>), <emphasis>Sphingobacterium mizutaii</emphasis>, and <emphasis>Weeksella virosa.</emphasis> All are indole, trypsin, pyrrolidonyl aminopeptidase, and alkaline phosphatase positive, except for <emphasis>B. zoohelcum</emphasis>, which is pyrrolidonyl aminopeptidase negative, and <emphasis>B. alpica</emphasis>, which is both trypsin and pyrrolidonyl aminopeptidase negative. <link linkend="ch0064s000000a0055">Table 4</link> presents an overview of the characteristics useful to differentiate among these species. It should be noted that phenotypic differentiation between these species is difficult and requires strict adherence to the described methods and the conditions under which they are performed. These methods and conditions have been thoroughly reviewed previously (<link linkend="ch0064s000000li0002">2</link>, <link linkend="ch0064s000000li0257">257</link>, <link linkend="ch0064s000000li0258">258</link>). Differentiation in the clinical microbiology laboratory is based on a limited number of phenotypic tests. Commercial identification kits are still often in use for differentiation, but discrepancies between the different commercial and conventional tests have been reported (<link linkend="ch0064s000000li0258">258</link>–<link linkend="ch0064s000000li0261">261</link>). Most commercial identification systems include <emphasis>Elizabethkingia meningoseptica</emphasis> in their analytical profile index, but this identification may be assigned to any of the <emphasis>Elizabethkingia</emphasis> species. Various molecular typing methods have shown to be more suitable for distinguishing these species, especially among the <emphasis>Chryseobacterium</emphasis> and <emphasis>Elizabethkingi</emphasis><emphasis>a</emphasis> species.</para>
    </sect1>
    <sect1 id="ch0064s0011">
      <title>Balneatrix alpica</title>
      <anchor id="ch0064s000011a0001"/>
      <anchor id="ch0064s000000a0108"/>
      <para id="ch0064s000000p0120">The genus<emphasis>Balneatrix</emphasis> accommodates only one species, <emphasis>B. alpica</emphasis>, which produces convex and smooth colonies of 2 to 3 mm in diameter. The center of the colonies is pale yellow after 2 to 3 days and pale brown after 4 days. <emphasis>B. alpica</emphasis> is a straight or curved, Gram-negative rod. It is the only motile species among the clinically relevant indole-positive GNF. Cells have one or two polar flagella.</para>
      <para id="ch0064s000000p0121">The species is strictly aerobic and saccharolytic. Both trypsin and pyrrolidonyl aminopeptidase are negative, unlike other indole-positive GNF. Growth occurs at 20 to 46°C on common media such as TSA but not on MacConkey agar.<emphasis>B. alpica</emphasis> acidifies fructose, glucose, glycerol, inositol, maltose, mannitol, mannose, sorbitol, and xylose. <emphasis>B. alpica</emphasis> is nitrate reductase and weakly gelatinase positive. It is similar to <emphasis>E. meningoseptica</emphasis> but can be differentiated from this species by its motility and nitrate reductase and by the absence of β-galactosidase.</para>
      <para id="ch0064s000000p0122"><emphasis>B. alpica</emphasis> was first isolated in 1987 during an outbreak of pneumonia and meningitis among persons who attended a hot (37°C) spring spa in southern France (<link linkend="ch0064s000000li0262">262</link>). Isolates from eight patients were recovered from blood, CSF, and sputum, and one was recovered from water. This species is only rarely isolated from human clinical specimens. Only one other report, on amoeba-associated microorganisms in intensive care unit pneumonia patients, has documented occurrence of this species (<link linkend="ch0064s000000li0263">263</link>).</para>
      <sect2 id="ch0064s0011s0001">
        <title>Bergeyella</title>
        <anchor id="ch0064s000011a0002"/>
        <anchor id="ch0064s000000a0109"/>
        <para id="ch0064s000000p0123">The genus<emphasis>Bergeyella</emphasis> currently includes two species with validated names, <emphasis>Bergeyella porcorum</emphasis> (<link linkend="ch0064s000000li0264">264</link>) and <emphasis>B. zoohelcum. B. zoohelcum</emphasis> comprises former CDC group IIj strains (<link linkend="ch0064s000000li0265">265</link>). <emphasis>B. zoohelcum</emphasis> and <emphasis>Weeksella virosa</emphasis> are morphologically and biochemically similar organisms with cells measuring 0.6 by 2 to 3 μm, with parallel sides and rounded ends. <emphasis>B. zoohelcum</emphasis> colonies are sticky and tan to yellow.</para>
        <para id="ch0064s000000p0124">Both<emphasis>B. zoohelcum</emphasis> and <emphasis>W. virosa</emphasis> fail to grow on MacConkey agar and are nonsaccharolytic. <emphasis>B. zoohelcum</emphasis> can be differentiated from <emphasis>W. virosa</emphasis> because it is pyrrolidonyl aminopeptidase negative, strongly urease positive, and resistant to colistin.</para>
        <para id="ch0064s000000p0125"><emphasis>B. zoohelcum</emphasis> is isolated mainly from wounds caused by animal (mostly dog) bites and can lead to meningitis, septicemia, and bacteremia (<link linkend="ch0064s000000li0265">265</link>–<link linkend="ch0064s000000li0268">268</link>). At present no specific antibiotic treatment is recommended, and antimicrobial susceptibility testing should be performed on significant clinical isolates. Harsent et al. (<link linkend="ch0064s000000li0269">269</link>) found significant multidrug resistances in isolates of this species. An additional species, “<emphasis>B. cardium</emphasis>” associated with infective endocarditis, has been proposed by Sohn et al. (<link linkend="ch0064s000000li0270">270</link>) and Guo et al. (<link linkend="ch0064s000000li0271">271</link>), and Mulliken et al. (<link linkend="ch0064s000000li0272">272</link>) found similar isolates to this species also associated with infectious endocarditis. A whole-genome sequence of an isolate of this species has been published by Pan et al. (<link linkend="ch0064s000000li0273">273</link>). The taxonomic status and clinical importance of this species remain unclear.</para>
        <anchor id="ch0064s000000a0110"/>
        <beginpage pagenum="927"/>
      </sect2>
      <sect2 id="ch0064s0011s0002">
        <title>Chryseobacterium</title>
        <anchor id="ch0064s000011a0003"/>
        <anchor id="ch0064s000000a0111"/>
        <para id="ch0064s000000p0126">The genus<emphasis>Chryseobacterium</emphasis> now harbors more than 100 species, including the former CDC group IIb comprising <emphasis>Chryseobacterium indologenes, Chryseobacterium gleum</emphasis>, and others which represent still unnamed taxa.</para>
        <para id="ch0064s000000p0127">Strains included in CDC group IIb are nonmotile rods. Cells of<emphasis>C. indologenes</emphasis> are phenotypically similar to those of <emphasis>Chryseobacterium anthropi, Chryseobacterium hominis, E. meningoseptica</emphasis>, and <emphasis>S. mizutaii</emphasis>, i.e., they are thinner in their central than in their peripheral portions and include filamentous forms. CDC group IIb strains are oxidase and catalase positive, produce flexirubin pigments (<link linkend="ch0064s000000li0002">2</link>), are moderately saccharolytic, and are esculin and gelatin hydrolysis positive. <emphasis>C. indologenes</emphasis> and <emphasis>C. gleum</emphasis> can be differentiated from each other by four characteristics: <emphasis>C. indologenes</emphasis> displays a broad beta-hemolysis area within 3 days of incubation at 37°C on SBA, is always arabinose negative, does not acidify ethylene glycol, and does not grow at 41°C. <emphasis>C. gleum</emphasis> exhibits pronounced alpha-hemolysis, resembling viridans discoloration, always acidifies ethylene glycol, is arabinose positive or delayed positive, and grows at 41°C.</para>
        <para id="ch0064s000000p0128">Beta-hemolysis is absent or very rare in other strains of CDC group IIb and is therefore almost specific for the identification of<emphasis>C. indologenes</emphasis>, while the profile of <emphasis>C. gleum</emphasis> may be shared by other strains of this group. It should be noted that some <emphasis>C. indologenes</emphasis> strains do not produce flexirubin. It should again be noted here that phenotypic differentiation of species within that genus, but also from <emphasis>Elizabethkingia</emphasis> species, is difficult and requires strict adherence to the described methods and the conditions under which they are performed.</para>
        <para id="ch0064s000000p0129">There are two<emphasis>Chryseobacterium</emphasis> species of major clinical interest, i.e., <emphasis>C. indologenes</emphasis> and <emphasis>C. gleum.</emphasis> Among CDC group IIb species, <emphasis>C. indologenes</emphasis> is usually considered most frequently isolated from clinical samples. <emphasis>C. indologenes</emphasis> has been reported with some 10 cases of ventilator-associated pneumonia (e.g., references <link linkend="ch0064s000000li0274">274</link>–<link linkend="ch0064s000000li0277">277</link>). Other health care-related infections due to <emphasis>C. indologenes</emphasis> have been linked to the use of catheters during hospital stays (<link linkend="ch0064s000000li0278">278</link>–<link linkend="ch0064s000000li0283">283</link>). Also, <emphasis>C. indologenes</emphasis> has been identified as the cause of neonatal meningitis (<link linkend="ch0064s000000li0284">284</link>, <link linkend="ch0064s000000li0285">285</link>). The full genome sequence of a multidrug-resistant strain isolated from a cystic fibrosis patient (<link linkend="ch0064s000000li0286">286</link>) and of a multidrug-resistant strain isolated from a wound (<link linkend="ch0064s000000li0287">287</link>) reveals the potential for this organism to become an emerging antibiotic-resistant pathogen (<link linkend="ch0064s000000li0286">286</link>).</para>
        <para id="ch0064s000000p0130"><emphasis>C. indologenes</emphasis> is difficult to distinguish from related organisms by using routine methods. The production of novel types of metallo-β-lactamases from <emphasis>C. indologenes</emphasis> has been studied in detail (<link linkend="ch0064s000000li0288">288</link>).</para>
        <para id="ch0064s000000p0131">Before the year 2006, three reports summarized most of the published cases of bacteremia and other infections caused by<emphasis>C. indologenes</emphasis> (<link linkend="ch0064s000000li0282">282</link>, <link linkend="ch0064s000000li0288">288</link>) or unidentified group IIb <emphasis>Flavobacterium</emphasis> (<link linkend="ch0064s000000li0289">289</link>–<link linkend="ch0064s000000li0292">292</link>). Since 2006, <emphasis>C. indologenes</emphasis> has been described as an emerging pathogen (<link linkend="ch0064s000000li0293">293</link>, <link linkend="ch0064s000000li0294">294</link>), and Mirza et al. (2017) (<link linkend="ch0064s000000li0295">295</link>) recently discovered that cystic fibrosis was the underlying disease for 80% of the <emphasis>Chryseobacterium</emphasis> and <emphasis>Elizabethkingia</emphasis> isolates from a pediatric hospital over a 4-year period.</para>
        <para id="ch0064s000000p0132">Two retrospective reviews of 10 patients and 215 patients, respectively, with<emphasis>C. indologenes</emphasis> bacteremia acquired in the intensive care unit over a 4-year and 7-year period found that most patients had received more than 14 days of broad-spectrum antibiotic treatment prior to bacteremia onset, most infections were polymicrobial, and the primary site of infection could not be identified in many cases (<link linkend="ch0064s000000li0267">267</link>, <link linkend="ch0064s000000li0296">296</link>). Many of these infections were polymicrobial, characterized by a coinfection with <emphasis>A. baumannii, Pseudomonas aeruginosa</emphasis>, or <emphasis>Klebsiella pneumoniae.</emphasis> These findings supported the view that <emphasis>Chryseobacterium</emphasis> spp. is involved in the formation of a polymicrobial biofilm and that secreting β-lactamases may indirectly facilitate the coinfecting pathogens, in a manner similar to <emphasis>Stenotrophomonas maltophilia</emphasis> (<link linkend="ch0064s000000li0297">297</link>). This is supported by the finding that biofilm production allows <emphasis>Chryseobacterium</emphasis> spp. to directly cause bacteremia, as suggested by a study of 34 patient isolates, where 80% (4 out of 5) of isolates from blood were involved in biofilm production (<link linkend="ch0064s000000li0298">298</link>).</para>
        <para id="ch0064s000000p0133">The first neonatal respiratory infections caused by<emphasis>C. gleum</emphasis> were reported in reference <link linkend="ch0064s000000li0299">299</link>. Since 2014, numerous <emphasis>C. gleum</emphasis> infections have been described from blood. Additional details are given by Hugo et al. (<link linkend="ch0064s000000li0300">300</link>).</para>
        <para id="ch0064s000000p0134">Holmes and coworkers (<link linkend="ch0064s000000li0301">301</link>) reported the first <emphasis>C. gleum</emphasis> infections from the vagina, from catheters, and in various body fluids. The absence of infection reports attributed to <emphasis>C. gleum</emphasis> from 1984 to 2014 seems to be mainly due to the fact that automated identification systems dominating the market during that time period did not include this species in their databases. A study from 2017 (<link linkend="ch0064s000000li0302">302</link>) compared identification with four automated systems for 22 isolates; these four systems identified correctly only 4 out of 22 isolates at the species level.</para>
        <para id="ch0064s000000p0135">The vast majority of reported<emphasis>Chryseobacterium</emphasis> infections were detected in people with underlying comorbidities, on ventilators, or with indwelling devices such as arterial and central venous catheters, endotracheal tubes, and drains; among them, elderly patients and neonates are the most challenging cases. Some more details on the literature are given by Hugo et al. (<link linkend="ch0064s000000li0300">300</link>).</para>
        <para id="ch0064s000000p0136">There are also reports on sepsis (<link linkend="ch0064s000000li0303">303</link>), soft tissue infection (<link linkend="ch0064s000000li0304">304</link>), or bacteremia (<link linkend="ch0064s000000li0305">305</link>) in healty individuals with no obvious exposure to health care environments.</para>
        <para id="ch0064s000000p0137">Some additional<emphasis>Chryseobacterium</emphasis> species that have been isolated from human clinical samples include “<emphasis>Candidatus</emphasis> C. massiliae,” “<emphasis>Candidatus</emphasis> C. timonae,” <emphasis>C. anthropi, C. nakagawai, C. bernardetii, C. hominis, C. taklimakanense, C. treverense</emphasis>, and <emphasis>C. oranimense.</emphasis> Their pathogenicity to humans has not been proven until now. The absence of these species from identification systems suggests that they are likely undetected (<link linkend="ch0064s000000li0300">300</link>).</para>
        <para id="ch0064s000000p0138"><emphasis>C. anthropi</emphasis> represents part of the strains formerly designated as CDC group IIe (<link linkend="ch0064s000000li0306">306</link>). Most strains display very sticky colonies, which are nonpigmented but may develop a slightly salmon-pinkish, rarely yellowish color after a few days. In contrast to <emphasis>C. hominis</emphasis>, the species is negative for esculin hydrolysis and acidification of ethylene glycol. In addition, many strains are susceptible to desferrioxamine. Most clinical isolates used for the description of C. <emphasis>anthropi</emphasis> were from wounds and blood cultures (<link linkend="ch0064s000000li0306">306</link>).</para>
        <para id="ch0064s000000p0139"><emphasis>C. hominis</emphasis> includes the strains formerly included in CDC group IIc and most of the strains of CDC group IIh (<link linkend="ch0064s000000li0307">307</link>). This species does not produce flexirubin pigments, but some strains exhibit a slightly yellowish pigmentation. Colonies are often mucoid. <emphasis>C. hominis</emphasis> can be differentiated from <emphasis>C. gleum</emphasis> by the absence of flexirubin pigments and the lack of acid production from arabinose. <emphasis>C. indologenes</emphasis> strains lacking flexirubin pigments may resemble <emphasis>C. hominis</emphasis>, but the latter is never beta-hemolytic and always acidifies ethylene glycol. Many strains of <emphasis>C. hominis</emphasis> have been isolated from blood. Others have been isolated from dialysis fluid, pus, the eye, infraorbital drain, and aortic valve, but their clinical significance remains to be assessed (<link linkend="ch0064s000000li0307">307</link>).</para>
        <anchor id="ch0064s000000a0112"/>
        <beginpage pagenum="928"/>
        <para id="ch0064s000000p0140"><emphasis>Chryseobacterium treverense</emphasis> includes some of the strains formerly designated as CDC group IIe (<link linkend="ch0064s000000li0308">308</link>). Although described as indole negative, <emphasis>C. treverense</emphasis> strains produce indole that should be detected using the method recommended for GNF (see <ulink url="ch0048#ch0048s0001">chapter 32</ulink> of this <emphasis>Manual</emphasis>). The species is phenotypically related to <emphasis>C. anthropi</emphasis> and <emphasis>C. hominis</emphasis> but can be distinguished by a negative (or very weak) gelatin hydrolysis and the absence of acetate alkalinization.</para>
        <para id="ch0064s000000p0141">It is apparent that this group of organisms is intrinsically resistant to many antibiotics, including polymyxins, aminoglycosides (gentamicin, streptomycin, kanamycin), chloramphenicol, and most β-lactams (penicillins, cephalosporins, carbapenems). A detailed report on this is given by Hugo et al. (<link linkend="ch0064s000000li0300">300</link>). The discussion of antibiotic susceptibility among <emphasis>Chryseobacterium</emphasis> and closely related taxa is difficult, due to the absence of officially recognized species-specific clinical breakpoints (<ulink url="https://clsi.org/standards/products/microbiology/documents/m100">https://clsi.org/standards/products/microbiology/documents/m100</ulink>; <ulink url="http://www.eucast.org/clinical_breakpoints/">http://www.eucast.org/clinical_breakpoints/</ulink>). In addition, the applied methods are essential for evaluating antibiotic susceptibility of a specific <emphasis>Chyrseobacterium</emphasis> isolate. Broth and agar dilution methods seem to give reliable results, but disk diffusion and Etest assays are not reliable (<link linkend="ch0064s000000li0309">309</link>–<link linkend="ch0064s000000li0311">311</link>).</para>
        <para id="ch0064s000000p0142"><emphasis>Chryseobacterium indologenes</emphasis> and <emphasis>C. gleum</emphasis> have, like <emphasis>Elizabethkingia meningoseptica</emphasis>, been found to produce carbapenem-hydrolyzing β-lactamases (<link linkend="ch0064s000000li0312">312</link>–<link linkend="ch0064s000000li0314">314</link>), which means that they are resistant to extended-spectrum cephalosporins and carbapenems, but not necessarily to ureidopenicillins, i.e., piperacillin. Many strains of the genus <emphasis>Chryseobacterium</emphasis> have also been found to be resistant to tetracyclines, erythromycin, and linezolid. Data on susceptibility to clindamycin, vancomycin, or trimethoprim-sulfamethoxazole vary. Rifampin seems to be the most active antibiotic, in addition to the newer quinolones (gatifloxacin, levofloxacin, and sparfloxacin) (<link linkend="ch0064s000000li0134">134</link>, <link linkend="ch0064s000000li0309">309</link>, <link linkend="ch0064s000000li0315">315</link>).</para>
        <para id="ch0064s000000p0143">Chen et al. (<link linkend="ch0064s000000li0316">316</link>) published a retrospective study of 215 patient isolates identified as belonging to the genus <emphasis>Chryseobacterium</emphasis> after colistin and tigecycline were given, and found that all isolates were resistant to colistin, aztreonam, gentamicin, and amikacin, and most were susceptible to trimethoprim-sulfamethoxazole (94.9%), followed by cefoperazone-sulbactam (59%) (<link linkend="ch0064s000000li0316">316</link>). Two years later, Chang et al. reported results on 34 <emphasis>C. indologenes</emphasis> isolates (confirmed by 16S rRNA gene sequence analysis) and found that all isolates were resistant to gentamicin, amikacin, ceftriaxone, chloramphenicol, colistin, and imipenem, some were susceptible to trimethoprim-sulfamethoxazole and ciprofloxacin, and all were susceptible to minocycline (<link linkend="ch0064s000000li0298">298</link>).</para>
        <para id="ch0064s000000p0144">It is unfortunately quite common that patients with<emphasis>Chryseobacterium</emphasis> infections are treated with an ineffective antibiotic. More details are given by Hugo et al. (<link linkend="ch0064s000000li0300">300</link>).</para>
      </sect2>
      <sect2 id="ch0064s0011s0003">
        <title>Elizabethkingia</title>
        <anchor id="ch0064s000011a0004"/>
        <anchor id="ch0064s000000a0113"/>
        <para id="ch0064s000000p0145">Colonies of<emphasis>E. meningoseptica</emphasis>, formerly <emphasis>Chryseobacterium meningosepticum</emphasis> (<link linkend="ch0064s000000li0259">259</link>), are smooth and large, either nonpigmented or producing a pale yellow or slightly salmon-pinkish pigment after 2 or 3 days. Characteristic features are acid production from mannitol and β-galactosidase activity. Gelatin and esculin hydrolysis are positive. <emphasis>Elizabethkingia</emphasis> and <emphasis>Chryseobacterium</emphasis> species can be differentiated as well on the basis of 16S rRNA gene sequence analysis (<link linkend="ch0064s000000li0259">259</link>, <link linkend="ch0064s000000li0306">306</link>). Since the original description of <emphasis>E. meningoseptica</emphasis> (initially by Elizabeth King in 1959 as <emphasis>Flavobacterium meningosepticum</emphasis>, causing invasive neonatal and infant disease, notably meningitis) this species has been considered as the most important of clinical relevance. But after the discovery that <emphasis>E. anophelis</emphasis> is the major component of clinically derived strain collections (<link linkend="ch0064s000000li0317">317</link>–<link linkend="ch0064s000000li0319">319</link>), it seems to be clear that many case reports and outbreaks initially attributed to <emphasis>E. meningoseptica</emphasis> have been due instead to <emphasis>E. anophelis.</emphasis> Unfortunately, the phenotypes of both species are very similar; the majority of phenotypic typing kits used in clinical laboratories are unable to separate these two species and still report any infection by an <emphasis>Elizabethkingia</emphasis> species as being due to <emphasis>E. meningoseptica</emphasis> (<link linkend="ch0064s000000li0318">318</link>, <link linkend="ch0064s000000li0319">319</link>)</para>
        <para id="ch0064s000000p0146"><emphasis>E. meningoseptica</emphasis> has been reported to be associated with (neonatal) meningitis (<link linkend="ch0064s000000li0320">320</link>), health care-related outbreaks (see references <link linkend="ch0064s000000li0321">321</link>, <link linkend="ch0064s000000li0322">322</link>), different types of infection (e.g., adult pneumonia and septicemia (<link linkend="ch0064s000000li0235">235</link>, <link linkend="ch0064s000000li0323">323</link>), and infections reported in dialysis units (<link linkend="ch0064s000000li0324">324</link>).</para>
        <para id="ch0064s000000p0147">Infections with<emphasis>Elizabethkingia</emphasis> species are rare. In an earlier study, von Graevenitz (<link linkend="ch0064s000000li0235">235</link>) estimated that about 120 cases of invasive neonatal disease had been reported in the literature by 1985, and later Bloch et al. found 308 patient reports in the English language literature up to 1994 of cultures positive for <emphasis>Elizabethkingia</emphasis>, of which about 60% were judged to represent true infections (<link linkend="ch0064s000000li0321">321</link>). Between the years 1994 and 2006, a total of 13 cases of neonatal infections were reported. Later, beween 2006 and 2018 a much larger total of 290 cases of infection caused by <emphasis>Elizabethkingia</emphasis>, and many additional individual cases, have been listed (details on the literature are given by Nicholson et al. [324]). From these increasing numbers, it seems to be obvious that <emphasis>Elizabethkingia</emphasis> may be regarded as an emerging pathogen (<link linkend="ch0064s000000li0321">321</link>, <link linkend="ch0064s000000li0325">325</link>–<link linkend="ch0064s000000li0327">327</link>).</para>
        <para id="ch0064s000000p0148"><emphasis>E. miricola</emphasis>, initially described as <emphasis>Chryseobacterium miricola</emphasis> by Li et al. (<link linkend="ch0064s000000li0328">328</link>), has been reported as the cause of sepsis (<link linkend="ch0064s000000li0329">329</link>) and urinary tract infection (<link linkend="ch0064s000000li0330">330</link>) and as an opportunistic oral pathogen in a patient with humoral immunodeficiency (<link linkend="ch0064s000000li0331">331</link>). In addition, this species, along with others of the “<emphasis>E. miricola</emphasis> cluster,” has been isolated from sputa, cough swabs, and tracheal aspirates of patients with cystic fibrosis (<link linkend="ch0064s000000li0332">332</link>) and has also been reported as the cause of exacerbation of pulmonary symptoms in a cystic fibrosis patient (<link linkend="ch0064s000000li0332">332</link>).</para>
        <para id="ch0064s000000p0149">After the description of<emphasis>E. anophelis</emphasis> in 2011 (<link linkend="ch0064s000000li0333">333</link>), many reports have been published revealing this organism to be an emerging pathogen, especially in immunocompromised patients. A first report of a meningitis case was published in 2013 (<link linkend="ch0064s000000li0334">334</link>). A transmission from mother to infant was reported in 2015, and a case of bacteremia with a high mortality was subsequently described (<link linkend="ch0064s000000li0334">334</link>). In the same year, an <emphasis>E. anophelis</emphasis> outbreak was reported and the complete genomes of some of the strains were sequenced (<link linkend="ch0064s000000li0335">335</link>). A global epidemiological study showed that distinct <emphasis>E. anophelis</emphasis> sublineages demonstrated high genetic relatedness between African isolates (<link linkend="ch0064s000000li0325">325</link>). <emphasis>E. anophelis</emphasis> was isolated from two separate patients with multiple organ dysfunction syndrome and lower respiratory tract infection (<link linkend="ch0064s000000li0336">336</link>). Janda and coworkers (<link linkend="ch0064s000000li0337">337</link>) concluded that, within a little more than 5 years since its taxonomic description in 2011, <emphasis>E. anophelis</emphasis> from the midgut of mosquitoes has emerged as an important cause of sepsis in adults and children and in cases of neonatal meningitis. At least three moderate- to large-scale outbreaks of disease have been caused by this bacterium, with the largest two occurring in the United States in 2015–2016. As a result, <emphasis>E. anophelis</emphasis> seems to be the predominant <emphasis>Elizabethkingia</emphasis> species found in blood cultures (<link linkend="ch0064s000000li0317">317</link>), and it is currently believed that many of the cases and outbreaks of <emphasis>E. meningoseptica</emphasis> reported in the literature were actually due to <emphasis>E. anophelis.</emphasis> More details on the pathogenicity of <emphasis>Elizabethkingia</emphasis> have been summarized by Nicholson et al. (<link linkend="ch0064s000000li0338">338</link>). Little is presently known regarding its epidemiology, modes of transmission, and pathogenicity factors (<link linkend="ch0064s000000li0337">337</link>).</para>
        <anchor id="ch0064s000000a0114"/>
        <beginpage pagenum="929"/>
        <para id="ch0064s000000p0150">The appropriate choice of effective antimicrobial agents for the treatment of chryseobacterial infections is difficult (<link linkend="ch0064s000000li0322">322</link>). <emphasis>Chryseobacterium</emphasis> species and <emphasis>E. meningoseptica</emphasis> are inherently resistant to many antimicrobial agents commonly used to treat infections caused by Gram-negative bacteria (aminoglycosides, β-lactam antibiotics, tetracyclines, and chloramphenicol) but are often susceptible to agents generally used for treating infections caused by Gram-positive bacteria (rifampin, clindamycin, erythromycin, trimethoprim-sulfamethoxazole, and vancomycin) (<link linkend="ch0064s000000li0134">134</link>, <link linkend="ch0064s000000li0166">166</link>, <link linkend="ch0064s000000li0235">235</link>). Although early investigators recommended vancomycin for treating serious infection with <emphasis>E. meningoseptica</emphasis>, subsequent studies showed greater <emphasis>in vitro</emphasis> activity of minocycline, rifampin, trimethoprim-sulfamethoxazole, and fluoroquinolones (<link linkend="ch0064s000000li0134">134</link>, <link linkend="ch0064s000000li0321">321</link>). Among the quinolones, levofloxacin is more active than ciprofloxacin and ofloxacin (<link linkend="ch0064s000000li0134">134</link>). <emphasis>C. indologenes</emphasis> is reported to be uniformly resistant to cephalothin, cefotaxime, ceftriaxone, aztreonam, aminoglycosides, erythromycin, clindamycin, vancomycin, and teicoplanin, while susceptibility to piperacillin, cefoperazone, ceftazidime, imipenem, quinolones, minocycline, and trimethoprim-sulfamethoxazole is variable, requiring testing of individual isolates (<link linkend="ch0064s000000li0134">134</link>). Several studies reported that administration of a fluoroquinolone, minocycline, trimethoprim-sulfamethoxazole, or rifampin and treatment of local infection improve the clinical outcome of patients with <emphasis>E. meningoseptica</emphasis> infections. The choice of appropriate antimicrobial therapy is further complicated by the fact that MIC breakpoints for resistance and susceptibility of chryseobacteria have not been established by the CLSI, and the results of disk diffusion testing are unreliable in predicting antimicrobial susceptibility of <emphasis>Chryseobacterium</emphasis> species (<link linkend="ch0064s000000li0339">339</link>). The Etest is a possible alternative to the standard agar dilution method for testing cefotaxime, ceftazidime, amikacin, minocycline, ofloxacin, and ciprofloxacin, but not piperacillin (<link linkend="ch0064s000000li0292">292</link>). Definitive therapy for clinically significant isolates should be guided by individual susceptibility patterns determined by an MIC method.</para>
      </sect2>
      <sect2 id="ch0064s0011s0004">
        <title>Empedobacter</title>
        <anchor id="ch0064s000011a0005"/>
        <anchor id="ch0064s000000a0115"/>
        <para id="ch0064s000000p0151"><emphasis>E. brevis</emphasis> (<link linkend="ch0064s000000li0340">340</link>) colonies are yellowish pigmented but do not produce flexirubin. <emphasis>E. brevis</emphasis> can be differentiated from <emphasis>C. indologenes, C. gleum</emphasis>, other CDC group IIb strains, and <emphasis>C. hominis</emphasis> by its lack of esculin hydrolysis. Growth on MacConkey agar and stronger gelatinase activity are useful to distinguish it from <emphasis>C. anthropi.</emphasis> The species is rarely recovered from clinical material (<link linkend="ch0064s000000li0341">341</link>, <link linkend="ch0064s000000li0342">342</link>).</para>
        <para id="ch0064s000000p0152">A second species of the genus<emphasis>Empedobacter</emphasis> is <emphasis>Empedobacter falsenii</emphasis> (formerly <emphasis>Wautersiella falsenii</emphasis>) (<link linkend="ch0064s000000li0343">343</link>). <emphasis>E. falsenii</emphasis> is closely related to <emphasis>E. brevis</emphasis>, from which it differs by its urease activity. Two genomovars have been described (<link linkend="ch0064s000000li0344">344</link>): genomovar 1 is always esculin positive and β-galactosidase negative, whereas 90% of the genomovar 2 strains are esculin negative and 63% are β-galactosidase positive.</para>
        <para id="ch0064s000000p0153"><emphasis>E. falsenii</emphasis> is more frequently isolated from clinical samples than <emphasis>E. brevis</emphasis> and was detected as causal agent of a respiratory tract infection in an immunocompromised man (<link linkend="ch0064s000000li0345">345</link>), in a sample from a cervical neck abscess (<link linkend="ch0064s000000li0346">346</link>), in a urine sample from an infant with pyelonephritis (<link linkend="ch0064s000000li0347">347</link>), and in a patient with cystic fibrosis (<link linkend="ch0064s000000li0348">348</link>). Genome sequence analyses of selected strains revealed extensive drug resistances, among them novel variants of metallo-β-lactamases (<link linkend="ch0064s000000li0349">349</link>–<link linkend="ch0064s000000li0351">351</link>).</para>
      </sect2>
      <sect2 id="ch0064s0011s0005">
        <title>Sphingobacterium</title>
        <anchor id="ch0064s000011a0006"/>
        <anchor id="ch0064s000000a0116"/>
        <para id="ch0064s000000p0154"><emphasis>S. mizutaii</emphasis>, previously known as <emphasis>Flavobacterium mizutaii</emphasis> (<link linkend="ch0064s000000li0243">243</link>) but originally described as <emphasis>Sphingobacterium mizutae</emphasis>, is an indole-positive <emphasis>Sphingobacterium</emphasis> species of clinical importance. It is saccharolytic—producing acid from a large number of carbohydrates, including xylose—similar to other <emphasis>Sphingobacterium</emphasis> species, from which it can be distinguished by its indole production, its failure to grow on MacConkey agar, and its usual lack of urease activity (<link linkend="ch0064s000000li0046">46</link>).</para>
        <para id="ch0064s000000p0155"><emphasis>S. mizutaii</emphasis> can be distinguished from <emphasis>Chryseobacterium</emphasis> and <emphasis>Empedobacter</emphasis> species by its lack of gelatin hydrolysis and of flexirubin production. <emphasis>S. mizutaii</emphasis> produces acid from xylose but not from ethylene glycol, allowing differentiation from other indole-positive species. The phenotypic profile of <emphasis>S. mizutaii</emphasis> is similar to that of the strains described as <emphasis>Chryseobacterium</emphasis> CDC group IIi. Furthermore, 16S rRNA gene sequencing confirms that most CDC group IIi strains actually belong to the species <emphasis>S. mizutaii</emphasis> (<link linkend="ch0064s000000li0241">241</link>). <emphasis>S. mizutaii</emphasis> has been isolated from blood, CSF, and wound specimens (<link linkend="ch0064s000000li0046">46</link>). A second species, <emphasis>Sphingobacterium cellulitidis</emphasis>, most closely related to <emphasis>S. mizutaii</emphasis> and showing a positive trytophan deaminase reaction, has been described as a cause of cellulitis infection (<link linkend="ch0064s000000li0249">249</link>).</para>
      </sect2>
      <sect2 id="ch0064s0011s0006">
        <title>Weeksella</title>
        <anchor id="ch0064s000011a0007"/>
        <anchor id="ch0064s000000a0117"/>
        <para id="ch0064s000000p0156"><emphasis>W. virosa</emphasis> colonies are mucoid and adherent to the agar, reminiscent of the sticky colonies of <emphasis>B. zoohelcum.</emphasis> Colonies are not pigmented after 24 h of incubation but may become yellowish tan to brown after 2 or 3 days. The cellular morphology of <emphasis>W. virosa</emphasis> is dealt with above in the discussion of <emphasis>B. zoohelcum. W. virosa</emphasis> can be differentiated from <emphasis>B. zoohelcum</emphasis> because it is urease negative and polymyxin B and colistin susceptible, whereas <emphasis>B. zoohelcum</emphasis> is rapid urease positive and polymyxin B and colistin resistant. <emphasis>W. virosa</emphasis> comprises former CDC group IIf strains (<link linkend="ch0064s000000li0352">352</link>). <emphasis>W. virosa</emphasis> is isolated mainly from urine and vaginal samples (<link linkend="ch0064s000000li0352">352</link>) and has been reported in cases of postoperative intracranial infection, fatal sepsis, and peritonitis (<link linkend="ch0064s000000li0353">353</link>–<link linkend="ch0064s000000li0355">355</link>). In contrast, <emphasis>B. zoohelcum</emphasis> is isolated mostly from animal bites. An additional species, <emphasis>Weeksella massiliensis</emphasis>, isolated from a patient with acute cystitis, has been described by Sankar et al. (<link linkend="ch0064s000000li0356">356</link>), but no futher report has been published so far for this species.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0064s0012">
      <title>Pink-Pigmented GNF</title>
      <anchor id="ch0064s000012a0001"/>
      <anchor id="ch0064s000000a0118"/>
      <para id="ch0064s000000p0157">It should be noted that colonies of<emphasis>C. anthropi</emphasis> and <emphasis>E. meningoseptica</emphasis> can be lightly salmon colored on some media after several days of incubation, but this is not to be confused with the clearly pink colonies of the taxa discussed here (<link linkend="ch0064s000000a0121">Table 5</link>).</para>
      <sect2 id="ch0064s0012s0001">
        <title>Asaia</title>
        <anchor id="ch0064s000012a0002"/>
        <anchor id="ch0064s000000a0119"/>
        <para id="ch0064s000000p0158"><emphasis>Asaia</emphasis> is a genus of the family <emphasis>Acetobacteraceae</emphasis> (<emphasis>Alphaproteobacteria</emphasis>) that includes eight species. The natural habitats of <emphasis>Asaia</emphasis> species are reported to be the flowers of the orchid tree, the plumbago plant, and fermented glutinous rice, all originating in hot tropical climates, particularly in Indonesia and Thailand.</para>
        <anchor id="ch0064s000000a0120"/>
        <beginpage pagenum="930"/>
        <table id="ch0064s000000t0005"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0064s000000a0121"/><link linkend="ch0064s000000a0030">TABLE 5</link></phrase></emphasis> Pink-pigmented GNF<superscript><emphasis><anchor id="ch0064s000000a0122"/><link linkend="ch0064s000000a0124">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="9">
            <tbody>
              <row>
                <entry><phrase role="center">Characteristic</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>Asaia</emphasis> spp. (2)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>Azopsirillum</emphasis> spp. (3)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>Methylobacterium</emphasis> spp. (4)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>Roseomonas cervicalis</emphasis> (2)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>Roseomonas gilardii</emphasis> subsp. <emphasis>gilardii</emphasis> and <emphasis>Roseomonas gilardii</emphasis> subsp. <emphasis>rosea</emphasis> (5)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>Roseomonas mucosa</emphasis> (9)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>Roseomonas</emphasis> genomic species 4 (1)</phrase>
                </entry>
                <entry><phrase role="left"><emphasis>Roseomonas</emphasis> genomic species 5 (4)</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Oxidase</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100<superscript>w</superscript></phrase>
                </entry>
                <entry><phrase role="center">11<superscript>w</superscript></phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100<superscript>w</superscript></phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Acidification of:</phrase>
                </entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left">Glucose</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">(25)</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">(20)</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">(100)</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Fructose</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">(100)<superscript>w</superscript></phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">50</phrase>
                </entry>
                <entry><phrase role="center">60/(40)</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">(100)</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Mannitol</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">(80)</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Xylose</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">(100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Arabinose</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Ethylene glycol</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Urease</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Nitrate reductase</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Esculin hydrolysis</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Trypsin</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Pyrrolidonyl aminopeptidase</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">β-Galactosidase (ONPG<superscript><emphasis><anchor id="ch0064s000000a0123"/><link linkend="ch0064s000000a0125">b</link></emphasis></superscript>)</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Susceptibility to:</phrase>
                </entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><phrase role="left">Colistin</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">40</phrase>
                </entry>
                <entry><phrase role="center">45</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">25</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="left">Desferrioxamine</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
                <entry><phrase role="center">100</phrase>
                </entry>
                <entry><phrase role="center">0</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0124"/><link linkend="ch0064s000000a0122">a</link></emphasis></superscript>Numbers in parentheses after organism names are numbers of strains tested. Values are percentages; those in parentheses represent delayed positivity. W, weakly positive reaction.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0064s000000a0125"/><link linkend="ch0064s000000a0123">b</link></emphasis></superscript>ONPG, <emphasis>o</emphasis>-nitrophenyl-β-<phrase role="small">D</phrase>-galactopyranoside.</para>
        <para id="ch0064s000000p0159">Growth of<emphasis>Asaia</emphasis> species is scant to moderate on SBA. Colonies are pale pink. In contrast to <emphasis>Methylobacterium</emphasis>, colonies are not dark under UV light. <emphasis>Asaia</emphasis> species are small to middle-sized, Gram-negative rods, usually motile by one or two polar or lateral flagella. The species are oxidase negative and strongly saccharolytic; i.e., glucose, mannitol, xylose, and <phrase role="small">L</phrase>-arabinose are acidified very rapidly, often within 1 h on low-peptone phenol red agar. Acid is also produced from ethylene glycol. Furthermore, <emphasis>Asaia</emphasis> species are biochemically rather inert, except for benzyl arginine aminopeptidase (trypsin) activity. <emphasis>Asaia</emphasis> species can be distinguished from <emphasis>Methylobacterium</emphasis> species by cell morphology, a stronger saccharolytic activity, and acid production from mannitol.</para>
        <para id="ch0064s000000p0160"><emphasis>A. bogorensis</emphasis> has been reported as a cause of peritonitis in a patient on automated peritoneal dialysis (<link linkend="ch0064s000000li0357">357</link>) and as a cause of bacteremia after intravenous drug abuse (<link linkend="ch0064s000000li0358">358</link>). <emphasis>A. lannensis</emphasis> has been identified as the cause of health care-related infections in pediatric patients with idiopathic dilated cardiomyopathy (<link linkend="ch0064s000000li0359">359</link>) and of bacteremia in an intravenous-drug user (<link linkend="ch0064s000000li0360">360</link>).</para>
        <para id="ch0064s000000p0161"><emphasis>Asaia</emphasis> species have been reported to be resistant to ceftazidime, meropenem, imipenem, trimethoprim, amikacin, vancomycin, aztreonam, penicillin, and ampicillin by disk diffusion (<link linkend="ch0064s000000li0361">361</link>). The <emphasis>A. bogorensis</emphasis> strain reported by Snyder et al. (<link linkend="ch0064s000000li0357">357</link>) was susceptible to aminoglycosides (amikacin, tobramycin, and gentamicin) and resistant to ceftazidime and meropenem by disk diffusion.</para>
      </sect2>
      <sect2 id="ch0064s0012s0002">
        <title>Azospirillum</title>
        <anchor id="ch0064s000012a0003"/>
        <anchor id="ch0064s000000a0126"/>
        <para id="ch0064s000000p0162"><emphasis>Azospirillum</emphasis> is a genus of nitrogen-fixing plant symbionts that is in a different order of bacteria, i.e., the order <emphasis>Rhodospirillales</emphasis> (<link linkend="ch0064s000000li0362">362</link>). The genus contains 23 species. Some strains of this genus may occasionally be isolated from clinical material (<link linkend="ch0064s000000li0363">363</link>).</para>
        <para id="ch0064s000000p0163">Colonies are pale pink and resemble those of<emphasis>Roseomonas.</emphasis> Cells are somewhat more rod shaped than <emphasis>Roseomonas</emphasis> and are motile by one or two polar flagella. Oxidase is positive and hydrolysis of urea is strongly positive, as in <emphasis>Roseomonas</emphasis> species. β-Galactosidase activity and esculin hydrolysis allow differentiation of <emphasis>Azospirillum</emphasis> from other pink-pigmented species.</para>
      </sect2>
      <sect2 id="ch0064s0012s0003">
        <title>Methylobacterium</title>
        <anchor id="ch0064s000012a0004"/>
        <anchor id="ch0064s000000a0127"/>
        <para id="ch0064s000000p0164">The genus<emphasis>Methylobacterium</emphasis> (family <emphasis>Methylobacteriaceae</emphasis>) consists of over 50 species. <emphasis>Methylobacterium</emphasis> species are isolated mostly from vegetation but may also occasionally be found in the hospital environment. <emphasis>M. mesophilicum</emphasis> (formerly <emphasis>Pseudomonas mesophilica, Pseudomonas extorquens</emphasis>, and <emphasis>Vibrio extorquens</emphasis>), <emphasis>M. extorquens</emphasis>, and <emphasis>M. zatmanii</emphasis> are the three most commonly isolated species from normally sterile body sites (blood, cerebrospinal fluid, bone marrow, synovia, and ascitic and peritoneal fluids) (<link linkend="ch0064s000000li0364">364</link>).</para>
        <anchor id="ch0064s000000a0128"/>
        <beginpage pagenum="931"/>
        <para id="ch0064s000000p0165">Colonies of<emphasis>Methylobacterium</emphasis> species are small, dry, and coral pink. Under UV light, <emphasis>Methylobacterium</emphasis> colonies appear dark due to absorption of UV light (<link linkend="ch0064s000000li0363">363</link>). Growth is fastidious on ordinary media such as TSA, producing 1-mm-diameter colonies after 4 to 5 days on SBA, modified Thayer-Martin, buffered charcoal-yeast extract, and Middlebrook 7H11 agars, with the best growth occurring on Sabouraud agar and usually no growth on MacConkey agar. Optimum growth occurs between 25 and 30°C. They are able to utilize methanol as a sole source of carbon and energy, although this characteristic may be lost on subculture. Cells are pleomorphic, vacuolated rods that stain poorly and may resist decolorization (<anchor id="ch0064s000000a0129"/><link linkend="ch0064s000000a0130">Fig. 4</link>). Motility by one polar flagellum is difficult to demonstrate. In the description of the genus (<link linkend="ch0064s000000li0365">365</link>), methylobacteria were reported to be oxidase positive, but the strains tested by Georges Wauters with the dimethyl-paraphenylenediamine reagent were all oxidase negative (see <ulink url="ch0062#ch0062s0001">chapter 45</ulink> of the previous edition of this <emphasis>Manual</emphasis>). Saccharolytic activity is weaker than in <emphasis>Asaia</emphasis> spp., no acid is produced from mannitol, and acid is produced irregularly from glucose. Arabinose, xylose, and ethylene glycol are acidified. Urea and starch are hydrolyzed.</para>
        <para id="ch0064s000000p0166">Although in general,<emphasis>Methylobacterium</emphasis> species cause mild clinical symptoms as opportunistic pathogens in immunocompromised patients, they have been reported to cause septicemia, continuous ambulatory peritoneal dialysis-related peritonitis, skin ulcers, synovitis, brain abscesses, and other infections, often in immunocompromised patients (<link linkend="ch0064s000000li0366">366</link>–<link linkend="ch0064s000000li0371">371</link>). Their ability to form biofilms and to resist high temperatures, drying, and disinfecting agents probably contributes to their colonization of hospital environments, e.g., endosocpes (<link linkend="ch0064s000000li0364">364</link>). Tap water has been implicated as a possible agent of transmission in hospital environments, and methods for monitoring water systems for methylobacteria have been described previously (<link linkend="ch0064s000000li0003">3</link>).</para>
        <para id="ch0064s000000p0167">Active drugs include aminoglycosides and trimethoprim-sulfamethoxazole, whereas β-lactam drugs show variable activity (<link linkend="ch0064s000000li0372">372</link>). These species are best tested for susceptibility by agar or broth dilution at 30°C for 48 h (<link linkend="ch0064s000000li0030">30</link>).</para>
        <figure id="ch0064s000000f0004"><title><phrase role="figureLabel"><anchor id="ch0064s000000a0130"/><link linkend="ch0064s000000a0129">FIGURE 4</link></phrase> Gram stain of <emphasis>Methylobacterium</emphasis>, showing pleomorphic, Gram-negative rods with vacuoles.</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0064f09.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
      </sect2>
      <sect2 id="ch0064s0012s0004">
        <title>Roseomonas</title>
        <anchor id="ch0064s000012a0005"/>
        <anchor id="ch0064s000000a0131"/>
        <para id="ch0064s000000p0168">As of July 2022, the genus<emphasis>Roseomonas</emphasis> includes 50 species, and the type species, <emphasis>R. gilardii</emphasis>, comprises the subspecies <emphasis>R. gilardii</emphasis> subsp. <emphasis>rosea</emphasis> and <emphasis>R. gilardii</emphasis> subsp. <emphasis>gilardii</emphasis> (<link linkend="ch0064s000000li0362">362</link>).</para>
        <para id="ch0064s000000p0169">The following<emphasis>Roseomonas</emphasis> species can be isolated from clinical samples: <emphasis>R. gilardii</emphasis> subsp. <emphasis>gilardii, R. gilardii</emphasis> subsp. <emphasis>rosea, R. mucosa</emphasis>, and <emphasis>R. cervicalis</emphasis>.</para>
        <para id="ch0064s000000p0170">Colonies are mucoid and runny and grow larger than those of<emphasis>Asaia</emphasis> and <emphasis>Methylobacterium.</emphasis> Pigmentation varies from pale pink to coral pink. <emphasis>Roseomonas</emphasis> cells are nonvacuolated, coccoid, plump rods, mostly in pairs and short chains (<anchor id="ch0064s000000a0132"/><link linkend="ch0064s000000a0134">Fig. 5</link>) and usually motile by one or two polar flagella, but motility is often difficult to demonstrate. Growth occurs at 37°C on ordinary media like SBA, and mostly on MacConkey agar, but the best growth is observed on Sabouraud agar. Oxidase is dependent on the species and often weak. Saccharolytic activity is also species dependent. All <emphasis>Roseomonas</emphasis> species strongly hydrolyze urea but not esculin. They are trypsin and β-galactosidase negative. Phenotypic distinction among the different species is based on oxidase, acid production from carbohydrates, and pyrrolidonyl aminopeptidase and nitrate reductase activities.</para>
        <para id="ch0064s000000p0171"><emphasis>R. mucosa</emphasis> rapidly acidifies arabinose, mannitol, and fructose. Glucose is acidified within 1 to 3 days. Oxidase is negative, and pyrrolidonyl aminopeptidase is positive. <emphasis>R. gilardii</emphasis> subsp. <emphasis>gilardii</emphasis> and <emphasis>R. gilardii</emphasis> subsp. <emphasis>rosea</emphasis> exhibit a weak oxidase reaction and are pyrrolidonyl aminopeptidase positive. The two subspecies cannot be differentiated by current phenotypic tests. They are less saccharolytic than <emphasis>R. mucosa</emphasis> and produce acid from arabinose and fructose, but only irregularly and slowly from mannitol and rarely from glucose. <emphasis>R. cervicalis</emphasis> is strongly oxidase positive but has no pyrrolidonyl aminopeptidase activity. Only arabinose and fructose are positive within 2 days and xylose within 3 or 4 days. The single strain of genomic species 4 examined is also oxidase positive and pyrrolidonyl aminopeptidase negative, and its saccharolytic activity is limited to acid production from glucose and fructose. It is the only species displaying nitrate reduction. Genomic species 5 is weakly oxidase positive and pyrrolidonyl aminopeptidase negative. It is the least saccharolytic species, with only a delayed acid production from fructose. Ethylene glycol is acidified by all species except by genomic species 4 and 5.</para>
        <para id="ch0064s000000p0172"><emphasis>Roseomonas</emphasis> species are uncommon isolates from humans, but they are nevertheless the most frequently isolated pink GNF. Clinical isolates have been recovered from blood, wounds, exudates, abscesses, genitourinary sites, continuous ambulatory peritoneal dialysis fluid, and bone (<link linkend="ch0064s000000li0373">373</link>–<link linkend="ch0064s000000li0377">377</link>). A total of 35 cases of opportunistic infections with <emphasis>Roseomonas</emphasis> species have been reviewed (<link linkend="ch0064s000000li0199">199</link>). In multiple-case reports, about 60% of the isolates recovered have been from blood, with about 20% from wounds, exudates, and abscesses and about 10% from genitourinary sites (<link linkend="ch0064s000000li0373">373</link>, <link linkend="ch0064s000000li0375">375</link>).</para>
        <anchor id="ch0064s000000a0133"/>
        <beginpage pagenum="932"/>
        <figure id="ch0064s000000f0005"><title><phrase role="figureLabel"><anchor id="ch0064s000000a0134"/><link linkend="ch0064s000000a0132">FIGURE 5</link></phrase> Gram stain of <emphasis>Roseomonas</emphasis>, showing Gram-negative, coccoid organisms.</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0064f05.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0064s000000p0173">Dé et al. (<link linkend="ch0064s000000li0373">373</link>) summarized susceptibility data from three published reports on a combined 80 strains of <emphasis>Roseomonas.</emphasis> All strains were susceptible to amikacin (100%); frequently susceptible to imipenem (99%), ciprofloxacin (90%), and ticarcillin (83%); less susceptible to ceftriaxone (38%), trimethoprim-sulfamethoxazole (30%), and ampicillin (13%); and rarely susceptible to ceftazidime (5%). All strains were resistant to cefepime. In catheter-related infections, eradication of the organism has proven difficult unless the infected catheter is removed.</para>
      </sect2>
      <sect2 id="ch0064s0012s0005">
        <title>ANTIMICROBIAL SUSCEPTIBILITIES</title>
        <anchor id="ch0064s000012a0006"/>
        <anchor id="ch0064s000000a0135"/>
        <para id="ch0064s000000p0174">Decisions about performing susceptibility testing are complicated by the fact that the CLSI interpretive guidelines for disk diffusion testing of GNF are limited to<emphasis>Pseudomonas</emphasis> species, <emphasis>B. cepacia, Stenotrophomonas maltophilia</emphasis>, and <emphasis>Acinetobacter</emphasis> species and therefore, except for <emphasis>Acinetobacter</emphasis> species, do not include the organisms covered in this chapter. Furthermore, results obtained with <emphasis>Acinetobacter</emphasis> species, for example by using disk diffusion, do not correlate with results obtained by conventional MIC methods. In general, laboratories should try to avoid performing disk diffusion-based susceptibility testing on the organisms included in this chapter. When clinical necessity dictates that susceptibility testing be performed, an overnight MIC method, e.g., Etest (bioMérieux) on Mueller-Hinton agar (<link linkend="ch0064s000000li0291">291</link>), is recommended.</para>
      </sect2>
      <sect2 id="ch0064s0012s0006">
        <title>EVALUATION, INTERPRETATION, AND REPORTING OF RESULTS</title>
        <anchor id="ch0064s000012a0007"/>
        <anchor id="ch0064s000000a0136"/>
        <para id="ch0064s000000p0175">Although certain GNF can, on occasion, be frank pathogens, e.g.,<emphasis>Burkholderia pseudomallei, E. meningoseptica</emphasis>, and <emphasis>P. aeruginosa</emphasis>, they are generally considered to be of low virulence and often occur in mixed infections, making it difficult to determine when to work up cultures and when to perform susceptibility studies. <emphasis>E. meningoseptica</emphasis> in neonatal meningitis, <emphasis>M. lacunata</emphasis> in eye infections, and <emphasis>B. catarrhalis</emphasis> in respiratory tract infections should be reported as significant pathogens. Direct Gram stain interpretation of clinical specimens may be of limited importance because these organisms often occur in mixed infections and because their clinical importance has to be interpreted taking into account the considerations discussed below. Decisions regarding the significance of GNF in a clinical specimen must consider the clinical condition of the patient and the source of the specimen submitted for culture. In general, the recovery of a GNF in pure culture from a normally sterile site warrants identification and susceptibility testing, whereas predominant growth of a GNF from a nonsterile specimen, such as an endotracheal culture from a patient with no clinical signs or symptoms of pneumonia, would not be worked up further. Identification of GNF may also be important to document health care-related outbreaks linked to hospital environments or medical devices. Because many GNF exhibit multiple antibiotic resistance, patients who are on antibiotics often become colonized with GNF. GNF species isolated in mixed cultures can usually be reported by descriptive identification, e.g., “growth of <emphasis>P. aeruginosa</emphasis> and two varieties of GNF not further identified.”</para>
      </sect2>
      <sect2 id="ch0064s0012s0007">
        <title>REFERENCES</title>
        <anchor id="ch0064s000012a0008"/>
        <anchor id="ch0064s000000a0137"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0064s000000li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Rossau R, Gillis M, De Ley J.</emphasis> 1991. Taxonomy of <citetitle><emphasis>Moraxellaceae</emphasis></citetitle> fam. nov., a new bacterial family to accommodate the genera <citetitle><emphasis>Moraxella, Acinetobacter</emphasis></citetitle>, and <citetitle><emphasis>Psychrobacter</emphasis></citetitle> and related organisms. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>310–319.</para>
          </listitem>
          <listitem id="ch0064s000000li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Bernardet JF, Nakagawa Y, Holmes B, Subcommittee on the Taxonomy of Flavobacterium and Cytophaga-Like Bacteria of the International Committee on Systematics of Prokaryotes.</emphasis> 2002. Proposed minimal standards for describing new taxa of the family Flavobacteriaceae and emended description of the family. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>1049–1070.</para>
          </listitem>
          <listitem id="ch0064s000000li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">García-López M, Meier-Kolthoff JP, Tindall BJ, Gronow S, Woyke T, Kyrpides NC, Hahnke RL, Göker M.</emphasis> 2019. Analysis of 1,000 type-strain genomes improves taxonomic classification of <citetitle><emphasis>Bacteroidetes. Front Microbiol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>2083.</para>
          </listitem>
          <listitem id="ch0064s000000li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Rice EW, Reasoner DJ, Johnson CH, DeMaria LA.</emphasis> 2000. Monitoring for methylobacteria in water systems. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>4296–4297.</para>
          </listitem>
          <listitem id="ch0064s000000li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Seifert H, Strate A, Pulverer G.</emphasis> 1995. Nosocomial bacteremia due to <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle>. Clinical features, epidemiology, and predictors of mortality. <citetitle><emphasis>Medicine (Baltimore)</emphasis></citetitle> <emphasis role="strong">74:</emphasis>340–349.</para>
          </listitem>
          <listitem id="ch0064s000000li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Davis KA, Moran KA, McAllister, CK, Gray, PJ.</emphasis> 2005. Multidrug-resistant Acinetobacter extremity infections in soldiers. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">11:</emphasis>1218–1224.</para>
          </listitem>
          <listitem id="ch0064s000000li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Dijkshoorn L, Nemec A, Seifert H.</emphasis> 2007. An increasing threat in the hospital: multidrug resistant <citetitle><emphasis>Acinetobacter baumannii. Nat Rev Microbiol</emphasis></citetitle> <emphasis role="strong">5</emphasis>(12)<emphasis role="strong">:</emphasis>939–951. doi:10.1038/nrmicro1789.</para>
          </listitem>
          <listitem id="ch0064s000000li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL.</emphasis> 2006. Fulminant community-acquired <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> pneumonia as a distinct clinical syndrome. <citetitle><emphasis>Chest</emphasis></citetitle> <emphasis role="strong">129:</emphasis>102–109.</para>
          </listitem>
          <listitem id="ch0064s000000li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Park KH, Shin JH, Lee SY, Kim SH, Jang MO, Kang SJ, Jung SI, Chung EK, Ko KS, Jang HC.</emphasis> 2013. The clinical characteristics, carbapenem resistance, and outcome of <citetitle><emphasis>Acinetobacter</emphasis></citetitle> bacteremia according to genospecies. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">8:</emphasis>e65026.</para>
          </listitem>
          <listitem id="ch0064s000000li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H.</emphasis> 2002. Community-acquired bacteremic <citetitle><emphasis>Acinetobacter pneumonia</emphasis></citetitle> in tropical Australia is caused by diverse strains of <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle>, with carriage in the throat in at-risk groups. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>685–686.</para>
          </listitem>
          <listitem id="ch0064s000000li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M.</emphasis> 1997. Distribution of <citetitle><emphasis>Acinetobacter</emphasis></citetitle> species on human skin: comparison of phenotypic and genotypic identification methods. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">35:</emphasis>2819–2825.</para>
          </listitem>
          <listitem id="ch0064s000000li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Dortet L, Legrand P, Soussy CJ, Cattoir V.</emphasis> 2006. Bacterial identification, clinical significance, and antimicrobial susceptibilities of <citetitle><emphasis>Acinetobacter ursingii</emphasis></citetitle> and <citetitle><emphasis>Acinetobacter schindleri</emphasis></citetitle>, two frequently misidentified opportunistic pathogens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">44:</emphasis>4471–4478.</para>
          </listitem>
          <listitem id="ch0064s000000li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen Ø, Norwegian Study Group of Acinetobacter.</emphasis> 2011. Species identification and molecular characterization of <citetitle><emphasis>Acinetobacter</emphasis></citetitle> spp. blood culture isolates from Norway. <citetitle><emphasis>J Antimicrob Chemother</emphasis></citetitle> <emphasis role="strong">66:</emphasis>738–744.</para>
          </listitem>
          <listitem id="ch0064s000000li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Turton JF, Shah J, Ozongwu C, Pike R.</emphasis> 2010. Incidence of <citetitle><emphasis>Acinetobacter</emphasis></citetitle> species other than <citetitle><emphasis>A. baumannii</emphasis></citetitle> among clinical isolates of <citetitle><emphasis>Acinetobacter</emphasis></citetitle>: evidence for emerging species. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">48:</emphasis>1445–1449.</para>
          </listitem>
          <listitem id="ch0064s000000li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">de Beaufort AJ, Bernards AT, Dijkshoorn L, van Boven CP.</emphasis> 1999. <citetitle><emphasis>Acinetobacter junii</emphasis></citetitle> causes life-threatening sepsis in preterm infants. <citetitle><emphasis>Acta Paediatr</emphasis></citetitle> <emphasis role="strong">88:</emphasis>772–775.</para>
          </listitem>
          <listitem id="ch0064s000000li0016" role="bibliographyEntry">
            <anchor id="ch0064s000000a0138"/>
            <para>16.<emphasis role="strong">Pellegrino FL, Vieira VV, Baio PV, dos Santos RM, dos Santos AL, Santos NG, Meohas MM, Santos RT, de Souza TC, da Silva Dias RC, Santoro-Lopes G, Riley LW, Moreira BM.</emphasis> 2011. <citetitle><emphasis>Acinetobacter soli</emphasis></citetitle> as a cause of bloodstream infection in a neonatal intensive care unit. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>2283–2285.</para>
          </listitem>
          <listitem id="ch0064s000000li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN, Wenzel RP, Seifert H.</emphasis> 2000. Nosocomial bloodstream infections caused by <citetitle><emphasis>Acinetobacter</emphasis></citetitle> species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">31:</emphasis>690–697.</para>
          </listitem>
          <listitem id="ch0064s000000li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">de Vries SP, Bootsma HJ, Hays JP, Hermans PW.</emphasis> 2009. Molecular aspects of <citetitle><emphasis>Moraxella catarrhalis</emphasis></citetitle> pathogenesis. <citetitle><emphasis>Microbiol Mol Biol Rev</emphasis></citetitle> <emphasis role="strong">73:</emphasis>389–406.</para>
          </listitem>
          <listitem id="ch0064s000000li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Karalus R, Campagnari A.</emphasis> 2000. <citetitle><emphasis>Moraxella catarrhalis</emphasis></citetitle>: a review of an important human mucosal pathogen. <citetitle><emphasis>Microbes Infect</emphasis></citetitle> <emphasis role="strong">2:</emphasis>547–559.</para>
          </listitem>
          <listitem id="ch0064s000000li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Shah SS, Ruth A, Coffin SE.</emphasis> 2000. Infection due to <citetitle><emphasis>Moraxella osloensis</emphasis></citetitle>: case report and review of the literature. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">30:</emphasis>179–181.</para>
          </listitem>
          <listitem id="ch0064s000000li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Vaneechoutte M, Claeys G, Steyaert S, De Baere T, Peleman R, Verschraegen G.</emphasis> 2000. Isolation of <citetitle><emphasis>Moraxella canis</emphasis></citetitle> from an ulcerated metastatic lymph node. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>3870–3871.</para>
          </listitem>
          <listitem id="ch0064s000000li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Di Stefano A, Ricciardolo FLM, Caramori G, Adcock IM, Chung KF, Barnes PJ, Brun P, Leonardi A, Andò F, Vallese D, Gnemmi I, Righi L, Cappello F, Balbi B.</emphasis> 2017. Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. <citetitle><emphasis>Eur Respir J</emphasis></citetitle> <emphasis role="strong">49:</emphasis>1602006.</para>
          </listitem>
          <listitem id="ch0064s000000li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">Evangelista P, Evangelista G, Ogrich L.</emphasis> 2017. Infection after total knee arthroplasty by <citetitle><emphasis>M. catarrhalis</emphasis></citetitle> associated with rheumatoid arthritis and DMARDs therapy. <citetitle><emphasis>Bull Hosp Jt Dis</emphasis></citetitle> 2013 <emphasis role="strong">75:</emphasis>140–142.</para>
          </listitem>
          <listitem id="ch0064s000000li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Maayan H, Cohen-Poradosu R, Halperin E, Rudensky B, Schlesinger Y, Yinnon AM, Raveh D.</emphasis> 2004. Infective endocarditis due to <citetitle><emphasis>Moraxella lacunata</emphasis></citetitle>: report of 4 patients and review of published cases of <citetitle><emphasis>Moraxella</emphasis></citetitle> endocarditis. <citetitle><emphasis>Scand J Infect Dis</emphasis></citetitle> <emphasis role="strong">36:</emphasis>878–881.</para>
          </listitem>
          <listitem id="ch0064s000000li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Park DE, et al, PERCH Study Group.</emphasis> 2017. Colonization density of the upper respiratory tract as a predictor of pneumonia—<citetitle><emphasis>Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus</emphasis></citetitle>, and <citetitle><emphasis>Pneumocystis jirovecii. Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">64</emphasis>(Suppl 3)<emphasis role="strong">:</emphasis>S328–S336.</para>
          </listitem>
          <listitem id="ch0064s000000li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">Vaneechoutte M, Verschraegen G, Claeys G, Weise B, Van den Abeele AM.</emphasis> 1990. Respiratory tract carrier rates of <citetitle><emphasis>Moraxella</emphasis></citetitle> (<citetitle><emphasis>Branhamella</emphasis></citetitle>) <citetitle><emphasis>catarrhalis</emphasis></citetitle> in adults and children and interpretation of the isolation of <citetitle><emphasis>M. catarrhalis</emphasis></citetitle> from sputum. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">28:</emphasis>2674–2680.</para>
          </listitem>
          <listitem id="ch0064s000000li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A.</emphasis> 2002. <citetitle><emphasis>Moraxella catarrhalis</emphasis></citetitle>: from emerging to established pathogen. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">15:</emphasis>125–144.</para>
          </listitem>
          <listitem id="ch0064s000000li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Rafiq I, Parthasarathy H, Tremlett C, Freeman LJ, Mullin M.</emphasis> 2011. Infective endocarditis caused by <citetitle><emphasis>Moraxella nonliquefaciens</emphasis></citetitle> in a percutaneous aortic valve replacement. <citetitle><emphasis>Cardiovasc Revasc Med</emphasis></citetitle> <emphasis role="strong">12:</emphasis>184–186.</para>
          </listitem>
          <listitem id="ch0064s000000li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Duployez C, Loïez C, Ledoux G, Armand S, Jaillette E, Wallet F.</emphasis> 2017. A fatal endocarditis case due to an emerging bacterium: <citetitle><emphasis>moraxella nonliquefaciens. IDCases</emphasis></citetitle> <emphasis role="strong">8:</emphasis>12–13.</para>
          </listitem>
          <listitem id="ch0064s000000li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Santee CA, Nagalingam NA, Faruqi AA, DeMuri GP, Gern JE, Wald ER, Lynch SV.</emphasis> 2016. Nasopharyngeal microbiota composition of children is related to the frequency of upper respiratory infection and acute sinusitis. <citetitle><emphasis>Microbiome</emphasis></citetitle> <emphasis role="strong">4:</emphasis>34.</para>
          </listitem>
          <listitem id="ch0064s000000li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Yi H, Yong D, Lee K, Cho YJ, Chun J.</emphasis> 2014. Profiling bacterial community in upper respiratory tracts. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">14:</emphasis>583.</para>
          </listitem>
          <listitem id="ch0064s000000li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">Kao C, Szymczak W, Munjal I.</emphasis> 2017. Meningitis due to <citetitle><emphasis>Moraxella nonliquefaciens</emphasis></citetitle> in a paediatric patient: a case report and review of the literature. <citetitle><emphasis>JMM Case Rep</emphasis></citetitle> <emphasis role="strong">4:</emphasis>e005086.</para>
          </listitem>
          <listitem id="ch0064s000000li0033" role="bibliographyEntry">
            <para>33.<emphasis role="strong">Dien Bard J, Lewinski M, Summanen PH, Deville JG.</emphasis> 2011. Sepsis with prolonged hypotension due to <citetitle><emphasis>Moraxella osloensis</emphasis></citetitle> in a non-immunocompromised child. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>138–141.</para>
          </listitem>
          <listitem id="ch0064s000000li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Roh KH, Kim CK, Koh E, Kim MS, Yong D, Park SC, Lee K, Chong Y.</emphasis> 2010. Three cases of <citetitle><emphasis>Moraxella osloensis</emphasis></citetitle> meningitis: a difficult experience in species identification and determination of clinical significance. <citetitle><emphasis>J Korean Med Sci</emphasis></citetitle> <emphasis role="strong">25:</emphasis>501–504.</para>
          </listitem>
          <listitem id="ch0064s000000li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Tabbuso T, Defourny L, Lali SE, Pasdermadjian S, Gilliaux O.</emphasis> 2021. <citetitle><emphasis>Moraxella osloensis</emphasis></citetitle> infection among adults and children: a pediatric case and literature review. <citetitle><emphasis>Arch Pediatr</emphasis></citetitle> <emphasis role="strong">28:</emphasis>348–351.</para>
          </listitem>
          <listitem id="ch0064s000000li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">Lee MY, Kim MH, Lee WI, Kang SY.</emphasis> 2021. Bacteremia caused by <citetitle><emphasis>Moraxella osloensis</emphasis></citetitle>: a fatal case of an immunocompromised patient and literature review. <citetitle><emphasis>Clin Lab</emphasis></citetitle> <emphasis role="strong">67:</emphasis>67.</para>
          </listitem>
          <listitem id="ch0064s000000li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Yamada A, Kasahara K, Ogawa Y, Samejima K, Eriguchi M, Yano H, Mikasa K, Tsuruya K.</emphasis> 2019. Peritonitis due to <citetitle><emphasis>Moraxella osloensis</emphasis></citetitle>: a case report and literature review. <citetitle><emphasis>J Infect Chemother</emphasis></citetitle> <emphasis role="strong">25:</emphasis>1050–1052.</para>
          </listitem>
          <listitem id="ch0064s000000li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">LaCroce SJ, Wilson MN, Romanowski JE, Newman JD, Jhanji V, Shanks RMQ, Kowalski RP.</emphasis> 2019. <citetitle><emphasis>Moraxella nonliquefaciens</emphasis></citetitle> and <citetitle><emphasis>M. osloensis</emphasis></citetitle> are important <citetitle><emphasis>Moraxella</emphasis></citetitle> species that cause ocular infections. <citetitle><emphasis>Microorganisms</emphasis></citetitle> <emphasis role="strong">7:</emphasis>163.</para>
          </listitem>
          <listitem id="ch0064s000000li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Dasari S, Shetty R, Devasia T.</emphasis> 2011. A rare case of <citetitle><emphasis>Moraxella lacunata</emphasis></citetitle> producing combined native mitral and aortic valve endocarditis. <citetitle><emphasis>Australas Med J</emphasis></citetitle> <emphasis role="strong">4:</emphasis>386–388.</para>
          </listitem>
          <listitem id="ch0064s000000li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Kutlesa M, Lepur D, Klinar I, Rudez I, Vincelj J, Bukovski S, Barsić B.</emphasis> 2007. <citetitle><emphasis>Moraxella lacunata</emphasis></citetitle>: a rare cause of infective endocarditis. <citetitle><emphasis>Scand J Infect Dis</emphasis></citetitle> <emphasis role="strong">39:</emphasis>917–919.</para>
          </listitem>
          <listitem id="ch0064s000000li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Jannes G, Vaneechoutte M, Lannoo M, Gillis M, Vancanneyt M, Vandamme P, Verschraegen G, Van Heuverswyn H, Rossau R.</emphasis> 1993. Polyphasic taxonomy leading to the proposal of <citetitle><emphasis>Moraxella canis</emphasis></citetitle> sp. nov. for <citetitle><emphasis>Moraxella catarrhalis</emphasis></citetitle>-like strains. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>438–449.</para>
          </listitem>
          <listitem id="ch0064s000000li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Anonymous.</emphasis> 1996. Appendix II: selective isolation of Acinetobacter spp. by enrichment cultivation, p 241–242. <citetitle><emphasis>In</emphasis></citetitle> Bergogne-Bérézin EJ, Joly-Guillou ML, Towner KJ (ed), <citetitle><emphasis>Acinetobacter: Microbiology, Epidemiology, Infections</emphasis></citetitle>, <citetitle><emphasis>Management.</emphasis></citetitle> CRC Press, Boca Raton, FL.</para>
          </listitem>
          <listitem id="ch0064s000000li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Vaneechoutte M, Verschraegen G, Claeys G, van den Abeele AM.</emphasis> 1988. Selective medium for <citetitle><emphasis>Branhamella catarrhalis</emphasis></citetitle> with acetazolamide as a specific inhibitor of <citetitle><emphasis>Neisseria</emphasis></citetitle> spp. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">26:</emphasis>2544–2548.</para>
          </listitem>
          <listitem id="ch0064s000000li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">O’Hara CM, Miller JM.</emphasis> 2003. Evaluation of the Vitek 2 ID-GNB assay for identification of members of the family <citetitle><emphasis>Enterobacteriaceae</emphasis></citetitle> and other nonenteric gram-negative bacilli and comparison with the Vitek GNI+ card. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>2096–2101.</para>
          </listitem>
          <listitem id="ch0064s000000li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Bosshard PP, Zbinden R, Abels S, Böddinghaus B, Altwegg M, Böttger EC.</emphasis> 2006. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">44:</emphasis>1359–1366.</para>
          </listitem>
          <listitem id="ch0064s000000li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Weyant RSMC, Weaver RE, Hollis DG, Jordan JG, Cook EC, Daneshvar MI.</emphasis> 1996. <citetitle><emphasis>Identification of Unusual Pathogenic Gram-Negative Aerobic and Facultatively Anaerobic Bacteria.</emphasis></citetitle> Williams and Wilkins, Baltimore, MD.</para>
          </listitem>
          <listitem id="ch0064s000000li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">Vanlaere E, Sergeant K, Dawyndt P, Kallow W, Erhard M, Sutton H, Dare D, Devreese B, Samyn B, Vandamme P.</emphasis> 2008. Matrix-assisted laser desorption ionisation-time-of of-flight mass spectrometry of intact cells allows rapid identification of <citetitle><emphasis>Burkholderia cepacia</emphasis></citetitle> complex. <citetitle><emphasis>J Microbiol Methods</emphasis></citetitle> <emphasis role="strong">75:</emphasis>279–286.</para>
          </listitem>
          <listitem id="ch0064s000000li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Mellmann A, Cloud J, Maier T, Keckevoet U, Ramminger I, Iwen P, Dunn J, Hall G, Wilson D, Lasala P, Kostrzewa M, Harmsen D.</emphasis> 2008. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>1946–1954.</para>
          </listitem>
          <listitem id="ch0064s000000li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Petti CA, Polage CR, Schreckenberger P.</emphasis> 2005. The role of 16S rRNA gene sequencing in identification of microorganisms misidentified by conventional methods. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>6123–6125.</para>
          </listitem>
          <listitem id="ch0064s000000li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Yoon SH, Ha SM, Kwon S, Lim J, Kim Y, Seo H, Chun J.</emphasis> 2017. Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">67:</emphasis>1613–1617.</para>
          </listitem>
          <listitem id="ch0064s000000li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">Su SC, Vaneechoutte M, Dijkshoorn L, Wei YF, Chen YL, Chang TC.</emphasis> 2009. Identification of non-fermenting Gram-negative bacteria of clinical importance by an oligonucleotide array. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>596–605.</para>
          </listitem>
          <listitem id="ch0064s000000li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">Dijkshoorn L, Van Harsselaar B, Tjernberg I, Bouvet PJ, Vaneechoutte M.</emphasis> 1998. Evaluation of amplified ribosomal DNA restriction analysis for identification of <citetitle><emphasis>Acinetobacter</emphasis></citetitle> genomic species. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">21:</emphasis>33–39.</para>
          </listitem>
          <listitem id="ch0064s000000li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Vaneechoutte M, Rossau R, De Vos P, Gillis M, Janssens D, Paepe N, De Rouck A, Fiers T, Claeys G, Kersters K.</emphasis> 1992. Rapid identification of bacteria of the <citetitle><emphasis>Comamonadaceae</emphasis></citetitle> with amplified ribosomal DNA-restriction analysis (ARDRA). <citetitle><emphasis>FEMS Microbiol Lett</emphasis></citetitle> <emphasis role="strong">72:</emphasis>227–233.</para>
          </listitem>
          <listitem id="ch0064s000000li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Catry B, Boyen F, Baele M, Dewulf J, de Kruif A, Vaneechoutte M, Haesebrouck F, Decostere A.</emphasis> 2007. Recovery of <citetitle><emphasis>Moraxella ovis</emphasis></citetitle> from the bovine respiratory tract and differentiation of <citetitle><emphasis>Moraxella</emphasis></citetitle> species by tDNA-intergenic spacer PCR. <citetitle><emphasis>Vet Microbiol</emphasis></citetitle> <emphasis role="strong">120:</emphasis>375–380.</para>
          </listitem>
          <listitem id="ch0064s000000li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Ehrenstein B, Bernards AT, Dijkshoorn L, Gerner-Smidt P, Towner KJ, Bouvet PJ, Daschner FD, Grundmann H.</emphasis> 1996. <citetitle><emphasis>Acinetobacter</emphasis></citetitle> species identification by using tRNA spacer fingerprinting. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">34:</emphasis>2414–2420.</para>
          </listitem>
          <listitem id="ch0064s000000li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Kanamori H, Parobek CM, Weber DJ, van Duin D, Rutala WA, Cairns BA, Juliano JJ.</emphasis> 2015. Next-generation sequencing and comparative analysis of sequential outbreaks caused by multidrug-resistant <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> at a large academic burn center. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1249–1257.</para>
          </listitem>
          <listitem id="ch0064s000000li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Nemec A.</emphasis> 2022 <emphasis role="strong">Acinetobacter. In</emphasis> Trujillo ME, Dedysh S, DeVos P, Hedlund B, Kampfer P, Rainey FA, Whitman WB (eds). <citetitle><emphasis>Bergey’s Manual of Systematics of Archaea and Bacteria.</emphasis></citetitle> Wiley; <ulink url="https://doi.org/10.1002/9781118960608.gbm01203.pub2">https://doi.org/10.1002/9781118960608.gbm01203.pub2</ulink>.</para>
          </listitem>
          <listitem id="ch0064s000000li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Dijkshoorn LNA.</emphasis> 2008. The diversity of the genus <citetitle><emphasis>Acinetobacter</emphasis></citetitle>, p 1–34. <citetitle><emphasis>In</emphasis></citetitle> Gerischer U (ed), <citetitle><emphasis>Acinetobacter Molecular Biology.</emphasis></citetitle> Caister Academic Press, Norwich, United Kingdom.</para>
          </listitem>
          <listitem id="ch0064s000000li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Álvarez-Pérez S, Lievens B, Jacquemyn H, Herrera CM.</emphasis> 2013. <citetitle><emphasis>Acinetobacter nectaris</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Acinetobacter boissieri</emphasis></citetitle> sp. nov., isolated from floral nectar of wild Mediterranean insect-pollinated plants. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">63:</emphasis>1532–1539.</para>
          </listitem>
          <listitem id="ch0064s000000li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Chu YW, Leung CM, Houang ET, Ng KC, Leung CB, Leung HY, Cheng AF.</emphasis> 1999. Skin carriage of acinetobacters in Hong Kong. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">37:</emphasis>2962–2967.</para>
          </listitem>
          <listitem id="ch0064s000000li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Zordan S, Prenger-Berninghoff E, Weiss R, van der Reijden T, van den Broek P, Baljer G, Dijkshoorn L.</emphasis> 2011. Multidrug-resistant <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> in veterinary clinics, Germany. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>1751–1754.</para>
          </listitem>
          <listitem id="ch0064s000000li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Vaneechoutte M, Devriese LA, Dijkshoorn L, Lamote B, Deprez P, Verschraegen G, Haesebrouck F.</emphasis> 2000. <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle>-infected vascular catheters collected from horses in an equine clinic. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>4280–4281.</para>
          </listitem>
          <listitem id="ch0064s000000li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">van den Broek PJ, Arends J, Bernards AT, De Brauwer E, Mascini EM, van der Reijden TJ, Spanjaard L, Thewessen EA, van der Zee A, van Zeijl JH, Dijkshoorn L.</emphasis> 2006. Epidemiology of multiple <citetitle><emphasis>Acinetobacter</emphasis></citetitle> outbreaks in The Netherlands during the period 1999-2001. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">12:</emphasis>837–843.</para>
          </listitem>
          <listitem id="ch0064s000000li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Marchaim D, Navon-Venezia S, Schwartz D, Tarabeia J, Fefer I, Schwaber MJ, Carmeli Y.</emphasis> 2007. Surveillance cultures and duration of carriage of multidrug-resistant <citetitle><emphasis>Acinetobacter baumannii. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>1551–1555.</para>
          </listitem>
          <listitem id="ch0064s000000li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">van den Broek PJ, van der Reijden TJ, van Strijen E, Helmig-Schurter AV, Bernards AT, Dijkshoorn L.</emphasis> 2009. Endemic and epidemic <citetitle><emphasis>Acinetobacter</emphasis></citetitle> species in a university hospital: an 8-year survey. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">47:</emphasis>3593–3599.</para>
          </listitem>
          <listitem id="ch0064s000000li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Touchon M, Cury J, Yoon EJ, Krizova L, Cerqueira GC, Murphy C, Feldgarden M, Wortman J, Clermont D, Lambert T, Grillot-Courvalin C, Nemec A, Courvalin P, Rocha EPC.</emphasis> 2014. The genomic diversification of the whole <citetitle><emphasis>Acinetobacter</emphasis></citetitle> genus: origins, mechanisms, and consequences. <citetitle><emphasis>Genome Biol Evol</emphasis></citetitle> <emphasis role="strong">6:</emphasis>2866–2882.</para>
          </listitem>
          <listitem id="ch0064s000000li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L.</emphasis> 2011. Genotypic and phenotypic characterization of the <citetitle><emphasis>Acinetobacter calcoaceticus-Acinetobacter baumannii</emphasis></citetitle> complex with the proposal of <citetitle><emphasis>Acinetobacter pittii</emphasis></citetitle> sp. nov. (formerly <citetitle><emphasis>Acinetobacter</emphasis></citetitle> genomic species 3) and <citetitle><emphasis>Acinetobacter nosocomialis</emphasis></citetitle> sp. nov. (formerly <citetitle><emphasis>Acinetobacter</emphasis></citetitle> genomic species 13TU). <citetitle><emphasis>Res Microbiol</emphasis></citetitle> <emphasis role="strong">162:</emphasis>393–404.</para>
          </listitem>
          <listitem id="ch0064s000000li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Peleg AY, Seifert H, Paterson DL.</emphasis> 2008. <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle>: emergence of a successful pathogen. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">21:</emphasis>538–582.</para>
          </listitem>
          <listitem id="ch0064s000000li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Bouvet PJM, Grimont PAD.</emphasis> 1986. Taxonomy of the genus Acinetobacter with the recognition of <citetitle><emphasis>Acinetobacter bauman-nii</emphasis></citetitle> sp. nov., <citetitle><emphasis>Acinetobacter haemolyticus</emphasis></citetitle> sp. nov., <citetitle><emphasis>Acinetobacter johnsonii</emphasis></citetitle> sp. nov., and <citetitle><emphasis>Acinetobacter junii</emphasis></citetitle> sp. nov. and emended descriptions of <citetitle><emphasis>Acinetobacter calcoaceticus</emphasis></citetitle> and <citetitle><emphasis>Acinetobacter lwoffii. Int J Syst Bacteriol</emphasis></citetitle> 36:228–240.</para>
          </listitem>
          <listitem id="ch0064s000000li0070" role="bibliographyEntry">
            <para>70.<emphasis role="strong">Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B.</emphasis> 2017. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">30:</emphasis>409–447.</para>
          </listitem>
          <listitem id="ch0064s000000li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Tjernberg I, Ursing J.</emphasis> 1989. Clinical strains of <citetitle><emphasis>Acinetobacter</emphasis></citetitle> classified by DNA-DNA hybridization. <citetitle><emphasis>APMIS</emphasis></citetitle> <emphasis role="strong">97:</emphasis>595–605.</para>
          </listitem>
          <listitem id="ch0064s000000li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Pailhoriès H, Tiry C, Eveillard M, Kempf M.</emphasis> 2018. <citetitle><emphasis>Acinetobacter</emphasis></citetitle> pittii isolated more frequently than <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> in blood cultures: the experience of a French hospital. <citetitle><emphasis>J Hosp Infect</emphasis></citetitle> <emphasis role="strong">99:</emphasis>360–363.</para>
          </listitem>
          <listitem id="ch0064s000000li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Nemec A, Krizova L, Maixnerova M, Sedo O, Brisse S, Higgins PG.</emphasis> 2015. <citetitle><emphasis>Acinetobacter seifertii</emphasis></citetitle> sp. nov., a member of the <citetitle><emphasis>Acinetobacter calcoaceticus-Acinetobacter baumannii</emphasis></citetitle> complex isolated from human clinical specimens. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">65:</emphasis>934–942.</para>
          </listitem>
          <listitem id="ch0064s000000li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Rooney AP, Dunlap CA, Flor-Weiler LB.</emphasis> 2016. <citetitle><emphasis>Acinetobacter lactucae</emphasis></citetitle> sp. nov., isolated from iceberg lettuce (Asteraceae: lactuca sativa). <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">66:</emphasis>3566–3572.</para>
          </listitem>
          <listitem id="ch0064s000000li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Cosgaya C, Marí-Almirall M, Van Assche A, Fernández-Orth D, Mosqueda N, Telli M, Huys G, Higgins PG, Seifert H, Lievens B, Roca I, Vila J.</emphasis> 2016. <citetitle><emphasis>Acinetobacter dijkshoorniae</emphasis></citetitle> sp. nov., a member of the <citetitle><emphasis>Acinetobacter calcoaceticus-Acinetobacter baumannii</emphasis></citetitle> complex mainly recovered from clinical samples in different countries. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">66:</emphasis>4105–4111.</para>
          </listitem>
          <listitem id="ch0064s000000li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Dunlap CA, Rooney AP.</emphasis> 2018. <citetitle><emphasis>Acinetobacter dijkshoorniae</emphasis></citetitle> is a later heterotypic synonym of <citetitle><emphasis>Acinetobacter lactucae. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">68:</emphasis>131–132.</para>
          </listitem>
          <listitem id="ch0064s000000li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Bouvet PJM, Grimont PAD.</emphasis> 1986. Taxonomy of the genus <citetitle><emphasis>Acinetobacter</emphasis></citetitle> with the recognition of <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> sp. nov., <citetitle><emphasis>Acinetobacter haemolyticus</emphasis></citetitle> sp. nov., <citetitle><emphasis>Acinetobacter johnsonii</emphasis></citetitle> sp. nov., and <citetitle><emphasis>Acinetobacter junii</emphasis></citetitle> sp. nov. and emended descriptions of <citetitle><emphasis>Acinetobacter calcoaceticus</emphasis></citetitle> and <citetitle><emphasis>Acinetobacter lwoffii. Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">36:</emphasis>228–240.</para>
          </listitem>
          <listitem id="ch0064s000000li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Wolf S, Barth-Jakschic E, Birkle K, Bader B, Marschal M, Liese J, Peter S, Oberhettinger P.</emphasis> 2021. <citetitle><emphasis>Acinetobacter geminorum</emphasis></citetitle> sp. nov., isolated from human throat swabs. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">71:</emphasis>005018.</para>
          </listitem>
          <listitem id="ch0064s000000li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">Nemec A, Radolfova-Krizova L, Maixnerova M, Vrestiakova E, Jezek P, Sedo O.</emphasis> 2016. Taxonomy of haemolytic and/or proteolytic strains of the genus <citetitle><emphasis>Acinetobacter</emphasis></citetitle> with the proposal of <citetitle><emphasis>Acinetobacter courvalinii</emphasis></citetitle> sp. nov. (genomic species 14 sensu Bouvet &amp; Jeanjean), <citetitle><emphasis>Acinetobacter dispersus</emphasis></citetitle> sp. nov. (genomic species 17), <citetitle><emphasis>Acinetobacter modestus</emphasis></citetitle> sp. nov., <citetitle><emphasis>Acinetobacter proteolyticus</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Acinetobacter vivianii</emphasis></citetitle> sp. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">66:</emphasis>1673–1685.</para>
          </listitem>
          <listitem id="ch0064s000000li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Nemec A, Radolfova-Krizova L, Maixnerova M, Sedo O.</emphasis> 2017. <citetitle><emphasis>Acinetobacter colistiniresistens</emphasis></citetitle> sp. nov. (formerly genomic species 13 sensu Bouvet and Jeanjean and genomic species 14 sensu Tjernberg and Ursing), isolated from human infections and characterized by intrinsic resistance to polymyxins. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">67:</emphasis>2134–2141.</para>
          </listitem>
          <listitem id="ch0064s000000li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Nemec A, Dijkshoorn L, Cleenwerck I, De Baere T, Janssens D, van der Reijden TJK, Ježek P, Vaneechoutte M.</emphasis> 2003. <citetitle><emphasis>Acinetobacter parvus</emphasis></citetitle> sp. nov., a small-colony-forming species isolated from human clinical specimens. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>1563–1567.</para>
          </listitem>
          <listitem id="ch0064s000000li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Nemec A, Radolfová-Křížová L, Maixnerová M, Nemec M, Clermont D, Bzdil J, Ježek P, Španělová P.</emphasis> 2019. Revising the taxonomy of the <citetitle><emphasis>Acinetobacter lwoffii</emphasis></citetitle> group: the description of <citetitle><emphasis>Acinetobacter pseudolwoffii</emphasis></citetitle> sp. nov. and emended description of <citetitle><emphasis>Acinetobacter lwoffii. Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>159–167.</para>
          </listitem>
          <listitem id="ch0064s000000li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJK, Dijkshoorn L.</emphasis> 2001. <citetitle><emphasis>Acinetobacter ursingii</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Acinetobacter schindleri</emphasis></citetitle> sp. nov., isolated from human clinical specimens. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>1891–1899.</para>
          </listitem>
          <listitem id="ch0064s000000li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Krizova L, McGinnis J, Maixnerova M, Nemec M, Poirel L, Mingle L, Sedo O, Wolfgang W, Nemec A.</emphasis> 2015. <citetitle><emphasis>Acinetobacter variabilis</emphasis></citetitle> sp. nov. (formerly DNA group 15 sensu Tjernberg &amp; Ursing), isolated from humans and animals. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">65:</emphasis>857–863.</para>
          </listitem>
          <listitem id="ch0064s000000li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Nemec A, Musílek M, Šedo O, De Baere T, Maixnerová M, van der Reijden TJK, Zdráhal Z, Vaneechoutte M, Dijkshoorn L.</emphasis> 2010. <citetitle><emphasis>Acinetobacter bereziniae</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Acinetobacter guillouiae</emphasis></citetitle> sp. nov., to accommodate <citetitle><emphasis>Acinetobacter</emphasis></citetitle> genomic species 10 and 11, respectively. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>896–903.</para>
          </listitem>
          <listitem id="ch0064s000000li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Yoon EJ, Goussard S, Touchon M, Krizova L, Cerqueira G, Murphy C, Lambert T, Grillot-Courvalin C, Nemec A, Courvalin P.</emphasis> 2014. Origin in <citetitle><emphasis>Acinetobacter guillouiae</emphasis></citetitle> and dissemination of the aminoglycoside-modifying enzyme Aph(3′)-VI. <citetitle><emphasis>MBio</emphasis></citetitle> <emphasis role="strong">5:</emphasis>e01972–e14.</para>
          </listitem>
          <listitem id="ch0064s000000li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Rivera-Izquierdo M, Valero-Ubierna C, Masso-Guijarro P.</emphasis> 2020. Nosocomial bacteraemia caused by Acinetobacter ursingii in neonatology critical care unit in Spain: a rising challenge. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">39:</emphasis>e28–e29.</para>
          </listitem>
          <listitem id="ch0064s000000li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Nemec A, Musílek M, Maixnerová M, De Baere T, van der Reijden TJK, Vaneechoutte M, Dijkshoorn L.</emphasis> 2009. <citetitle><emphasis>Acinetobacter beijerinckii</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Acinetobacter gyllenbergii</emphasis></citetitle> sp. nov., haemolytic organisms isolated from humans. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>118–124.</para>
          </listitem>
          <listitem id="ch0064s000000li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Jeong S, Hong JS, Kim JO, Kim KH, Lee W, Bae IK, Lee K, Jeong SH.</emphasis> 2016. Identification of <citetitle><emphasis>Acinetobacter</emphasis></citetitle> species using matrix-assisted laser desorption ionization-time of flight mass spectrometry. <citetitle><emphasis>Ann Lab Med</emphasis></citetitle> <emphasis role="strong">36:</emphasis>325–334.</para>
          </listitem>
          <listitem id="ch0064s000000li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">Hsueh PR, Kuo LC, Chang TC, Lee TF, Teng SH, Chuang YC, Teng LJ, Sheng WH.</emphasis> 2014. Evaluation of the Bruker Biotyper matrix-assisted laser desorption ionization–time of flight mass spectrometry system for identification of blood isolates of <citetitle><emphasis>Acinetobacter</emphasis></citetitle> species. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>3095–3100.</para>
          </listitem>
          <listitem id="ch0064s000000li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Šedo O, Radolfová-Křížová L, Nemec A, Zdráhal Z.</emphasis> 2018. Limitations of routine MALDI-TOF mass spectrometric identification of <citetitle><emphasis>Acinetobacter</emphasis></citetitle> species and remedial actions. <citetitle><emphasis>J Microbiol Methods</emphasis></citetitle> <emphasis role="strong">154:</emphasis>79–85.</para>
          </listitem>
          <listitem id="ch0064s000000li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL.</emphasis> 2006. Identification of <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> by detection of the <citetitle><emphasis>bla</emphasis></citetitle><subscript>OXA-51</subscript>-like carbapenemase gene intrinsic to this species. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">44:</emphasis>2974–2976.</para>
          </listitem>
          <listitem id="ch0064s000000li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L.</emphasis> 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of <citetitle><emphasis>Acinetobacter baumannii. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>4328–4335.</para>
          </listitem>
          <listitem id="ch0064s000000li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Minandri F, D’Arezzo S, Antunes LC, Pourcel C, Principe L, Petrosillo N, Visca P.</emphasis> 2012. Evidence of diversity among epidemiologically related carbapenemase-producing <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> strains belonging to international clonal lineage II. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>590–597.</para>
          </listitem>
          <listitem id="ch0064s000000li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Karah N, Wai SN, Uhlin BE.</emphasis> 2021. CRISPR-based subtyping to track the evolutionary history of a global clone of Acinetobacter baumannii. <citetitle><emphasis>Infect Genet Evol</emphasis></citetitle> <emphasis role="strong">90:</emphasis>104774.</para>
          </listitem>
          <listitem id="ch0064s000000li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Zander E, Nemec A, Seifert H, Higgins PG.</emphasis> 2012. Association between β-lactamase-encoding <citetitle><emphasis>bla</emphasis></citetitle><subscript>OXA-51</subscript> variants and DiversiLab rep-PCR-based typing of <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> isolates. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>1900–1904.</para>
          </listitem>
          <listitem id="ch0064s000000li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">Fitzpatrick MA, Ozer EA, Hauser AR.</emphasis> 2016. Utility of whole-genome sequencing in characterizing <citetitle><emphasis>Acinetobacter</emphasis></citetitle> epidemiology and analyzing hospital outbreaks. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">54:</emphasis>593–612.</para>
          </listitem>
          <listitem id="ch0064s000000li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">Roberts LW, Forde BM, Hurst T, Ling W, Nimmo GR, Bergh H, George N, Hajkowicz K, McNamara JF, Lipman J, Permana B, Schembri MA, Paterson D, Beatson SA, Harris PNA.</emphasis> 2021. Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care. <citetitle><emphasis>Microb Genom</emphasis></citetitle> <emphasis role="strong">7:</emphasis>mgen000530.</para>
          </listitem>
          <listitem id="ch0064s000000li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodríguez-Valera F.</emphasis> 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of <citetitle><emphasis>Acinetobacter baumannii. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>4382–4390.</para>
          </listitem>
          <listitem id="ch0064s000000li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S.</emphasis> 2010. The population structure of <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle>: expanding multiresistant clones from an ancestral susceptible genetic pool. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">5:</emphasis>e10034.</para>
          </listitem>
          <listitem id="ch0064s000000li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Karah N, Sundsfjord A, Towner K, Samuelsen Ø.</emphasis> 2012. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of <citetitle><emphasis>Acinetobacter baumannii. Drug Resist Updat</emphasis></citetitle> <emphasis role="strong">15:</emphasis>237–247.</para>
          </listitem>
          <listitem id="ch0064s000000li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">Higgins PG, Prior K, Harmsen D, Seifert H.</emphasis> 2017. Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">12</emphasis><emphasis role="strong">:</emphasis>e0179228.</para>
          </listitem>
          <listitem id="ch0064s000000li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">Cerezales M, Xanthopoulou K, Wille J, Bustamante Z, Seifert H, Gallego L, Higgins PG.</emphasis> 2019. <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> analysis by core genome multi-locus sequence typing in two hospitals in Bolivia: endemicity of international clone 7 isolates (CC25). <citetitle><emphasis>Int J Antimicrob Agents</emphasis></citetitle> <emphasis role="strong">53:</emphasis>844–849.</para>
          </listitem>
          <listitem id="ch0064s000000li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Dijkshoorn L, Nemec A, Seifert H.</emphasis> 2007. An increasing threat in hospitals: multidrug-resistant <citetitle><emphasis>Acinetobacter baumannii. Nat Rev Microbiol</emphasis></citetitle> <emphasis role="strong">5:</emphasis>939–951.</para>
          </listitem>
          <listitem id="ch0064s000000li0105" role="bibliographyEntry">
            <para>105.<emphasis role="strong">Nemec A, Dijkshoorn L, van der Reijden TJK.</emphasis> 2004. Long-term predominance of two pan-European clones among multi-resistant <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> strains in the Czech Republic. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>147–153.</para>
          </listitem>
          <listitem id="ch0064s000000li0106" role="bibliographyEntry">
            <para>106.<emphasis role="strong">Krizova L, Nemec A.</emphasis> 2010. A 63 kb genomic resistance island found in a multidrug-resistant <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> isolate of European clone I from 1977. <citetitle><emphasis>J Antimicrob Chemother</emphasis></citetitle> <emphasis role="strong">65:</emphasis>1915–1918.</para>
          </listitem>
          <listitem id="ch0064s000000li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Krizova L, Dijkshoorn L, Nemec A.</emphasis> 2011. Diversity and evolution of AbaR genomic resistance islands in <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> strains of European clone I. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">55:</emphasis>3201–3206.</para>
          </listitem>
          <listitem id="ch0064s000000li0108" role="bibliographyEntry">
            <para>108.<emphasis role="strong">Higgins PG, Dammhayn C, Hackel M, Seifert H.</emphasis> 2010. Global spread of carbapenem-resistant <citetitle><emphasis>Acinetobacter baumannii. J Antimicrob Chemother</emphasis></citetitle> <emphasis role="strong">65:</emphasis>233–238.</para>
          </listitem>
          <listitem id="ch0064s000000li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L.</emphasis> 2008. Emergence of carbapenem resistance in <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. <citetitle><emphasis>J Antimicrob Chemother</emphasis></citetitle> <emphasis role="strong">62:</emphasis>484–489.</para>
          </listitem>
          <listitem id="ch0064s000000li0110" role="bibliographyEntry">
            <para>110.<emphasis role="strong">Stietz MS, Ramírez MS, Vilacoba E, Merkier AK, Limansky AS, Centrón D, Catalano M.</emphasis> 2013. <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. <citetitle><emphasis>Infect Genet Evol</emphasis></citetitle> <emphasis role="strong">14:</emphasis>294–301.</para>
          </listitem>
          <listitem id="ch0064s000000li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">Pournaras S, Dafopoulou K, Del Franco M, Zarkotou O, Dimitroulia E, Protonotariou E, Poulou A, Zarrilli R, Tsakris A, Skoura L, Themeli-Digalaki K, Perivolioti E, Tsiplakou S, Karavassilis V, Panopoulou M, Orfanidou M, Hadjichristodoulou C, Levidiotou S, Gikas A, Greek Study Group on Acinetobacter Antimicrobial Resistance.</emphasis> 2017. Predominance of international clone 2 OXA-23-producing-<citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> clinical isolates in Greece, 2015: results of a nationwide study. <citetitle><emphasis>Int J Antimicrob Agents</emphasis></citetitle> <emphasis role="strong">49:</emphasis>749–753.</para>
          </listitem>
          <listitem id="ch0064s000000li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">Chen Y, Gao J, Zhang H, Ying C.</emphasis> 2017. Spread of the blaOXA-23-containing Tn2008 in carbapenem-resistant <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> isolates grouped in CC92 from China. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">8:</emphasis>163.</para>
          </listitem>
          <listitem id="ch0064s000000li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">Endo S, Sasano M, Yano H, Inomata S, Ishibashi N, Aoyagi T, Hatta M, Gu Y, Yamada M, Tokuda K, Kitagawa M, Kunishima H, Hirakata Y, Kaku M.</emphasis> 2012. IMP-1-producing carbapenem-resistant <citetitle><emphasis>Acinetobacter ursingii</emphasis></citetitle> from Japan. <citetitle><emphasis>J Antimicrob Chemother</emphasis></citetitle> <emphasis role="strong">67:</emphasis>2533–2534.</para>
          </listitem>
          <listitem id="ch0064s000000li0114" role="bibliographyEntry">
            <para>114.<emphasis role="strong">Park YK, Jung SI, Park KH, Kim SH, Ko KS.</emphasis> 2012. Characteristics of carbapenem-resistant <citetitle><emphasis>Acinetobacter</emphasis></citetitle> spp. other than <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> in South Korea. <citetitle><emphasis>Int J Antimicrob Agents</emphasis></citetitle> <emphasis role="strong">39:</emphasis>81–85.</para>
          </listitem>
          <listitem id="ch0064s000000li0115" role="bibliographyEntry">
            <para>115.<emphasis role="strong">Faccone D, Martino F, Pasteran F, Albornoz E, Biondi E, Vazquez M, Rapoport M, Rodrigo V, De Belder D, Gomez S, Corso A.</emphasis> 2019. Multiple clones of metallo-β-lactamase-producing <citetitle><emphasis>Acinetobacter ursingii</emphasis></citetitle> in a children hospital from Argentina. <citetitle><emphasis>Infect Genet Evol</emphasis></citetitle> <emphasis role="strong">67:</emphasis>145–149.</para>
          </listitem>
          <listitem id="ch0064s000000li0116" role="bibliographyEntry">
            <para>116.<emphasis role="strong">Tavares LCB, Cunha MPV, de Vasconcellos FM, Bertani AMJ, de Barcellos TAF, Bueno MS, Santos CA, Sant’Ana DA, Ferreira AM, Mondelli AL, Montelli AC, Sadatsune T, Sacchi CT, Gonçalves CR, Tiba-Casas MR, Camargo CH.</emphasis> 2020. Genomic and clinical characterization of IMP-1-producing multidrug-resistant <citetitle><emphasis>Acinetobacter bereziniae</emphasis></citetitle> isolates from bloodstream infections in a Brazilian tertiary hospital. <citetitle><emphasis>Microb Drug Resist</emphasis></citetitle> <emphasis role="strong">26:</emphasis>1399–1404.</para>
          </listitem>
          <listitem id="ch0064s000000li0117" role="bibliographyEntry">
            <para>117.<emphasis role="strong">Blackwell GA, Nigro SJ, Hall RM.</emphasis> 2015. Evolution of AbGRI2-0, the progenitor of the AbGRI2 resistance island in global clone 2 of <citetitle><emphasis>Acinetobacter baumannii. Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1421–1429.</para>
          </listitem>
          <listitem id="ch0064s000000li0118" role="bibliographyEntry">
            <para>118.<emphasis role="strong">Holt K, Kenyon JJ, Hamidian M, Schultz MB, Pickard DJ, Dougan G, Hall R.</emphasis> 2016. Five decades of genome evolution in the globally distributed, extensively antibiotic-resistant <citetitle><emphasis>Acinetobacter baumannii</emphasis></citetitle> global clone 1. <citetitle><emphasis>Microb Genom</emphasis></citetitle> <emphasis role="strong">2:</emphasis>e000052.</para>
          </listitem>
          <listitem id="ch0064s000000li0119" role="bibliographyEntry">
            <para>119.<emphasis role="strong">Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL.</emphasis> 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">18:</emphasis>268–281.</para>
          </listitem>
          <listitem id="ch0064s000000li0120" role="bibliographyEntry">
            <para>120.<emphasis role="strong">Arroyo LA, García-Curiel A, Pachón-Ibañez ME, Llanos AC, Ruiz M, Pachón J, Aznar J.</emphasis> 2005. Reliability of the E-test method for detection of colistin resistance in clinical isolates of <citetitle><emphasis>Acinetobacter baumannii. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>903–905.</para>
          </listitem>
          <listitem id="ch0064s000000li0121" role="bibliographyEntry">
            <para>121.<emphasis role="strong">Greenberg DE, Porcella SF, Stock F, Wong A, Conville PS, Murray PR, Holland SM, Zelazny AM.</emphasis> 2006. <citetitle><emphasis>Granulibacter bethesdensis</emphasis></citetitle> gen. nov., sp. nov., a distinctive pathogenic acetic acid bacterium in the family <citetitle><emphasis>Acetobacteraceae. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>2609–2616.</para>
          </listitem>
          <listitem id="ch0064s000000li0122" role="bibliographyEntry">
            <para>122.<emphasis role="strong">Rebelo M, Ding L, Cordeiro AI, Neves C, Simões MJ, Zelazny AM, Holland SM, Neves JF.</emphasis> 2019. Fatal meningitis in patient with X-linked chronic granulomatous disease caused by virulent <citetitle><emphasis>Granulibacter bethesdensis. Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">25:</emphasis>976–979.</para>
          </listitem>
          <listitem id="ch0064s000000li0123" role="bibliographyEntry">
            <para>123.<emphasis role="strong">Mayer EF, Gialanella P, Munjal I, Cunningham-Rundles C, Dara J.</emphasis> 2017. Fulminant sepsis due to <citetitle><emphasis>Granulibacter bethesdensis</emphasis></citetitle> in a 4-year-old boy with X-linked chronic granulomatous disease. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">36:</emphasis>1165–1166.</para>
          </listitem>
          <listitem id="ch0064s000000li0124" role="bibliographyEntry">
            <para>124.<emphasis role="strong">Greenberg DE, Sturdevant DE, Marshall-Batty KR, Chu J, Pettinato AM, Virtaneva K, Lane J, Geller BL, Porcella SF, Gallin JI, Holland SM, Zarember KA.</emphasis> 2015. Simultaneous host-pathogen transcriptome analysis during <citetitle><emphasis>Granulibacter bethesdensis</emphasis></citetitle> infection of neutrophils from healthy subjects and patients with chronic granulomatous disease. <citetitle><emphasis>Infect Immun</emphasis></citetitle> <emphasis role="strong">83:</emphasis>4277–4292.</para>
          </listitem>
          <listitem id="ch0064s000000li0125" role="bibliographyEntry">
            <para>125.<emphasis role="strong">Chu J, Smelkinson MG, Dorward DW, Zarember KA, Gallin JI.</emphasis> 2017. Early intracellular trafficking of <citetitle><emphasis>Granulibacter bethesdensis</emphasis></citetitle> in human macrophages. <citetitle><emphasis>Infect Immun</emphasis></citetitle> <emphasis role="strong">85:</emphasis>e00847–e16.</para>
          </listitem>
          <listitem id="ch0064s000000li0126" role="bibliographyEntry">
            <para>126.<emphasis role="strong">Helsel LO, Hollis D, Steigerwalt AG, Morey RE, Jordan J, Aye T, Radosevic J, Jannat-Khah D, Thiry D, Lonsway DR, Patel JB, Daneshvar MI, Levett PN.</emphasis> 2007. Identification of “<citetitle><emphasis>Haematobacter</emphasis></citetitle>,” a new genus of aerobic Gram-negative rods isolated from clinical specimens, and reclassification of <citetitle><emphasis>Rhodobacter massiliensis</emphasis></citetitle> as “<citetitle><emphasis>Haematobacter massiliensis</emphasis></citetitle> comb. nov.” <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>1238–1243.</para>
          </listitem>
          <listitem id="ch0064s000000li0127" role="bibliographyEntry">
            <para>127.<emphasis role="strong">Buscher A, Li L, Han XY, Trautner BW.</emphasis> 2010. Aortic valve endocarditis possibly caused by a <citetitle><emphasis>Haematobacter</emphasis></citetitle>-like species. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">48:</emphasis>3791–3793.</para>
          </listitem>
          <listitem id="ch0064s000000li0128" role="bibliographyEntry">
            <para>128.<emphasis role="strong">Cheng JW, Wang P, Xiao M, Yuan Y, Kudinha T, Zhao Y, Kong F, Xu YC.</emphasis> 2017. First case report of endocarditis caused by haematobacter massiliensis in China. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>709.</para>
          </listitem>
          <listitem id="ch0064s000000li0129" role="bibliographyEntry">
            <para>129.<emphasis role="strong">Vela AI, Sánchez-Porro C, Aragón V, Olvera A, Domínguez L, Ventosa A, Fernández-Garayzábal JF.</emphasis> 2010. <citetitle><emphasis>Moraxella porci</emphasis></citetitle> sp. nov., isolated from pigs. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>2446–2450.</para>
          </listitem>
          <listitem id="ch0064s000000li0130" role="bibliographyEntry">
            <para>130.<emphasis role="strong">Vandamme P, Gillis M, Vancanneyt M, Hoste B, Kersters K, Falsen E.</emphasis> 1993. <citetitle><emphasis>Moraxella lincolnii</emphasis></citetitle> sp. nov., isolated from the human respiratory tract, and reevaluation of the taxonomic position of <citetitle><emphasis>Moraxella osloensis. Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>474–481.</para>
          </listitem>
          <listitem id="ch0064s000000li0131" role="bibliographyEntry">
            <para>131.<emphasis role="strong">Bøvre KFJ, Hagen N, Jantzen E, Frøholm LO.</emphasis> 1976. <citetitle><emphasis>Moraxella atlantae</emphasis></citetitle> sp. nov. and its distinction from <citetitle><emphasis>Moraxella phenylpyrouvica. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">26:</emphasis>511–521.</para>
          </listitem>
          <listitem id="ch0064s000000li0132" role="bibliographyEntry">
            <para>132.<emphasis role="strong">Speeleveld E, Fossépré JM, Gordts B, Van Landuyt HW.</emphasis> 1994. Comparison of three rapid methods, tributyrine, 4-methylumbelliferyl butyrate, and indoxyl acetate, for rapid identification of <citetitle><emphasis>Moraxella catarrhalis. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">32:</emphasis>1362–1363.</para>
          </listitem>
          <listitem id="ch0064s000000li0133" role="bibliographyEntry">
            <para>133.<emphasis role="strong">Bombicino KA, Almuzara MN, Famiglietti AM, Vay C.</emphasis> 2007. Evaluation of pyrrolidonyl arylamidase for the identification of nonfermenting Gram-negative rods. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">57:</emphasis>101–103.</para>
          </listitem>
          <listitem id="ch0064s000000li0134" role="bibliographyEntry">
            <para>134.<emphasis role="strong">Spangler SK, Visalli MA, Jacobs MR, Appelbaum PC.</emphasis> 1996. Susceptibilities of non-<citetitle><emphasis>Pseudomonas aeruginosa</emphasis></citetitle> gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, d-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">40:</emphasis>772–775.</para>
          </listitem>
          <listitem id="ch0064s000000li0135" role="bibliographyEntry">
            <para>135.<emphasis role="strong">Zhang Y, Zhang F, Wang H, Zhao C, Wang Z, Cao B, Du Y, Feng X, Hu Y, Hu B, Ji P, Liu Z, Liu Y, Liao W, Lu J, Sun H, Wang Z, Xu X, Xu X, Yang Q, Yu Y, Zhang R, Zhuo C.</emphasis> 2016. Antimicrobial susceptibility of <citetitle><emphasis>Streptococcus pneumoniae, Haemophilus influenzae</emphasis></citetitle> and <citetitle><emphasis>Moraxella catarrhalis</emphasis></citetitle> isolated from community-acquired respiratory tract infections in China: results from the CARTIPS Antimicrobial Surveillance Program. <citetitle><emphasis>J Glob Antimicrob Resist</emphasis></citetitle> <emphasis role="strong">5:</emphasis>36–41.</para>
          </listitem>
          <listitem id="ch0064s000000li0136" role="bibliographyEntry">
            <para>136.<emphasis role="strong">Liu YL, Xiao M, Cheng JW, Xu HP, Xu ZP, Ye S, Zhang WJ, Kudinha T, Kong F, Xu YC.</emphasis> 2017. <citetitle><emphasis>Moraxella catarrhalis</emphasis></citetitle> macrolide-resistant isolates are highly concentrated in two MLST clonal complexes, CCN10 and CC363. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">8:</emphasis>201.</para>
          </listitem>
          <listitem id="ch0064s000000li0137" role="bibliographyEntry">
            <para>137.<emphasis role="strong">Liu YL, Li DF, Xu HP, Xiao M, Cheng JW, Zhang L, Xu ZP, Chen XX, Zhang G, Kudinha T, Kong F, Gong YP, Wang XY, Zhang YX, Wu HL, Xu YC.</emphasis> 2016. Use of next generation sequence to investigate potential novel macrolide resistance mechanisms in a population of <citetitle><emphasis>Moraxella catarrhalis</emphasis></citetitle> isolates. <citetitle><emphasis>Sci Rep</emphasis></citetitle> <emphasis role="strong">6:</emphasis>35711.</para>
          </listitem>
          <listitem id="ch0064s000000li0138" role="bibliographyEntry">
            <para>138.<emphasis role="strong">Rossau R, Kersters K, Falsen E, Jantzen E, Segers P, Union A, Nehls L, De Ley J.</emphasis> 1987. <citetitle><emphasis>Oligella</emphasis></citetitle>, a new genus including <citetitle><emphasis>Oligella urethralis</emphasis></citetitle> comb. nov. (formerly <citetitle><emphasis>Moraxella urethralis</emphasis></citetitle>) and <citetitle><emphasis>Oligella ureolytica</emphasis></citetitle> sp. nov. (formerly CDC group IVe): relationship to <citetitle><emphasis>Taylorella equigenitalis</emphasis></citetitle> and related taxa. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">37:</emphasis>198–210.</para>
          </listitem>
          <listitem id="ch0064s000000li0139" role="bibliographyEntry">
            <para>139.<emphasis role="strong">Baqi M, Mazzulli T.</emphasis> 1996. <citetitle><emphasis>Oligella</emphasis></citetitle> infections: case report and review of the literature. <citetitle><emphasis>Can J Infect Dis</emphasis></citetitle> <emphasis role="strong">7:</emphasis>377–379.</para>
          </listitem>
          <listitem id="ch0064s000000li0140" role="bibliographyEntry">
            <para>140.<emphasis role="strong">Yamaguchi H, Yamaguchi Y, Hadano Y, Hayashi K, Nagahara C, Muratani T, Ohkusu K.</emphasis> 2017. The first case report of emphysematous pyelonephritis and bacteremia due to <citetitle><emphasis>Oligella urethralis. Int J Med Microbiol</emphasis></citetitle> <emphasis role="strong">307:</emphasis>151–153.</para>
          </listitem>
          <listitem id="ch0064s000000li0141" role="bibliographyEntry">
            <para>141.<emphasis role="strong">Pagotto A, Merluzzi S, Pillinini P, Valeri M.</emphasis> 2016. Bloodstream infection with <citetitle><emphasis>Oligella ureolytica</emphasis></citetitle>: a case report and review of the literature. <citetitle><emphasis>Infez Med</emphasis></citetitle> <emphasis role="strong">24:</emphasis>58–61.</para>
          </listitem>
          <listitem id="ch0064s000000li0142" role="bibliographyEntry">
            <para>142.<emphasis role="strong">Simmons T, Fennelly E, Loughran D.</emphasis> 2015. <citetitle><emphasis>Oligella ureolytica</emphasis></citetitle> bacteremia in elderly woman, United States. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">21:</emphasis>1271–1273.</para>
          </listitem>
          <listitem id="ch0064s000000li0143" role="bibliographyEntry">
            <para>143.<emphasis role="strong">Pugliese A, Pacris B, Schoch PE, Cunha BA.</emphasis> 1993. <citetitle><emphasis>Oligella urethralis</emphasis></citetitle> urosepsis. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>1069–1070.</para>
          </listitem>
          <listitem id="ch0064s000000li0144" role="bibliographyEntry">
            <para>144.<emphasis role="strong">Fernández-Olmos A, García-Castillo M, Morosini M-I, Lamas A, Máiz L, Cantón R.</emphasis> 2012. MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. <citetitle><emphasis>J Cyst Fibros</emphasis></citetitle> <emphasis role="strong">11:</emphasis>59–62.</para>
          </listitem>
          <listitem id="ch0064s000000li0145" role="bibliographyEntry">
            <para>145.<emphasis role="strong">Beauruelle C, Le Bars H, Bocher S, Tandé D, Héry-Arnaud G.</emphasis> 2019. The Brief Case: extragenitourinary location of <citetitle><emphasis>Oligella urethralis. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>e01542–e18.</para>
          </listitem>
          <listitem id="ch0064s000000li0146" role="bibliographyEntry">
            <para>146.<emphasis role="strong">Pickett MJ, von Graevenitz A, Pfyffer GE, Pünter V, Altwegg M.</emphasis> 1996. Phenotypic features distinguishing <citetitle><emphasis>Oligella urethralis</emphasis></citetitle> from <citetitle><emphasis>Moraxella osloensis. Med Microbiol Lett</emphasis></citetitle> <emphasis role="strong">5:</emphasis>265–270.</para>
          </listitem>
          <listitem id="ch0064s000000li0147" role="bibliographyEntry">
            <para>147.<emphasis role="strong">Branda JA, Rychert J, Burnham C-A, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia LF, Westblade LF, Ferraro MJ.</emphasis> 2014. Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">78:</emphasis>129–131.</para>
          </listitem>
          <listitem id="ch0064s000000li0148" role="bibliographyEntry">
            <para>148.<emphasis role="strong">Almuzara M, Barberis C, Traglia G, Famiglietti A, Ramirez MS, Vay C.</emphasis> 2015. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry for species identification of nonfermenting Gram-negative bacilli. <citetitle><emphasis>J Microbiol Methods</emphasis></citetitle> <emphasis role="strong">112:</emphasis>24–27.</para>
          </listitem>
          <listitem id="ch0064s000000li0149" role="bibliographyEntry">
            <para>149.<emphasis role="strong">Schulthess B, Bloemberg GV, Zbinden A, Mouttet F, Zbinden R, Böttger EC, Hombach M.</emphasis> 2016. Evaluation of the Bruker MALDI Biotyper for identification of fastidious Gram-negative rods. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">54:</emphasis>543–548.</para>
          </listitem>
          <listitem id="ch0064s000000li0150" role="bibliographyEntry">
            <para>150.<emphasis role="strong">Demir T, Celenk N.</emphasis> 2014. Bloodstream infection with <citetitle><emphasis>Oligella ureolytica</emphasis></citetitle> in a newborn infant: a case report and review of the literature. <citetitle><emphasis>J Infect Dev Ctries</emphasis></citetitle> <emphasis role="strong">8:</emphasis>793–795.</para>
          </listitem>
          <listitem id="ch0064s000000li0151" role="bibliographyEntry">
            <para>151.<emphasis role="strong">Kersters K, Vancanneyt M.</emphasis> 2015. Oligella. <citetitle><emphasis>In</emphasis></citetitle> Whitman WB, Rainey F, Kampfer P, Trujillo M, Chun J, DeVos P, Hedlund B, Dedysh S (ed), <citetitle><emphasis>Bergey’s Manual of Systematics of Archaea and Bacteria.</emphasis></citetitle> Wiley, New York, NY.</para>
          </listitem>
          <listitem id="ch0064s000000li0152" role="bibliographyEntry">
            <para>152.<emphasis role="strong">Daneshvar MI, Hollis DG, Weyant RS, Steigerwalt AG, Whitney AM, Douglas MP, Macgregor JP, Jordan JG, Mayer LW, Rassouli SM, Barchet W, Munro C, Shuttleworth L, Bernard K.</emphasis> 2003. <citetitle><emphasis>Paracoccus yeeii</emphasis></citetitle> sp. nov. (formerly CDC group EO-2), a novel bacterial species associated with human infection. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>1289–1294.</para>
          </listitem>
          <listitem id="ch0064s000000li0153" role="bibliographyEntry">
            <para>153.<emphasis role="strong">Funke G, Frodl R, Sommer H.</emphasis> 2004. First comprehensively documented case of <citetitle><emphasis>Paracoccus yeei</emphasis></citetitle> infection in a human. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>3366–3368.</para>
          </listitem>
          <listitem id="ch0064s000000li0154" role="bibliographyEntry">
            <para>154.<emphasis role="strong">Sastre A, González-Arregoces J, Romainoik I, Mariño S, Lucas C, Monfá E, Stefan G, de León B, Prieto M.</emphasis> 2016. <citetitle><emphasis>Paracoccus yeei</emphasis></citetitle> peritonitis in peritoneal dialysis. <citetitle><emphasis>Nefrologia</emphasis></citetitle> <emphasis role="strong">36:</emphasis>445–446.</para>
          </listitem>
          <listitem id="ch0064s000000li0155" role="bibliographyEntry">
            <para>155.<emphasis role="strong">McGinnis JM, Cole JA, Dickinson MC, Mingle LA, Lapierre P, Musser KA, Wolfgang WJ.</emphasis> 2015. <citetitle><emphasis>Paracoccus sanguinis</emphasis></citetitle> sp. nov., isolated from clinical specimens of New York State patients. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">65:</emphasis>1877–1882.</para>
          </listitem>
          <listitem id="ch0064s000000li0156" role="bibliographyEntry">
            <para>156.<emphasis role="strong">Cobo F, Medina MJ, Navarro-Marí JM, Valdezate S.</emphasis> 2021. First isolation in Spain of <citetitle><emphasis>Paracoccus sanguinis</emphasis></citetitle> in blood cultures. <citetitle><emphasis>Enferm Infecc Microbiol Clin Engl Ed</emphasis></citetitle> <emphasis role="strong">39:</emphasis>359–360.</para>
          </listitem>
          <listitem id="ch0064s000000li0157" role="bibliographyEntry">
            <para>157.<emphasis role="strong">Deschaght P, Janssens M, Vaneechoutte M, Wauters G.</emphasis> 2012. <citetitle><emphasis>Psychrobacter</emphasis></citetitle> isolates of human origin, other than <citetitle><emphasis>Psychrobacter phenylpyruvicus</emphasis></citetitle>, are predominantly <citetitle><emphasis>Psychrobacter faecalis</emphasis></citetitle> and <citetitle><emphasis>Psychrobacter pulmonis</emphasis></citetitle>, with emended description of <citetitle><emphasis>P. faecalis. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">62:</emphasis>671–674.</para>
          </listitem>
          <listitem id="ch0064s000000li0158" role="bibliographyEntry">
            <para>158.<emphasis role="strong">Kämpfer P, Albrecht A, Buczolits S, Busse HJ.</emphasis> 2002. <citetitle><emphasis>Psychrobacter faecalis</emphasis></citetitle> sp. nov., a new species from a bioaerosol originating from pigeon faeces. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">25:</emphasis>31–36.</para>
          </listitem>
          <listitem id="ch0064s000000li0159" role="bibliographyEntry">
            <para>159.<emphasis role="strong">Vela AI, Collins MD, Latre MV, Mateos A, Moreno MA, Hutson R, Domínguez L, Fernández-Garayzábal JF.</emphasis> 2003. <citetitle><emphasis>Psychrobacter pulmonis</emphasis></citetitle> sp. nov., isolated from the lungs of lambs. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>415–419.</para>
          </listitem>
          <listitem id="ch0064s000000li0160" role="bibliographyEntry">
            <para>160.<emphasis role="strong">Wirth SE, Ayala-Del-Río HL, Cole JA, Kohlerschmidt DJ, Musser KA, Sepúlveda-Torres LDC, Thompson LM, Wolfgang WJ.</emphasis> 2012. <citetitle><emphasis>Psychrobacter sanguinis</emphasis></citetitle> sp. nov., recovered from four clinical specimens over a 4-year period. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">62:</emphasis>49–54.</para>
          </listitem>
          <listitem id="ch0064s000000li0161" role="bibliographyEntry">
            <para>161.<emphasis role="strong">Bonwitt J, Tran M, Droz A, Gonzalez A, Glover WA.</emphasis> 2018. <citetitle><emphasis>Psychrobacter sanguinis</emphasis></citetitle> wound infection associated with marine environment exposure, Washington, USA. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">24:</emphasis>1942–1944.</para>
          </listitem>
          <listitem id="ch0064s000000li0162" role="bibliographyEntry">
            <para>162.<emphasis role="strong">Le Guern R, Wallet F, Vega E, Courcol RJ, Loïez C.</emphasis> 2014. <citetitle><emphasis>Psychrobacter sanguinis</emphasis></citetitle>: an unusual bacterium for nosocomial meningitis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>3475–3477.</para>
          </listitem>
          <listitem id="ch0064s000000li0163" role="bibliographyEntry">
            <para>163.<emphasis role="strong">Ortiz-Alcántara JM, Segura-Candelas JM, Garcés-Ayala F, Gonzalez-Durán E, Rodríguez-Castillo A, Alcántara-Pérez P, Wong-Arámbula C, González-Villa M, León-Ávila G, García-Chéquer AJ, Diaz-Quiñonez JA, Méndez-Tenorio A, Ramírez-González JE.</emphasis> 2016. Fatal <citetitle><emphasis>Psychrobacter</emphasis></citetitle> sp. infection in a pediatric patient with meningitis identified by metagenomic next-generation sequencing in cerebrospinal fluid. <citetitle><emphasis>Arch Microbiol</emphasis></citetitle> <emphasis role="strong">198:</emphasis>129–135.</para>
          </listitem>
          <listitem id="ch0064s000000li0164" role="bibliographyEntry">
            <para>164.<emphasis role="strong">Hurtado-Ortiz R, Nazimoudine A, Criscuolo A, Hugon P, Mornico D, Brisse S, Bizet C, Clermont D.</emphasis> 2017. <citetitle><emphasis>Psychrobacter pasteurii</emphasis></citetitle> and <citetitle><emphasis>Psychrobacter piechaudii</emphasis></citetitle> sp. nov., two novel species within the genus <citetitle><emphasis>Psychrobacter. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">67:</emphasis>3192–3197.</para>
          </listitem>
          <listitem id="ch0064s000000li0165" role="bibliographyEntry">
            <para>165.<emphasis role="strong">Kumaria A, Crusz SA, Lister M, Kirkman MA, Macarthur DC.</emphasis> 2021. <citetitle><emphasis>Psychrobacter piechaudii</emphasis></citetitle> shunt infection: first report of human infection. <citetitle><emphasis>Childs Nerv Syst</emphasis></citetitle> <emphasis role="strong">28:</emphasis>1–4.</para>
          </listitem>
          <listitem id="ch0064s000000li0166" role="bibliographyEntry">
            <para>166.<emphasis role="strong">Fass RJ, Barnishan J.</emphasis> 1980. In vitro susceptibilities of nonfermentative gram-negative bacilli other than <citetitle><emphasis>Pseudomonas aeruginosa</emphasis></citetitle> to 32 antimicrobial agents. <citetitle><emphasis>Rev Infect Dis</emphasis></citetitle> <emphasis role="strong">2:</emphasis>841–853.</para>
          </listitem>
          <listitem id="ch0064s000000li0167" role="bibliographyEntry">
            <para>167.<emphasis role="strong">Almuzara MN, Palombarani S, Tuduri A, Figueroa S, Gianecini A, Sabater L, Ramirez MS, Vay CA.</emphasis> 2011. First case of fulminant sepsis due to <citetitle><emphasis>Wohlfahrtiimonas chitiniclastica. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>2333–2335.</para>
          </listitem>
          <listitem id="ch0064s000000li0168" role="bibliographyEntry">
            <para>168.<emphasis role="strong">Tóth EM, Schumann P, Borsodi AK, Kéki Z, Kovács AL, Márialigeti K.</emphasis> 2008. <citetitle><emphasis>Wohlfahrtiimonas chitiniclastica</emphasis></citetitle> gen. nov., sp. nov., a new gammaproteobacterium isolated from <citetitle><emphasis>Wohlfahrtia magnifica</emphasis></citetitle> (Diptera: sarcophagidae). <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">58:</emphasis>976–981.</para>
          </listitem>
          <listitem id="ch0064s000000li0169" role="bibliographyEntry">
            <para>169.<emphasis role="strong">Rebaudet S, Genot S, Renvoise A, Fournier PE, Stein A.</emphasis> 2009. <citetitle><emphasis>Wohlfahrtiimonas chitiniclastica</emphasis></citetitle> bacteremia in homeless woman. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">15:</emphasis>985–987.</para>
          </listitem>
          <listitem id="ch0064s000000li0170" role="bibliographyEntry">
            <para>170.<emphasis role="strong">Katanami Y, Kutsuna S, Nagashima M, Takaya S, Yamamoto K, Takeshita N, Hayakawa K, Kato Y, Kanagawa S, Ohmagari N.</emphasis> 2018. <citetitle><emphasis>Wohlfahrtiimonas chitiniclastica</emphasis></citetitle> bacteremia in hospitalized homeless man with squamous cell carcinoma. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">24:</emphasis>1746–1748.</para>
          </listitem>
          <listitem id="ch0064s000000li0171" role="bibliographyEntry">
            <para>171.<emphasis role="strong">Harfouch O, Luethy PM, Noval M, Baghdadi JD.</emphasis> 2021. <citetitle><emphasis>Wohlfahrtiimonas chitiniclastica</emphasis></citetitle> monomicrobial bacteremia in a homeless man. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>3195–3197.</para>
          </listitem>
          <listitem id="ch0064s000000li0172" role="bibliographyEntry">
            <para>172.<emphasis role="strong">Schröttner P, Rudolph WW, Damme U, Lotz C, Jacobs E, Gunzer F.</emphasis> 2017. <citetitle><emphasis>Wohlfahrtiimonas chitiniclastica</emphasis></citetitle>: current insights into an emerging human pathogen. <citetitle><emphasis>Epidemiol Infect</emphasis></citetitle> <emphasis role="strong">145:</emphasis>1292–1303.</para>
          </listitem>
          <listitem id="ch0064s000000li0173" role="bibliographyEntry">
            <para>173.<emphasis role="strong">Kopf A, Bunk B, Coldewey SM, Gunzer F, Riedel T, Schröttner P.</emphasis> 2021. Identification and antibiotic profiling of <citetitle><emphasis>Wohlfahrtiimonas chitiniclastica</emphasis></citetitle>, an underestimated human pathogen. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">12:</emphasis>712775.</para>
          </listitem>
          <listitem id="ch0064s000000li0174" role="bibliographyEntry">
            <para>174.<emphasis role="strong">Gupta AK, Dharne MS, Rangrez AY, Verma P, Ghate HV, Rohde M, Patole MS, Shouche YS.</emphasis> 2011. <citetitle><emphasis>Ignatzschineria indica</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Ignatzschineria ureiclastica</emphasis></citetitle> sp. nov., isolated from adult flesh flies (Diptera: sarcophagidae). <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">61:</emphasis>1360–1369.</para>
          </listitem>
          <listitem id="ch0064s000000li0175" role="bibliographyEntry">
            <para>175.<emphasis role="strong">Tanida K, von Wichert G, Hentschke M, Fenner T.</emphasis> 2019. Sepsis due to <citetitle><emphasis>Ignatzschineria ureiclastica</emphasis></citetitle> caused by maggot-infested wounds in a homeless man in Germany: a case report. <citetitle><emphasis>SN Compr Clin Med</emphasis></citetitle> <emphasis role="strong">1:</emphasis>1080–1083.</para>
          </listitem>
          <listitem id="ch0064s000000li0176" role="bibliographyEntry">
            <para>176.<emphasis role="strong">DiFranza LT, Annavajhala MK, Uhlemann AC, Green DA.</emphasis> 2021. The Brief Case: a maggot mystery—<citetitle><emphasis>Ignatzschineria</emphasis></citetitle> larvae sepsis secondary to an infested wound. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">59</emphasis><emphasis role="strong">:</emphasis>02279–20.</para>
          </listitem>
          <listitem id="ch0064s000000li0177" role="bibliographyEntry">
            <para>177.<emphasis role="strong">Qiu J, Zhou H, Jing Y, Dong C.</emphasis> 2019. Association between blood microbiome and type 2 diabetes mellitus: a nested case-control study. <citetitle><emphasis>J Clin Lab Anal</emphasis></citetitle> <emphasis role="strong">33:</emphasis>e22842.</para>
          </listitem>
          <listitem id="ch0064s000000li0178" role="bibliographyEntry">
            <para>178.<emphasis role="strong">Vogel BF, Venkateswaran K, Christensen H, Falsen E, Christiansen G, Gram L.</emphasis> 2000. Polyphasic taxonomic approach in the description of <citetitle><emphasis>Alishewanella fetalis</emphasis></citetitle> gen. nov., sp. nov., isolated from a human foetus. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>1133–1142.</para>
          </listitem>
          <listitem id="ch0064s000000li0179" role="bibliographyEntry">
            <para>179.<emphasis role="strong">Coenye T, Goris J, Spilker T, Vandamme P, LiPuma JJ.</emphasis> 2002. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of <citetitle><emphasis>Inquilinus limosus</emphasis></citetitle> gen. nov., sp. nov. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>2062–2069.</para>
          </listitem>
          <listitem id="ch0064s000000li0180" role="bibliographyEntry">
            <para>180.<emphasis role="strong">Wellinghausen N, Essig A, Sommerburg O.</emphasis> 2005. <citetitle><emphasis>Inquilinus limosus</emphasis></citetitle> in patients with cystic fibrosis, Germany. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">11:</emphasis>457–459.</para>
          </listitem>
          <listitem id="ch0064s000000li0181" role="bibliographyEntry">
            <para>181.<emphasis role="strong">Cicatiello AG, Iula DV, Pagliuca C, Pastore G, Pagliarulo C, Catania MR, Catania MR, Colicchio R, Picardi M, Raia V, Salvatore P.</emphasis> 2014. Identification of <citetitle><emphasis>Inquilinus limosus</emphasis></citetitle> in cystic fibrosis: a first report in Italy. <citetitle><emphasis>New Microbiol</emphasis></citetitle> <emphasis role="strong">37:</emphasis>567–571.</para>
          </listitem>
          <listitem id="ch0064s000000li0182" role="bibliographyEntry">
            <para>182.<emphasis role="strong">Degand N, Carbonnelle E, Dauphin B, Beretti JL, Le Bourgeois M, Sermet-Gaudelus I, Segonds C, Berche P, Nassif X, Ferroni A.</emphasis> 2008. Matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>3361–3367.</para>
          </listitem>
          <listitem id="ch0064s000000li0183" role="bibliographyEntry">
            <para>183.<emphasis role="strong">Chiron R, Marchandin H, Counil F, Jumas-Bilak E, Freydière AM, Bellon G, Husson MO, Turck D, Brémont F, Chabanon G, Segonds C.</emphasis> 2005. Clinical and microbiological features of <citetitle><emphasis>Inquilinus</emphasis></citetitle> sp. isolates from five patients with cystic fibrosis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>3938–3943.</para>
          </listitem>
          <listitem id="ch0064s000000li0184" role="bibliographyEntry">
            <para>184.<emphasis role="strong">Hayes D Jr, Murphy BS, Kuhn RJ, Anstead MI, Feola DJ.</emphasis> 2009. Mucoid <citetitle><emphasis>Inquilinus limosus</emphasis></citetitle> in a young adult with cystic fibrosis. <citetitle><emphasis>Pediatr Pulmonol</emphasis></citetitle> <emphasis role="strong">44:</emphasis>619–621.</para>
          </listitem>
          <listitem id="ch0064s000000li0185" role="bibliographyEntry">
            <para>185.<emphasis role="strong">Salvador-García C, Yagüe-Guirao G, Pastor-Vivero MD, Sáez-Nieto JA.</emphasis> 2013. Chronic colonization of <citetitle><emphasis>Inquilinus limosus</emphasis></citetitle> in a patient with cystic fibrosis: first report in Spain. <citetitle><emphasis>Enferm Infecc Microbiol Clin</emphasis></citetitle> <emphasis role="strong">31:</emphasis>414–415.</para>
          </listitem>
          <listitem id="ch0064s000000li0186" role="bibliographyEntry">
            <para>186.<emphasis role="strong">McHugh KE, Rhoads DD, Wilson DA, Highland KB, Richter SS, Procop GW.</emphasis> 2016. <citetitle><emphasis>Inquilinus limosus</emphasis></citetitle> in pulmonary disease: case report and review of the literature. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">86:</emphasis>446–449.</para>
          </listitem>
          <listitem id="ch0064s000000li0187" role="bibliographyEntry">
            <para>187.<emphasis role="strong">Magalhães AP, Lopes SP, Pereira MO.</emphasis> 2017. Insights into cystic fibrosis polymicrobial consortia: the role of species interactions in biofilm development, phenotype, and response to in-use antibiotics. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">7:</emphasis>2146.</para>
          </listitem>
          <listitem id="ch0064s000000li0188" role="bibliographyEntry">
            <para>188.<emphasis role="strong">Lenhart-Pendergrass PM, Caverly LJ, Wagner BD, Sagel SD, Nick JA, LiPuma JJ, Martiniano SL.</emphasis> 2021. Clinical characteristics and outcomes associated with Inquilinus infection in cystic fibrosis. <citetitle><emphasis>J Cyst Fibros</emphasis></citetitle> <emphasis role="strong">20:</emphasis>310–315.</para>
          </listitem>
          <listitem id="ch0064s000000li0189" role="bibliographyEntry">
            <para>189.<emphasis role="strong">Vancanneyt MSP, Torck U, Hoste B, Bernardet JF, Vandamme P, Kersters K.</emphasis> 1996. Reclassification of <citetitle><emphasis>Flavobacterium odoratum</emphasis></citetitle> (Stutzer 1929) strains to a new genus, <citetitle><emphasis>Myroides</emphasis></citetitle>, as <citetitle><emphasis>Myroides odoratus</emphasis></citetitle> comb. nov. and <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle> sp. nov. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>926–932.</para>
          </listitem>
          <listitem id="ch0064s000000li0190" role="bibliographyEntry">
            <para>190.<emphasis role="strong">Schröttner P, Rudolph WW, Eing BR, Bertram S, Gunzer F.</emphasis> 2014. Comparison of VITEK2, MALDI-TOF MS, and 16S rDNA sequencing for identification of <citetitle><emphasis>Myroides odoratus</emphasis></citetitle> and <citetitle><emphasis>Myroides odoratimimus. Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">79:</emphasis>155–159.</para>
          </listitem>
          <listitem id="ch0064s000000li0191" role="bibliographyEntry">
            <para>191.<emphasis role="strong">Benedetti P, Rassu M, Pavan G, Sefton A, Pellizzer G.</emphasis> 2011. Septic shock, pneumonia, and soft tissue infection due to <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle>: report of a case and review of <citetitle><emphasis>Myroides</emphasis></citetitle> infections. <citetitle><emphasis>Infection</emphasis></citetitle> <emphasis role="strong">39:</emphasis>161–165.</para>
          </listitem>
          <listitem id="ch0064s000000li0192" role="bibliographyEntry">
            <para>192.<emphasis role="strong">Holmes B, Snell JJ, Lapage SP.</emphasis> 1979. <citetitle><emphasis>Flavobacterium odoratum</emphasis></citetitle>: a species resistant to a wide range of antimicrobial agents. <citetitle><emphasis>J Clin Pathol</emphasis></citetitle> <emphasis role="strong">32:</emphasis>73–77.</para>
          </listitem>
          <listitem id="ch0064s000000li0193" role="bibliographyEntry">
            <para>193.<emphasis role="strong">Lahmer T, Beitz A, Ehmer U, Schmid RM, Huber W.</emphasis> 2016. Septic shock due to <citetitle><emphasis>Myroides odoratus</emphasis></citetitle> in a medical intensive care unit patient with severe necrotising pancreatitis. <citetitle><emphasis>Anaesth Intensive Care</emphasis></citetitle> <emphasis role="strong">44:</emphasis>298–299.</para>
          </listitem>
          <listitem id="ch0064s000000li0194" role="bibliographyEntry">
            <para>194.<emphasis role="strong">Prateek S, Gupta P, Mittal G, Singh AK.</emphasis> 2015. Fatal case of pericardial effusion due to <citetitle><emphasis>Myroides odoratus</emphasis></citetitle>: a rare case report. <citetitle><emphasis>J Clin Diagn Res</emphasis></citetitle> <emphasis role="strong">9:</emphasis>DD01–DD02.</para>
          </listitem>
          <listitem id="ch0064s000000li0195" role="bibliographyEntry">
            <para>195.<emphasis role="strong">Green BT, Green K, Nolan PE.</emphasis> 2001. <citetitle><emphasis>Myroides odoratus</emphasis></citetitle> cellulitis and bacteremia: case report and review. <citetitle><emphasis>Scand J Infect Dis</emphasis></citetitle> <emphasis role="strong">33:</emphasis>932–934.</para>
          </listitem>
          <listitem id="ch0064s000000li0196" role="bibliographyEntry">
            <para>196.<emphasis role="strong">Willems P, Muller J, Verhaegen J, Saegeman V, Desmet S.</emphasis> 2017. How to treat a fulminant erysipelas and sepsis caused by <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle>: case report and literature review. <citetitle><emphasis>Acta Clin Belg</emphasis></citetitle> <emphasis role="strong">72:</emphasis>331–335.</para>
          </listitem>
          <listitem id="ch0064s000000li0197" role="bibliographyEntry">
            <para>197.<emphasis role="strong">Ktari S, Mnif B, Koubaa M, Mahjoubi F, Ben Jemaa M, Mhiri MN, Hammami A.</emphasis> 2012. Nosocomial outbreak of <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle> urinary tract infection in a Tunisian hospital. <citetitle><emphasis>J Hosp Infect</emphasis></citetitle> <emphasis role="strong">80:</emphasis>77–81.</para>
          </listitem>
          <listitem id="ch0064s000000li0198" role="bibliographyEntry">
            <para>198.<emphasis role="strong">Maraki S, Sarchianaki E, Barbagadakis S.</emphasis> 2012. <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle> soft tissue infection in an immunocompetent child following a pig bite: case report and literature review. <citetitle><emphasis>Braz J Infect Dis</emphasis></citetitle> <emphasis role="strong">16:</emphasis>390–392.</para>
          </listitem>
          <listitem id="ch0064s000000li0199" role="bibliographyEntry">
            <para>199.<emphasis role="strong">Endicott-Yazdani TR, Dhiman N, Benavides R, Spak CW.</emphasis> 2015. <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle> bacteremia in a diabetic patient. <citetitle><emphasis>Proc Bayl Univ Med Cent</emphasis></citetitle> <emphasis role="strong">28:</emphasis>342–343.</para>
          </listitem>
          <listitem id="ch0064s000000li0200" role="bibliographyEntry">
            <para>200.<emphasis role="strong">Mahapatra A, Mohapatra PR, Choudhury S, Deep N.</emphasis> 2019. Empyema caused by <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle> in a patient with liver abscess. <citetitle><emphasis>Lung India</emphasis></citetitle> <emphasis role="strong">36:</emphasis>459–460.</para>
          </listitem>
          <listitem id="ch0064s000000li0201" role="bibliographyEntry">
            <para>201.<emphasis role="strong">Lu Y, Xia W, Zhang X, Ni F, Mei Y.</emphasis> 2020. A confirmed catheter-related blood stream infection (CRBSI) in an immunocompetent patient due to <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle>: case report and literature review. <citetitle><emphasis>Infect Drug Resist</emphasis></citetitle> <emphasis role="strong">13:</emphasis>139–144.</para>
          </listitem>
          <listitem id="ch0064s000000li0202" role="bibliographyEntry">
            <para>202.<emphasis role="strong">Kutlu HH, Avcı M, Dal T, Arı O, Durmaz R.</emphasis> 2020. A healthcare-associated outbreak of urinary tract infections due to <citetitle><emphasis>Myroides odoratimimus. Jpn J Infect Dis</emphasis></citetitle> <emphasis role="strong">73:</emphasis>421–426.</para>
          </listitem>
          <listitem id="ch0064s000000li0203" role="bibliographyEntry">
            <para>203.<emphasis role="strong">Yang S, Liu Q, Shen Z, Wang H, He L.</emphasis> 2020. Molecular epidemiology of <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle> in nosocomial catheter-related infection at a general hospital in China. <citetitle><emphasis>Infect Drug Resist</emphasis></citetitle> <emphasis role="strong">13:</emphasis>1981–1993.</para>
          </listitem>
          <listitem id="ch0064s000000li0204" role="bibliographyEntry">
            <para>204.<emphasis role="strong">Beharrysingh R.</emphasis> 2017. <citetitle><emphasis>Myroides bacteremia</emphasis></citetitle>: a case report and concise review. <citetitle><emphasis>IDCases</emphasis></citetitle> <emphasis role="strong">8:</emphasis>34–36.</para>
          </listitem>
          <listitem id="ch0064s000000li0205" role="bibliographyEntry">
            <para>205.<emphasis role="strong">Al-Bayssari C, Gupta SK, Dabboussi F, Hamze M, Rolain JM.</emphasis> 2015. MUS-2, a novel variant of the chromosome-encoded β-lactamase MUS-1, from <citetitle><emphasis>Myroides odoratimimus. New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">7:</emphasis>67–71.</para>
          </listitem>
          <listitem id="ch0064s000000li0206" role="bibliographyEntry">
            <para>206.<emphasis role="strong">Hu S, Jiang T, Zhou Y, Ming D, Gao H, Wang M.</emphasis> 2017. Genomic analysis of the multi-drug-resistant clinical isolate <citetitle><emphasis>Myroides odoratimimus</emphasis></citetitle> PR63039. <citetitle><emphasis>Mol Genet Genomics</emphasis></citetitle> <emphasis role="strong">292:</emphasis>133–144.</para>
          </listitem>
          <listitem id="ch0064s000000li0207" role="bibliographyEntry">
            <para>207.<emphasis role="strong">Paek J, Shin JH, Shin Y, Park IS, Jin TE, Kook JK, Wie SH, Cho HG, Park SJ, Chang YH.</emphasis> 2015. <citetitle><emphasis>Myroides injenensis</emphasis></citetitle> sp. nov., a new member isolated from human urine. <citetitle><emphasis>Antonie van Leeuwenhoek</emphasis></citetitle> <emphasis role="strong">107:</emphasis>201–207.</para>
          </listitem>
          <listitem id="ch0064s000000li0208" role="bibliographyEntry">
            <para>208.<emphasis role="strong">Kim DS, Paek J, Shin JH, Kim DW, Jung MY, Kim RN, Sin Y, Kook JK, Nam SH, Kim A, Kang A, Park HS, Choi SH, Chang YH.</emphasis> 2012. Genome sequence of <citetitle><emphasis>Myroides injenensis</emphasis></citetitle> M09-0166(T), isolated from clinical specimens. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">194:</emphasis>2748–2749.</para>
          </listitem>
          <listitem id="ch0064s000000li0209" role="bibliographyEntry">
            <para>209.<emphasis role="strong">LaVergne S, Gaufin T, Richman D.</emphasis> 2019. <citetitle><emphasis>Myroides injenensis</emphasis></citetitle> bacteremia and severe cellulitis. <citetitle><emphasis>Open Forum Infect Dis</emphasis></citetitle> <emphasis role="strong">6:</emphasis>ofz282.</para>
          </listitem>
          <listitem id="ch0064s000000li0210" role="bibliographyEntry">
            <para>210.<emphasis role="strong">Moreno E, Blasco JM, Letesson JJ, Gorvel JP, Moriyón I.</emphasis> 2022. Pathogenicity and its implications in taxonomy: the <citetitle><emphasis>Brucella</emphasis></citetitle> and <citetitle><emphasis>Ochrobactrum</emphasis></citetitle> case. <citetitle><emphasis>Pathogens</emphasis></citetitle> <emphasis role="strong">11:</emphasis>377.</para>
          </listitem>
          <listitem id="ch0064s000000li0211" role="bibliographyEntry">
            <para>211.<emphasis role="strong">Holmes BPM, Kiredjian M, Kersters K.</emphasis> 1988. <citetitle><emphasis>Ochrobactrum anthropi</emphasis></citetitle> gen. nov., sp. nov. from human clinical specimens and previously known as group Vd. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>406–416.</para>
          </listitem>
          <listitem id="ch0064s000000li0212" role="bibliographyEntry">
            <para>212.<emphasis role="strong">Velasco J, Romero C, López-Goñi I, Leiva J, Díaz R, Moriyón I.</emphasis> 1998. Evaluation of the relatedness of <citetitle><emphasis>Brucella</emphasis></citetitle> spp. and <citetitle><emphasis>Ochrobactrum anthropi</emphasis></citetitle> and description of <citetitle><emphasis>Ochrobactrum intermedium</emphasis></citetitle> sp. nov., a new species with a closer relationship to <citetitle><emphasis>Brucella</emphasis></citetitle> spp. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">48:</emphasis>759–768.</para>
          </listitem>
          <listitem id="ch0064s000000li0213" role="bibliographyEntry">
            <para>213.<emphasis role="strong">Kämpfer P, Scholz HC, Huber B, Falsen E, Busse HJ.</emphasis> 2007. <citetitle><emphasis>Ochrobactrum haematophilum</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Ochrobactrum pseudogrignonense</emphasis></citetitle> sp. nov., isolated from human clinical specimens. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>2513–2518.</para>
          </listitem>
          <listitem id="ch0064s000000li0214" role="bibliographyEntry">
            <para>214.<emphasis role="strong">Teyssier C, Marchandin H, Jean-Pierre H, Masnou A, Dusart G, Jumas-Bilak E.</emphasis> 2007. <citetitle><emphasis>Ochrobactrum pseudintermedium</emphasis></citetitle> sp. nov., a novel member of the family <citetitle><emphasis>Brucellaceae</emphasis></citetitle>, isolated from human clinical samples. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>1007–1013.</para>
          </listitem>
          <listitem id="ch0064s000000li0215" role="bibliographyEntry">
            <para>215.<emphasis role="strong">Wattam AR, Foster JT, Mane SP, Beckstrom-Sternberg SM, Beckstrom-Sternberg JM, Dickerman AW, Keim P, Pearson T, Shukla M, Ward DV, Williams KP, Sobral BW, Tsolis RM, Whatmore AM, O’Callaghan D.</emphasis> 2014. Comparative phylogenomics and evolution of the brucellae reveal a path to virulence. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">196:</emphasis>920–930.</para>
          </listitem>
          <listitem id="ch0064s000000li0216" role="bibliographyEntry">
            <para>216.<emphasis role="strong">Saavedra J, Garrido C, Folgueira D, Torres MJ, Ramos JT.</emphasis> 1999. <citetitle><emphasis>Ochrobactrum anthropi</emphasis></citetitle> bacteremia associated with a catheter in an immunocompromised child and review of the pediatric literature. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">18:</emphasis>658–660.</para>
          </listitem>
          <listitem id="ch0064s000000li0217" role="bibliographyEntry">
            <para>217.<emphasis role="strong">Khasawneh W, Yusef D.</emphasis> 2017. <citetitle><emphasis>Ochrobactrum anthropi</emphasis></citetitle> fulminant early-onset neonatal sepsis, a case report and review of literature. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">36:</emphasis>1167–1168.</para>
          </listitem>
          <listitem id="ch0064s000000li0218" role="bibliographyEntry">
            <para>218.<emphasis role="strong">Ozdemir D, Soypacaci Z, Sahin I, Bicik Z, Sencan I.</emphasis> 2006. <citetitle><emphasis>Ochrobactrum anthropi</emphasis></citetitle> endocarditis and septic shock in a patient with no prosthetic valve or rheumatic heart disease: case report and review of the literature. <citetitle><emphasis>Jpn J Infect Dis</emphasis></citetitle> <emphasis role="strong">59:</emphasis>264–265.</para>
          </listitem>
          <listitem id="ch0064s000000li0219" role="bibliographyEntry">
            <para>219.<emphasis role="strong">Gigi R, Flusser G, Kadar A, Salai M, Elias S.</emphasis> 2017. <citetitle><emphasis>Ochrobactrum anthropi</emphasis></citetitle>-caused osteomyelitis in the foot mimicking a bone tumor: case report and review of the literature. <citetitle><emphasis>J Foot Ankle Surg</emphasis></citetitle> <emphasis role="strong">56:</emphasis>851–853.</para>
          </listitem>
          <listitem id="ch0064s000000li0220" role="bibliographyEntry">
            <para>220.<emphasis role="strong">Naik C, Kulkarni H, Darabi A, Bhanot N.</emphasis> 2013. <citetitle><emphasis>Ochrobactrum anthropi</emphasis></citetitle>: a rare cause of pneumonia. <citetitle><emphasis>J Infect Chemother</emphasis></citetitle> <emphasis role="strong">19:</emphasis>162–165.</para>
          </listitem>
          <listitem id="ch0064s000000li0221" role="bibliographyEntry">
            <para>221.<emphasis role="strong">Zhu M, Zhao X, Zhu Q, Zhang Z, Dai Y, Chen L, Liang Z.</emphasis> 2018. Clinical characteristics of patients with <citetitle><emphasis>Ochrobactrum anthropi</emphasis></citetitle> bloodstream infection in a Chinese tertiary-care hospital: a 7-year study. <citetitle><emphasis>J Infect Public Health</emphasis></citetitle> <emphasis role="strong">11:</emphasis>873–877.</para>
          </listitem>
          <listitem id="ch0064s000000li0222" role="bibliographyEntry">
            <para>222.<emphasis role="strong">Ezzedine H, Mourad M, Van Ossel C, Logghe C, Squifflet JP, Renault F, Wauters G, Gigi J, Wilmotte L, Haxhe JJ.</emphasis> 1994. An outbreak of <citetitle><emphasis>Ochrobactrum anthropi</emphasis></citetitle> bacteraemia in five organ transplant patients. <citetitle><emphasis>J Hosp Infect</emphasis></citetitle> <emphasis role="strong">27:</emphasis>35–42.</para>
          </listitem>
          <listitem id="ch0064s000000li0223" role="bibliographyEntry">
            <para>223.<emphasis role="strong">Apisarnthanarak A, Kiratisin P, Mundy LM.</emphasis> 2005. Evaluation of <citetitle><emphasis>Ochrobactrum intermedium</emphasis></citetitle> bacteremia in a patient with bladder cancer. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">53:</emphasis>153–155.</para>
          </listitem>
          <listitem id="ch0064s000000li0224" role="bibliographyEntry">
            <para>224.<emphasis role="strong">Bharucha T, Sharma D, Sharma H, Kandil H, Collier S.</emphasis> 2016. <citetitle><emphasis>Ochromobactrum intermedium:</emphasis></citetitle> an emerging opportunistic pathogen—case of recurrent bacteraemia associated with infective endocarditis in a haemodialysis patient. <citetitle><emphasis>New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">15:</emphasis>14–15.</para>
          </listitem>
          <listitem id="ch0064s000000li0225" role="bibliographyEntry">
            <para>225.<emphasis role="strong">Wu W, Jiang Y, Zhou W, Liu X, Kuang L.</emphasis> 2021. The first case of <citetitle><emphasis>Ochrobactrum intermedium</emphasis></citetitle> bacteremia in a pediatric patient with malignant tumor. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">21:</emphasis>1252.</para>
          </listitem>
          <listitem id="ch0064s000000li0226" role="bibliographyEntry">
            <para>226.<emphasis role="strong">Kulkarni GJ, Shetty S, Dharne MS, Shouche YS.</emphasis> 2014. Genome sequencing analysis reveals virulence-related gene content of <citetitle><emphasis>Ochrobactrum intermedium</emphasis></citetitle> strain 229E, a urease-positive strain isolated from the human gastric niche. <citetitle><emphasis>FEMS Microbiol Lett</emphasis></citetitle> <emphasis role="strong">359:</emphasis>12–15.</para>
          </listitem>
          <listitem id="ch0064s000000li0227" role="bibliographyEntry">
            <para>227.<emphasis role="strong">Holmes B, Segers P, Coenye T, Vancanneyt M, Vandamme P.</emphasis> 2006. <citetitle><emphasis>Pannonibacter phragmitetus</emphasis></citetitle>, described from a Hungarian soda lake in 2003, had been recognized several decades earlier from human blood cultures as <citetitle><emphasis>Achromobacter</emphasis></citetitle> groups B and E. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>2945–2948.</para>
          </listitem>
          <listitem id="ch0064s000000li0228" role="bibliographyEntry">
            <para>228.<emphasis role="strong">Jenks PJ, Shaw EJ.</emphasis> 1997. Recurrent septicaemia due to “<citetitle><emphasis>Achromobacter</emphasis></citetitle> group B”. <citetitle><emphasis>J Infect</emphasis></citetitle> <emphasis role="strong">34:</emphasis>143–145.</para>
          </listitem>
          <listitem id="ch0064s000000li0229" role="bibliographyEntry">
            <para>229.<emphasis role="strong">Wang M, Zhang X, Jiang T, Hu S, Yi Z, Zhou Y, Ming D, Chen S.</emphasis> 2017. Liver abscess caused by <citetitle><emphasis>Pannonibacter phragmitetus</emphasis></citetitle>: case report and literature review. <citetitle><emphasis>Front Med (Lausanne)</emphasis></citetitle> <emphasis role="strong">4:</emphasis>48.</para>
          </listitem>
          <listitem id="ch0064s000000li0230" role="bibliographyEntry">
            <para>230.<emphasis role="strong">Kämpfer P, Rosselló-Mora R, Scholz HC, Welinder-Olsson C, Falsen E, Busse HJ.</emphasis> 2006. Description of <citetitle><emphasis>Pseudochrobactrum</emphasis></citetitle> gen. nov., with the two species <citetitle><emphasis>Pseudochrobactrum asaccharolyticum</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Pseudochrobactrum saccharolyticum</emphasis></citetitle> sp. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>1823–1829.</para>
          </listitem>
          <listitem id="ch0064s000000li0231" role="bibliographyEntry">
            <para>231.<emphasis role="strong">Aujoulat F, Marchandin H, Zorgniotti I, Masnou A, Jumas-Bilak E.</emphasis> 2015. <citetitle><emphasis>Rhizobium pusense</emphasis></citetitle> is the main human pathogen in the genus <citetitle><emphasis>Agrobacterium</emphasis></citetitle>/<citetitle><emphasis>Rhizobium. Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">21:</emphasis>472.e1–472.e5.</para>
          </listitem>
          <listitem id="ch0064s000000li0232" role="bibliographyEntry">
            <para>232.<emphasis role="strong">Dunne WM Jr, Tillman J, Murray JC.</emphasis> 1993. Recovery of a strain of <citetitle><emphasis>Agrobacterium radiobacter</emphasis></citetitle> with a mucoid phenotype from an immunocompromised child with bacteremia. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">31:</emphasis>2541–2543.</para>
          </listitem>
          <listitem id="ch0064s000000li0233" role="bibliographyEntry">
            <para>233.<emphasis role="strong">Zahoor BA.</emphasis> 2016. <citetitle><emphasis>Rhizobium radiobacter</emphasis></citetitle> endocarditis in an intravenous drug user: clinical presentation, diagnosis, and treatment. <citetitle><emphasis>Ann Vasc Surg</emphasis></citetitle> <emphasis role="strong">35:</emphasis>206.e9–206.e11.</para>
          </listitem>
          <listitem id="ch0064s000000li0234" role="bibliographyEntry">
            <para>234.<emphasis role="strong">Barker NH, Thompson JM, Mullen MG, Weekes MA, Nguyen LN, Haynes CK, Miller D.</emphasis> 2016. <citetitle><emphasis>Rhizobium radiobacter</emphasis></citetitle>: a recently recognized cause of bacterial keratitis. <citetitle><emphasis>Cornea</emphasis></citetitle> <emphasis role="strong">35:</emphasis>679–682.</para>
          </listitem>
          <listitem id="ch0064s000000li0235" role="bibliographyEntry">
            <para>235.<emphasis role="strong">Von Graevenitz A.</emphasis> 1985. Ecology, clinical significance and antimicrobial susceptibility of infrequently encountered glucose-nonfermenting Gram-negative rods, p 181–232. <citetitle><emphasis>In</emphasis></citetitle> Gilardi GL (ed), <citetitle><emphasis>Nonfermentative Gram-Negative Rods: Laboratory Identification and Clinical Aspects.</emphasis></citetitle> Marcel Dekker, New York, NY.</para>
          </listitem>
          <listitem id="ch0064s000000li0236" role="bibliographyEntry">
            <para>236.<emphasis role="strong">Nozue H, Hayashi T, Hashimoto Y, Ezaki T, Hamasaki K, Ohwada K, Terawaki Y.</emphasis> 1992. Isolation and characterization of <citetitle><emphasis>Shewanella alga</emphasis></citetitle> from human clinical specimens and emendation of the description of <citetitle><emphasis>S. alga</emphasis></citetitle> Simidu et al., 1990, 335. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>628–634.</para>
          </listitem>
          <listitem id="ch0064s000000li0237" role="bibliographyEntry">
            <para>237.<emphasis role="strong">Khashe S, Janda JM.</emphasis> 1998. Biochemical and pathogenic properties of <citetitle><emphasis>Shewanella alga</emphasis></citetitle> and <citetitle><emphasis>Shewanella putrefaciens. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">36:</emphasis>783–787.</para>
          </listitem>
          <listitem id="ch0064s000000li0238" role="bibliographyEntry">
            <para>238.<emphasis role="strong">Vignier N, Barreau M, Olive C, Baubion E, Théodose R, Hochedez P, Cabié A.</emphasis> 2013. Human infection with <citetitle><emphasis>Shewanella putrefaciens</emphasis></citetitle> and <citetitle><emphasis>S. algae</emphasis></citetitle>: report of 16 cases in Martinique and review of the literature. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">89:</emphasis>151–156.</para>
          </listitem>
          <listitem id="ch0064s000000li0239" role="bibliographyEntry">
            <para>239.<emphasis role="strong">Khim LP, Jie Teng TZ, Junnarkar SP.</emphasis> 2022. Letter to the Editor: <citetitle><emphasis>Shewanella algae</emphasis></citetitle>: an emerging pathogen implicated in acute cholangitis. <citetitle><emphasis>Surg Infect (Larchmt)</emphasis></citetitle> <emphasis role="strong">23:</emphasis>607–608.</para>
          </listitem>
          <listitem id="ch0064s000000li0240" role="bibliographyEntry">
            <para>240.<emphasis role="strong">Takata T, Chikumi H, Morishita S, Hamada S, Hoi S, Iyama T, Fukui T, Matono T, Fukuda S, Munemura C, Isomoto H.</emphasis> 2017. <citetitle><emphasis>Shewanella algae</emphasis></citetitle> bacteremia in an end-stage renal disease patient: a case report and review of the literature. <citetitle><emphasis>Intern Med</emphasis></citetitle> <emphasis role="strong">56:</emphasis>729–732.</para>
          </listitem>
          <listitem id="ch0064s000000li0241" role="bibliographyEntry">
            <para>241.<emphasis role="strong">Wauters G, Janssens M, De Baere T, Vaneechoutte M, Deschaght P.</emphasis> 2012. Isolates belonging to CDC group II-i belong predominantly to <citetitle><emphasis>Sphingobacterium mizutaii</emphasis></citetitle> Yabuuchi et al. 1983: emended descriptions of <citetitle><emphasis>S. mizutaii</emphasis></citetitle> and of the genus <citetitle><emphasis>Sphingobacterium. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">62:</emphasis>2598–2601.</para>
          </listitem>
          <listitem id="ch0064s000000li0242" role="bibliographyEntry">
            <para>242.<emphasis role="strong">Takeuchi MYA, Yokota A.</emphasis> 1992. Proposals of <citetitle><emphasis>Sphingobacterium faecium</emphasis></citetitle> sp. nov., <citetitle><emphasis>Sphingobacterium piscium</emphasis></citetitle> sp. nov., <citetitle><emphasis>Sphingobacterium heparinum</emphasis></citetitle> comb. nov., <citetitle><emphasis>Sphingobacterium thalpophilum</emphasis></citetitle> comb. nov. and two genospecies of the genus <citetitle><emphasis>Sphingobacterium</emphasis></citetitle>, and synonymy of <citetitle><emphasis>Flavobacterium yabuuchiae</emphasis></citetitle> and <citetitle><emphasis>Sphingobacterium spiritivorum. J Gen Appl Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>465–482.</para>
          </listitem>
          <listitem id="ch0064s000000li0243" role="bibliographyEntry">
            <para>243.<emphasis role="strong">Yabuuchi E, Kaneko T, Yano I, Moss CW, Miyoshi N.</emphasis> 1983. <citetitle><emphasis>Sphingobacterium</emphasis></citetitle> gen. nov., <citetitle><emphasis>Sphingobacterium spiritivorum</emphasis></citetitle> comb. nov., <citetitle><emphasis>Sphingobacterium multivorum</emphasis></citetitle> com. nov., <citetitle><emphasis>Sphingobacterium mizutae</emphasis></citetitle> sp. nov., and <citetitle><emphasis>Flavobacterium indologenes</emphasis></citetitle> sp. nov.: glucose-nonfermenting gram-negative rods in CDC groups IIk-2 and IIb. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">33:</emphasis>580–598.</para>
          </listitem>
          <listitem id="ch0064s000000li0244" role="bibliographyEntry">
            <para>244.<emphasis role="strong">Barahona F, Slim J.</emphasis> 2015. <citetitle><emphasis>Sphingobacterium multivorum</emphasis></citetitle>: case report and literature review. <citetitle><emphasis>New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">7:</emphasis>33–36.</para>
          </listitem>
          <listitem id="ch0064s000000li0245" role="bibliographyEntry">
            <para>245.<emphasis role="strong">Grimaldi D, Doloy A, Fichet J, Bourgeois E, Zuber B, Wajsfisz A, Mira JP, Poyart C, Pène F.</emphasis> 2012. Necrotizing fasciitis and septic shock related to the uncommon gram-negative pathogen <citetitle><emphasis>Sphingobacterium multivorum. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>202–203.</para>
          </listitem>
          <listitem id="ch0064s000000li0246" role="bibliographyEntry">
            <para>246.<emphasis role="strong">Holmes B, Owen RJ, Weaver RE.</emphasis> 1981. <citetitle><emphasis>Flavobacterium multivorum</emphasis></citetitle>, a new species isolated from human clinical specimens and previously known as group IIK, biotype 2. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">31:</emphasis>21–34.</para>
          </listitem>
          <listitem id="ch0064s000000li0247" role="bibliographyEntry">
            <para>247.<emphasis role="strong">Kroumova V, Rossati A, Bargiacchi O, Garavelli PL, Camaggi A, Caroppo S, Andreoni S.</emphasis> 2017. From soil to blood: first human case of <citetitle><emphasis>Sphingobacterium hotanense</emphasis></citetitle> bacteraemia. <citetitle><emphasis>Infez Med</emphasis></citetitle> <emphasis role="strong">25:</emphasis>75–76.</para>
          </listitem>
          <listitem id="ch0064s000000li0248" role="bibliographyEntry">
            <para>248.<emphasis role="strong">Holmes B, Owen RJ, Hollis DG.</emphasis> 1982. <citetitle><emphasis>Flavobacterium spiritivorum</emphasis></citetitle>, a new species isolated from human clinical specimens. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">32:</emphasis>157–165.</para>
          </listitem>
          <listitem id="ch0064s000000li0249" role="bibliographyEntry">
            <para>249.<emphasis role="strong">Huys G, Purohit P, Tan CH, Snauwaert C, Vos P, Saffar HA, Obaid IA, Busse HJ, Seemann T, John Albert M.</emphasis> 2017. <citetitle><emphasis>Sphingobacterium cellulitidis</emphasis></citetitle> sp. nov., isolated from clinical and environmental sources. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">67:</emphasis>1415–1421.</para>
          </listitem>
          <listitem id="ch0064s000000li0250" role="bibliographyEntry">
            <para>250.<emphasis role="strong">Hsueh PR, Teng LJ, Yang PC, Chen YC, Pan HJ, Ho SW, Luh KT.</emphasis> 1998. Nosocomial infections caused by <citetitle><emphasis>Sphingomonas paucimobilis</emphasis></citetitle>: clinical features and microbiological characteristics. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">26:</emphasis>676–681.</para>
          </listitem>
          <listitem id="ch0064s000000li0251" role="bibliographyEntry">
            <para>251.<emphasis role="strong">Lin JN, Lai CH, Chen YH, Lin HL, Huang CK, Chen WF, Wang JL, Chung HC, Liang SH, Lin HH.</emphasis> 2010. <citetitle><emphasis>Sphingomonas paucimobilis</emphasis></citetitle> bacteremia in humans: 16 case reports and a literature review. <citetitle><emphasis>J Microbiol Immunol Infect</emphasis></citetitle> <emphasis role="strong">43:</emphasis>35–42.</para>
          </listitem>
          <listitem id="ch0064s000000li0252" role="bibliographyEntry">
            <para>252.<emphasis role="strong">Demir T, Dadali M.</emphasis> 2016. Recurrent complicated urinary tract infection due to rare pathogen <citetitle><emphasis>Sphingomonas paucimobilis</emphasis></citetitle>: contamination or real deal? <citetitle><emphasis>Infez Med</emphasis></citetitle> <emphasis role="strong">24:</emphasis>241–244.</para>
          </listitem>
          <listitem id="ch0064s000000li0253" role="bibliographyEntry">
            <para>253.<emphasis role="strong">Santarelli A, Mascitti M, Galeazzi R, Marziali A, Busco F, Procaccini M.</emphasis> 2016. Oral ulcer by <citetitle><emphasis>Sphingomonas paucimobilis</emphasis></citetitle>: first report. <citetitle><emphasis>Int J Oral Maxillofac Surg</emphasis></citetitle> <emphasis role="strong">45:</emphasis>1280–1282.</para>
          </listitem>
          <listitem id="ch0064s000000li0254" role="bibliographyEntry">
            <para>254.<emphasis role="strong">Bolen RD, Palavecino E, Gomadam A, Balakrishnan N, Datar S.</emphasis> 2015. <citetitle><emphasis>Sphingomonas paucimobilis</emphasis></citetitle> meningitis and ventriculitis in an immunocompromised host. <citetitle><emphasis>J Neurol Sci</emphasis></citetitle> <emphasis role="strong">359:</emphasis>18–20.</para>
          </listitem>
          <listitem id="ch0064s000000li0255" role="bibliographyEntry">
            <para>255.<emphasis role="strong">Yabuuchi E, Yano I, Oyaizu H, Hashimoto Y, Ezaki T, Yamamoto H.</emphasis> 1990. Proposals of <citetitle><emphasis>Sphingomonas paucimobilis</emphasis></citetitle> gen. nov. and comb. nov., <citetitle><emphasis>Sphingomonas parapaucimobilis</emphasis></citetitle> sp. nov., <citetitle><emphasis>Sphingomonas yanoikuyae</emphasis></citetitle> sp. nov., <citetitle><emphasis>Sphingomonas adhaesiva</emphasis></citetitle> sp. nov., <citetitle><emphasis>Sphingomonas capsulata</emphasis></citetitle> comb. nov., and two genospecies of the genus <citetitle><emphasis>Sphingomonas. Microbiol Immunol</emphasis></citetitle> <emphasis role="strong">34:</emphasis>99–119.</para>
          </listitem>
          <listitem id="ch0064s000000li0256" role="bibliographyEntry">
            <para>256.<emphasis role="strong">Wallner J, Frei R, Burkhalter F.</emphasis> 2016. A rare case of peritoneal dialysis-associated peritonitis with <citetitle><emphasis>Sphingomonas koreensis. Perit Dial Int</emphasis></citetitle> <emphasis role="strong">36:</emphasis>224–225.</para>
          </listitem>
          <listitem id="ch0064s000000li0257" role="bibliographyEntry">
            <para>257.<emphasis role="strong">Bernardet J-F, Nakagawa Y.</emphasis> 2006. An introduction to the family <citetitle><emphasis>Flavobacteriaceae</emphasis></citetitle>, p 455–480. <citetitle><emphasis>In</emphasis></citetitle> Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E (ed), <citetitle><emphasis>The Prokaryotes: A Handbook on the Biology of Bacteria</emphasis></citetitle>, 3rd ed. Springer, New York, NY.</para>
          </listitem>
          <listitem id="ch0064s000000li0258" role="bibliographyEntry">
            <para>258.<emphasis role="strong">Bernardet J, Bruun B, Hugo C.</emphasis> 2006. The genera <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> and <citetitle><emphasis>Elizabethkingia</emphasis></citetitle>, p 638–676. <citetitle><emphasis>In</emphasis></citetitle> Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E (ed), <citetitle><emphasis>The Prokaryotes: a Handbook on the Biology of Bacteria</emphasis></citetitle>, 3rd ed. Springer, New York, NY.</para>
          </listitem>
          <listitem id="ch0064s000000li0259" role="bibliographyEntry">
            <para>259.<emphasis role="strong">Kim KK, Kim MK, Lim JH, Park HY, Lee ST.</emphasis> 2005. Transfer of <citetitle><emphasis>Chryseobacterium meningosepticum</emphasis></citetitle> and <citetitle><emphasis>Chryseobacterium miricola</emphasis></citetitle> to <citetitle><emphasis>Elizabethkingia</emphasis></citetitle> gen. nov. as <citetitle><emphasis>Elizabethkingia meningoseptica</emphasis></citetitle> comb. nov. and <citetitle><emphasis>Elizabethkingia miricola</emphasis></citetitle> comb. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>1287–1293.</para>
          </listitem>
          <listitem id="ch0064s000000li0260" role="bibliographyEntry">
            <para>260.<emphasis role="strong">Bruun B, Ursing J.</emphasis> 1987. Phenotypic characterization of <citetitle><emphasis>Flavobacterium meningosepticum</emphasis></citetitle> strains identified by DNA-DNA hybridization. <citetitle><emphasis>Acta Pathol Microbiol Immunol Scand [B]</emphasis></citetitle> <emphasis role="strong">95:</emphasis>41–47.</para>
          </listitem>
          <listitem id="ch0064s000000li0261" role="bibliographyEntry">
            <para>261.<emphasis role="strong">Bernardet JF, Vancanneyt M, Matte-Tailliez O, Grisez L, Tailliez P, Bizet C, Nowakowski M, Kerouault B, Swings J.</emphasis> 2005. Polyphasic study of <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> strains isolated from diseased aquatic animals. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">28:</emphasis>640–660.</para>
          </listitem>
          <listitem id="ch0064s000000li0262" role="bibliographyEntry">
            <para>262.<emphasis role="strong">Dauga C, Gillis M, Vandamme P, Ageron E, Grimont F, Kersters K, de Mahenge C, Peloux Y, Grimont PA.</emphasis> 1993. <citetitle><emphasis>Balneatrix alpica</emphasis></citetitle> gen. nov., sp. nov., a bacterium associated with pneumonia and meningitis in a spa therapy center. <citetitle><emphasis>Res Microbiol</emphasis></citetitle> <emphasis role="strong">144:</emphasis>35–46.</para>
          </listitem>
          <listitem id="ch0064s000000li0263" role="bibliographyEntry">
            <para>263.<emphasis role="strong">Bousbia S, Papazian L, Saux P, Forel JM, Auffray JP, Martin C, Raoult D, La Scola B.</emphasis> 2013. Serologic prevalence of amoeba-associated microorganisms in intensive care unit pneumonia patients. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">8:</emphasis>e58111.</para>
          </listitem>
          <listitem id="ch0064s000000li0264" role="bibliographyEntry">
            <para>264.<emphasis role="strong">Zamora L, Domínguez L, Fernández-Garayzábal JF, Vela AI.</emphasis> 2016. <citetitle><emphasis>Bergeyella porcorum</emphasis></citetitle> sp. nov., isolated from pigs. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">39:</emphasis>160–163.</para>
          </listitem>
          <listitem id="ch0064s000000li0265" role="bibliographyEntry">
            <para>265.<emphasis role="strong">Holmes BSA, Weaver RE, Brenner DJ.</emphasis> 1986. <citetitle><emphasis>Weeksella virosa</emphasis></citetitle> gen. nov., sp. nov. (formerly group IIf), found in human clinical specimens. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">8:</emphasis>185–190.</para>
          </listitem>
          <listitem id="ch0064s000000li0266" role="bibliographyEntry">
            <para>266.<emphasis role="strong">Montejo M, Aguirrebengoa K, Ugalde J, Lopez L, Saez Nieto JA, Hernández JL.</emphasis> 2001. <citetitle><emphasis>Bergeyella zoohelcum</emphasis></citetitle> bacteremia after a dog bite. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">33:</emphasis>1608–1609.</para>
          </listitem>
          <listitem id="ch0064s000000li0267" role="bibliographyEntry">
            <para>267.<emphasis role="strong">Chen Y, Liao K, Ai L, Guo P, Huang H, Wu Z, Liu M.</emphasis> 2017. Bacteremia caused by <citetitle><emphasis>Bergeyella zoohelcum</emphasis></citetitle> in an infective endocarditis patient: case report and review of literature. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>271.</para>
          </listitem>
          <listitem id="ch0064s000000li0268" role="bibliographyEntry">
            <para>268.<emphasis role="strong">Yi J, Humphries R, Doerr L, Jerris RC, Westblade LF.</emphasis> 2016. <citetitle><emphasis>Bergeyella zoohelcum</emphasis></citetitle> associated with abscess and cellulitis after a dog bite. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">35:</emphasis>214–216.</para>
          </listitem>
          <listitem id="ch0064s000000li0269" role="bibliographyEntry">
            <para>269.<emphasis role="strong">Harsent R, Macleod J, Rowlands RS, Smith PM, Rushmere N, Blaxland J.</emphasis> 2022. The identification of multidrug-resistant microorganisms including <citetitle><emphasis>Bergeyella zoohelcum</emphasis></citetitle> acquired from the skin/prosthetic interface of amputees and their susceptibility to Medihoney™ and garlic extract (allicin). <citetitle><emphasis>Microorganisms</emphasis></citetitle> <emphasis role="strong">10:</emphasis>299.</para>
          </listitem>
          <listitem id="ch0064s000000li0270" role="bibliographyEntry">
            <para>270.<emphasis role="strong">Sohn KM, Huh K, Baek JY, Kim YS, Kang CI, Peck KR, Lee NY, Song JH, Ko KS, Chung DR.</emphasis> 2015. A new causative bacteria of infective endocarditis, <citetitle><emphasis>Bergeyella cardium</emphasis></citetitle> sp. nov. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">81:</emphasis>213–216.</para>
          </listitem>
          <listitem id="ch0064s000000li0271" role="bibliographyEntry">
            <para>271.<emphasis role="strong">Guo LN, Li Y, Hsueh PR, Wang P, Zhao YP, Xu YC.</emphasis> 2018. Microbiological characteristics of a novel species most closely related to ‘<citetitle><emphasis>Bergeyella cardium</emphasis></citetitle>’ as a pathogen of infectious endocarditis. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">13</emphasis><emphasis role="strong">:</emphasis>e0191715.</para>
          </listitem>
          <listitem id="ch0064s000000li0272" role="bibliographyEntry">
            <para>272.<emphasis role="strong">Mulliken JS, Langelier C, Budak JZ, Miller S, Dynerman D, Hao S, Li LM, Crawford E, Lyden A, Woodworth MH, DeRisi JL, Desmond E, Browne C, Luu A, Grandis DJ, Grossman W, Deuse T, Melcher GP.</emphasis> 2019. <citetitle><emphasis>Bergeyella cardium</emphasis></citetitle>: clinical characteristics and draft genome of an emerging pathogen in native and prosthetic valve endocarditis. <citetitle><emphasis>Open Forum Infect Dis</emphasis></citetitle> <emphasis role="strong">6:</emphasis>ofz134.</para>
          </listitem>
          <listitem id="ch0064s000000li0273" role="bibliographyEntry">
            <para>273.<emphasis role="strong">Pan H, Li W, Sun E, Zhang Y.</emphasis> 2020. Characterization and whole genome sequencing of a novel strain of Bergeyella cardium related to infective endocarditis. <citetitle><emphasis>BMC Microbiol</emphasis></citetitle> <emphasis role="strong">20:</emphasis>32.</para>
          </listitem>
          <listitem id="ch0064s000000li0274" role="bibliographyEntry">
            <para>274.<emphasis role="strong">Antonello VS, Daht P, Polli J, Gross M Jr, Colvero M.</emphasis> 2017. Ventilator-associated pneumonia in neonatal intensive care unit due to <citetitle><emphasis>Chryseobacterium indologenes. Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">36:</emphasis>e353–e355.</para>
          </listitem>
          <listitem id="ch0064s000000li0275" role="bibliographyEntry">
            <para>275.<emphasis role="strong">González-Castro A, Alsasua A, Peñasco Y, Rodríguez JC, Duerto J.</emphasis> 2017. Tracheo-bronchitis and pneumonia associated with mechanical ventilation by <citetitle><emphasis>Chryseobacterium indologenes. Rev Esp Anestesiol Reanim</emphasis></citetitle> <emphasis role="strong">64:</emphasis>294–298.</para>
          </listitem>
          <listitem id="ch0064s000000li0276" role="bibliographyEntry">
            <para>276.<emphasis role="strong">Atici S, Ünkar ZA, Erdem K, Kadayifci EK, Karaaslan A, Memişoğlu AC, Soysal A, Toprak NU, Söyletir G, Özek E, Bakır M.</emphasis> 2016. Ventilator-associated pneumonia caused by <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle>: a rare infant case and review of the literature. <citetitle><emphasis>Springerplus</emphasis></citetitle> <emphasis role="strong">5:</emphasis>1741.</para>
          </listitem>
          <listitem id="ch0064s000000li0277" role="bibliographyEntry">
            <para>277.<emphasis role="strong">Aykac K, Ozsurekci Y, Tuncer O, Sancak B, Cengiz AB, Kara A, Ceyhan M.</emphasis> 2016. Six cases during 2012-2015 and literature review of <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> infections in pediatric patients. <citetitle><emphasis>Can J Microbiol</emphasis></citetitle> <emphasis role="strong">62:</emphasis>812–819.</para>
          </listitem>
          <listitem id="ch0064s000000li0278" role="bibliographyEntry">
            <para>278.<emphasis role="strong">Corbella M, Brandolini M, Cambieri P, Decembrino N, Pagani M, Bottazzi A, Muzzi A, Zecca M, Mariani B, Marone P.</emphasis> 2017. A catheter-related bloodstream infection caused by <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> successfully treated with antibiotic-lock rescue therapy. <citetitle><emphasis>New Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>223–225.</para>
          </listitem>
          <listitem id="ch0064s000000li0279" role="bibliographyEntry">
            <para>279.<emphasis role="strong">Wang X, Hu Z, Fan Y, Wang H.</emphasis> 2014. <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> catheter-related meningitis in an elderly patient after intracranial aneurysm clipping surgery. <citetitle><emphasis>Neurol Sci</emphasis></citetitle> <emphasis role="strong">35:</emphasis>113–115.</para>
          </listitem>
          <listitem id="ch0064s000000li0280" role="bibliographyEntry">
            <para>280.<emphasis role="strong">Kodama Y, Nishimura M, Nakashima K, Ito N, Fukano R, Okamura J, Inagaki J.</emphasis> 2013. [Central intravenous catheter-related bacteremia due to Chryseobacterium indologenes after cord blood transplantation]. <citetitle><emphasis>Rinsho Ketsueki</emphasis></citetitle> <emphasis role="strong">54:</emphasis>305–310.</para>
          </listitem>
          <listitem id="ch0064s000000li0281" role="bibliographyEntry">
            <para>281.<emphasis role="strong">Akay M, Gunduz E, Gulbas Z.</emphasis> 2006. Catheter-related bacteremia due to <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> in a bone marrow transplant recipient. <citetitle><emphasis>Bone Marrow Transplant</emphasis></citetitle> <emphasis role="strong">37:</emphasis>435–436.</para>
          </listitem>
          <listitem id="ch0064s000000li0282" role="bibliographyEntry">
            <para>282.<emphasis role="strong">Hsueh PR, Teng LJ, Ho SW, Hsieh WC, Luh KT.</emphasis> 1996. Clinical and microbiological characteristics of <citetitle><emphasis>Flavobacterium indologenes</emphasis></citetitle> infections associated with indwelling devices. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">34:</emphasis>1908–1913.</para>
          </listitem>
          <listitem id="ch0064s000000li0283" role="bibliographyEntry">
            <para>283.<emphasis role="strong">Eshwara VK, Sasi A, Munim F, Purkayastha J, Lewis LE, Mukhopadhyay C.</emphasis> 2014. Neonatal meningitis and sepsis by <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle>: a rare and resistant bacterium. <citetitle><emphasis>Indian J Pediatr</emphasis></citetitle> <emphasis role="strong">81:</emphasis>611–613.</para>
          </listitem>
          <listitem id="ch0064s000000li0284" role="bibliographyEntry">
            <para>284.<emphasis role="strong">Hendaus MA, Zahraldin K.</emphasis> 2013. <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> meningitis in a healthy newborn: a case report. <citetitle><emphasis>Oman Med J</emphasis></citetitle> <emphasis role="strong">28:</emphasis>133–134.</para>
          </listitem>
          <listitem id="ch0064s000000li0285" role="bibliographyEntry">
            <para>285.<emphasis role="strong">Cimmino T, Rolain JM.</emphasis> 2016. Whole genome sequencing for deciphering the resistome of <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle>, an emerging multidrug-resistant bacterium isolated from a cystic fibrosis patient in Marseille, France. <citetitle><emphasis>New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">12:</emphasis>35–42.</para>
          </listitem>
          <listitem id="ch0064s000000li0286" role="bibliographyEntry">
            <para>286.<emphasis role="strong">Yu CY, Ang GY, Cheng HJ, Cheong YM, Yin WF, Chan KG.</emphasis> 2015. Draft genome sequence of a multidrug-resistant <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> isolate from Malaysia. <citetitle><emphasis>Genom Data</emphasis></citetitle> <emphasis role="strong">7:</emphasis>185–186.</para>
          </listitem>
          <listitem id="ch0064s000000li0287" role="bibliographyEntry">
            <para>287.<emphasis role="strong">Perilli M, Caporale B, Celenza G, Pellegrini C, Docquier JD, Mezzatesta M, Rossolini GM, Stefani S, Amicosante G.</emphasis> 2007. Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of <citetitle><emphasis>Chryseobacterium indologenes. Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">51:</emphasis>2988–2990.</para>
          </listitem>
          <listitem id="ch0064s000000li0288" role="bibliographyEntry">
            <para>288.<emphasis role="strong">Hsueh PR, Hsiue TR, Wu JJ, Teng LJ, Ho SW, Hsieh WC, Luh KT.</emphasis> 1996b. <citetitle><emphasis>Flavobacterium indologenes</emphasis></citetitle> bacteremia: clinical and microbiological characteristics. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">23:</emphasis>550–555.</para>
          </listitem>
          <listitem id="ch0064s000000li0289" role="bibliographyEntry">
            <para>289.<emphasis role="strong">Bagely DH Jr, Alexander JC Jr, Gill VJ, Dolin R, Ketcham AS.</emphasis> 1976. Late <citetitle><emphasis>Flavobacterium</emphasis></citetitle> species meningitis after craniofacial exenteration. <citetitle><emphasis>Arch Intern Med</emphasis></citetitle> <emphasis role="strong">136:</emphasis>229–231.</para>
          </listitem>
          <listitem id="ch0064s000000li0290" role="bibliographyEntry">
            <para>290.<emphasis role="strong">Stamm WE, Colella JJ, Anderson RL, Dixon RE, Dixon RE.</emphasis> 1975. Indwelling arterial catheters as a source of nosocomial bacteremia. An outbreak caused by <citetitle><emphasis>Flavobacterium</emphasis></citetitle> species. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">292:</emphasis>1099–1102.</para>
          </listitem>
          <listitem id="ch0064s000000li0291" role="bibliographyEntry">
            <para>291.<emphasis role="strong">Hsueh PR, Hsiue TR, Hsieh WC.</emphasis> 1996. Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">22:</emphasis>858–860.</para>
          </listitem>
          <listitem id="ch0064s000000li0292" role="bibliographyEntry">
            <para>292.<emphasis role="strong">Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT.</emphasis> 1997. Increasing incidence of nosocomial <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> infections in Taiwan. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">16:</emphasis>568–574.</para>
          </listitem>
          <listitem id="ch0064s000000li0293" role="bibliographyEntry">
            <para>293.<emphasis role="strong">Mukerji R, Kakarala R, Smith SJ, Kusz HG.</emphasis> 2016. <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle>: an emerging infection in the USA. <citetitle><emphasis>BMJ Case Rep</emphasis></citetitle> <emphasis role="strong">2016:</emphasis>bcr2016214486.</para>
          </listitem>
          <listitem id="ch0064s000000li0294" role="bibliographyEntry">
            <para>294.<emphasis role="strong">Olbrich P, Rivero-Garvía M, Falcón-Neyra MD, Lepe JA, Cisneros JM, Marquez-Rivas J, Neth O.</emphasis> 2014. <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> central nervous system infection in infancy: an emergent pathogen? <citetitle><emphasis>Infection</emphasis></citetitle> <emphasis role="strong">42:</emphasis>179–183.</para>
          </listitem>
          <listitem id="ch0064s000000li0295" role="bibliographyEntry">
            <anchor id="ch0064s000000a0146"/>
            <para>295.<emphasis role="strong">Mirza HC, Tuncer Ö, Ölmez S,</emphasis> Ş<emphasis role="strong">ener B, Tuğcu GD, Özçelik U, Gürsoy NC, Otlu B, Büyükçam A, Kara A, Sancak B.</emphasis> 2018. Clinical strains of <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> and <citetitle><emphasis>Elizabethkingia</emphasis></citetitle> spp. isolated from pediatric patients in a University hospital: performance of MALDI-TOF MS-based identification, antimicrobial susceptibilities, and baseline patient characteristics. <citetitle><emphasis>Microb Drug Resist</emphasis></citetitle> <emphasis role="strong">24:</emphasis>816–821.</para>
          </listitem>
          <listitem id="ch0064s000000li0296" role="bibliographyEntry">
            <para>296.<emphasis role="strong">Chou DW, Wu SL, Lee CT, Tai FT, Yu WL.</emphasis> 2011. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> bacteremia in an intensive care unit. <citetitle><emphasis>Jpn J Infect Dis</emphasis></citetitle> <emphasis role="strong">64:</emphasis>520–524.</para>
          </listitem>
          <listitem id="ch0064s000000li0297" role="bibliographyEntry">
            <para>297.<emphasis role="strong">Kataoka D, Fujiwara H, Kawakami T, Tanaka Y, Tanimoto A, Ikawa S, Tanaka Y.</emphasis> 2003. The indirect pathogenicity of <citetitle><emphasis>Stenotrophomonas maltophilia. Int J Antimicrob Agents</emphasis></citetitle> <emphasis role="strong">22:</emphasis>601–606.</para>
          </listitem>
          <listitem id="ch0064s000000li0298" role="bibliographyEntry">
            <para>298.<emphasis role="strong">Chang YC, Lo HH, Hsieh HY, Chang SM.</emphasis> 2015. Identification, epidemiological relatedness, and biofilm formation of clinical <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> isolates from central Taiwan. <citetitle><emphasis>J Microbiol Immunol Infect</emphasis></citetitle> <emphasis role="strong">48:</emphasis>559–564.</para>
          </listitem>
          <listitem id="ch0064s000000li0299" role="bibliographyEntry">
            <para>299.<emphasis role="strong">Virok DP, Ábrók M, Szél B, Tajti Z, Mader K, Urbán E, Tálosi G.</emphasis> 2014. <citetitle><emphasis>Chryseobacterium gleum</emphasis></citetitle> - a novel bacterium species detected in neonatal respiratory tract infections. <citetitle><emphasis>J Matern Fetal Neonatal Med</emphasis></citetitle> <emphasis role="strong">27:</emphasis>1926–1929.</para>
          </listitem>
          <listitem id="ch0064s000000li0300" role="bibliographyEntry">
            <para>300.<emphasis role="strong">Hugo C, Bernardet J, Nicholson AC, Kämpfer P.</emphasis> 2019. <emphasis role="strong">Chryseobacterium.</emphasis> <citetitle><emphasis>In</emphasis></citetitle> Trujillo ME, Dedysh S, DeVos P, Hedlund B, Kämpfer P, Rainey FA, Whitman WB (ed), <citetitle><emphasis>Bergey’s Manual of Systematics of Archaea and Bacteria.</emphasis></citetitle> Wiley, Hoboken, NJ.</para>
          </listitem>
          <listitem id="ch0064s000000li0301" role="bibliographyEntry">
            <para>301.<emphasis role="strong">Holmes B, Owen RJ, Steigerwalt AG, Brenner DJ.</emphasis> 1984. <citetitle><emphasis>Flavobacterium gleum</emphasis></citetitle>, a new species found in human clinical specimens. <citetitle><emphasis>Int J Syst Bacteriol</emphasis></citetitle> <emphasis role="strong">34:</emphasis>21–25.</para>
          </listitem>
          <listitem id="ch0064s000000li0302" role="bibliographyEntry">
            <para>302.<emphasis role="strong">de Carvalho Filho EB, Marson FAL, Levy CE.</emphasis> 2017. Challenges in the identification of <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> and <citetitle><emphasis>Elizabethkingia meningoseptica</emphasis></citetitle> in cases of nosocomial infections and patients with cystic fibrosis. <citetitle><emphasis>New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">20:</emphasis>27–33.</para>
          </listitem>
          <listitem id="ch0064s000000li0303" role="bibliographyEntry">
            <para>303.<emphasis role="strong">McKew G.</emphasis> 2014. Severe sepsis due to <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> in an immunocompetent adventure traveler. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>4100–4101.</para>
          </listitem>
          <listitem id="ch0064s000000li0304" role="bibliographyEntry">
            <para>304.<emphasis role="strong">Srinivasan G, Muthusamy S, Raveendran V, Joseph NM, Easow JM.</emphasis> 2016. Unforeseeable presentation of <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> infection in a paediatric patient. <citetitle><emphasis>BMC Res Notes</emphasis></citetitle> <emphasis role="strong">9:</emphasis>212.</para>
          </listitem>
          <listitem id="ch0064s000000li0305" role="bibliographyEntry">
            <para>305.<emphasis role="strong">Esposito S, Russo E, De Simone G, Gioia R, Noviello S, Vitolo M, Rega MR, Massari A, Posteraro L.</emphasis> 2015. Transient bacteraemia due to <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> in an immunocompetent patient: a case report and literature review. <citetitle><emphasis>J Chemother</emphasis></citetitle> <emphasis role="strong">27:</emphasis>324–329.</para>
          </listitem>
          <listitem id="ch0064s000000li0306" role="bibliographyEntry">
            <para>306.<emphasis role="strong">Kämpfer P, Vaneechoutte M, Lodders N, De Baere T, Avesani V, Janssens M, Busse HJ, Wauters G.</emphasis> 2009. Description of <citetitle><emphasis>Chryseobacterium anthropi</emphasis></citetitle> sp. nov. to accommodate clinical isolates biochemically similar to <citetitle><emphasis>Kaistella koreensis</emphasis></citetitle> and <citetitle><emphasis>Chryseobacterium haifense</emphasis></citetitle>, proposal to reclassify <citetitle><emphasis>Kaistella koreensis</emphasis></citetitle> as <citetitle><emphasis>Chryseobacterium koreense</emphasis></citetitle> comb. nov. and emended description of the genus <citetitle><emphasis>Chryseobacterium. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>2421–2428.</para>
          </listitem>
          <listitem id="ch0064s000000li0307" role="bibliographyEntry">
            <para>307.<emphasis role="strong">Vaneechoutte M, Kämpfer P, De Baere T, Avesani V, Janssens M, Wauters G.</emphasis> 2007. <citetitle><emphasis>Chryseobacterium hominis</emphasis></citetitle> sp. nov., to accommodate clinical isolates biochemically similar to CDC groups II-h and II-c. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">57:</emphasis>2623–2628.</para>
          </listitem>
          <listitem id="ch0064s000000li0308" role="bibliographyEntry">
            <para>308.<emphasis role="strong">Yassin AF, Hupfer H, Siering C, Busse HJ.</emphasis> 2010. <citetitle><emphasis>Chryseobacterium treverense</emphasis></citetitle> sp. nov., isolated from a human clinical source. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>1993–1998.</para>
          </listitem>
          <listitem id="ch0064s000000li0309" role="bibliographyEntry">
            <para>309.<emphasis role="strong">Fraser SL, Jorgensen JH.</emphasis> 1997. Reappraisal of the antimicrobial susceptibilities of <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> and <citetitle><emphasis>Flavobacterium</emphasis></citetitle> species and methods for reliable susceptibility testing. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">41:</emphasis>2738–2741.</para>
          </listitem>
          <listitem id="ch0064s000000li0310" role="bibliographyEntry">
            <para>310.<emphasis role="strong">Michel C, Matte-Tailliez O, Kerouault B, Bernardet J-F.</emphasis> 2005. Resistance pattern and assessment of phenicol agents’ minimum inhibitory concentration in multiple drug resistant <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> isolates from fish and aquatic habitats. <citetitle><emphasis>J Appl Microbiol</emphasis></citetitle> <emphasis role="strong">99:</emphasis>323–332.</para>
          </listitem>
          <listitem id="ch0064s000000li0311" role="bibliographyEntry">
            <para>311.<emphasis role="strong">Hada V, Sharma A.</emphasis> 2017. Inconsistency in disk diffusion while testing carbapenems in <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> spp. <citetitle><emphasis>Indian J Med Microbiol</emphasis></citetitle> <emphasis role="strong">35:</emphasis>317.</para>
          </listitem>
          <listitem id="ch0064s000000li0312" role="bibliographyEntry">
            <para>312.<emphasis role="strong">Bellais S, Léotard S, Poirel L, Naas T, Nordmann P.</emphasis> 1999. Molecular characterization of a carbapenem-hydrolyzing beta-lactamase from <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> (<citetitle><emphasis>Flavobacterium</emphasis></citetitle>) <citetitle><emphasis>indologenes. FEMS Microbiol Lett</emphasis></citetitle> <emphasis role="strong">171:</emphasis>127–132.</para>
          </listitem>
          <listitem id="ch0064s000000li0313" role="bibliographyEntry">
            <para>313.<emphasis role="strong">Bellais S, Aubert D, Naas T, Nordmann P.</emphasis> 2000. Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in <citetitle><emphasis>Chryseobacterium meningosepticum. Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">44:</emphasis>1878–1886.</para>
          </listitem>
          <listitem id="ch0064s000000li0314" role="bibliographyEntry">
            <para>314.<emphasis role="strong">Bellais S, Naas T, Nordmann P.</emphasis> 2002. Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from <citetitle><emphasis>Chryseobacterium gleum. Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">46:</emphasis>966–970.</para>
          </listitem>
          <listitem id="ch0064s000000li0315" role="bibliographyEntry">
            <para>315.<emphasis role="strong">Kirby JT, Sader HS, Walsh TR, Jones RN.</emphasis> 2004. Antimicrobial susceptibility and epidemiology of a worldwide collection of <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>445–448.</para>
          </listitem>
          <listitem id="ch0064s000000li0316" role="bibliographyEntry">
            <para>316.<emphasis role="strong">Chen FL, Wang GC, Teng SO, Ou TY, Yu FL, Lee WS.</emphasis> 2013. Clinical and epidemiological features of <citetitle><emphasis>Chryseobacterium indologenes</emphasis></citetitle> infections: analysis of 215 cases. <citetitle><emphasis>J Microbiol Immunol Infect</emphasis></citetitle> <emphasis role="strong">46:</emphasis>425–432.</para>
          </listitem>
          <listitem id="ch0064s000000li0317" role="bibliographyEntry">
            <para>317.<emphasis role="strong">Chew KL, Cheng B, Lin RTP, Teo JWP.</emphasis> 2018. <citetitle><emphasis>Elizabethkingia anophelis</emphasis></citetitle> is the dominant <citetitle><emphasis>Elizabethkingia</emphasis></citetitle> species found in blood cultures in Singapore. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>e01445–e17.</para>
          </listitem>
          <listitem id="ch0064s000000li0318" role="bibliographyEntry">
            <para>318.<emphasis role="strong">Han MS, Kim H, Lee Y, Kim M, Ku NS, Choi JY, Yong D, Jeong SH, Lee K, Chong Y.</emphasis> 2016. Relative prevalence and antimicrobial susceptibility of clinical isolates of <citetitle><emphasis>Elizabethkingia</emphasis></citetitle> species based on 16S rRNA gene sequencing. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">55:</emphasis>274–280.</para>
          </listitem>
          <listitem id="ch0064s000000li0319" role="bibliographyEntry">
            <para>319.<emphasis role="strong">Nicholson AC, Gulvik CA, Whitney AM, Humrighouse BW, Graziano J, Emery B, Bell M, Loparev V, Juieng P, Gartin J, Bizet C, Clermont D, Criscuolo A, Brisse S, McQuiston JR.</emphasis> 2018. Revisiting the taxonomy of the genus <citetitle><emphasis>Elizabethkingia</emphasis></citetitle> using whole-genome sequencing, optical mapping, and MALDI-TOF, along with proposal of three novel <citetitle><emphasis>Elizabethkingia</emphasis></citetitle> species: <citetitle><emphasis>Elizabethkingia bruuniana</emphasis></citetitle> sp. nov., <citetitle><emphasis>Elizabethkingia ursingii</emphasis></citetitle> sp. nov., and <citetitle><emphasis>Elizabethkingia occulta</emphasis></citetitle> sp. nov. <citetitle><emphasis>Antonie van Leeuwenhoek</emphasis></citetitle> <emphasis role="strong">111:</emphasis>55–72.</para>
          </listitem>
          <listitem id="ch0064s000000li0320" role="bibliographyEntry">
            <para>320.<emphasis role="strong">Lin JN, Lai CH, Yang CH, Huang YH, Lin HF, Lin HH.</emphasis> 2017. Comparison of four automated microbiology systems with 16S rRNA gene sequencing for identification of <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> and <citetitle><emphasis>Elizabethkingia</emphasis></citetitle> species. <citetitle><emphasis>Sci Rep</emphasis></citetitle> <emphasis role="strong">7:</emphasis>13824.</para>
          </listitem>
          <listitem id="ch0064s000000li0321" role="bibliographyEntry">
            <para>321.<emphasis role="strong">Bloch KC, Nadarajah R, Jacobs R.</emphasis> 1997. <citetitle><emphasis>Chryseobacterium meningosepticum</emphasis></citetitle>: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. <citetitle><emphasis>Medicine (Baltimore)</emphasis></citetitle> <emphasis role="strong">76:</emphasis>30–41.</para>
          </listitem>
          <listitem id="ch0064s000000li0322" role="bibliographyEntry">
            <para>322.<emphasis role="strong">Hung PP, Lin YH, Lin CF, Liu MF, Shi ZY.</emphasis> 2008. <citetitle><emphasis>Chryseobacterium meningosepticum</emphasis></citetitle> infection: antibiotic susceptibility and risk factors for mortality. <citetitle><emphasis>J Microbiol Immunol Infect</emphasis></citetitle> <emphasis role="strong">41:</emphasis>137–144.</para>
          </listitem>
          <listitem id="ch0064s000000li0323" role="bibliographyEntry">
            <para>323.<emphasis role="strong">Ceyhan M, Celik M.</emphasis> 2011. <citetitle><emphasis>Elizabethkingia meningosepticum</emphasis></citetitle> (<citetitle><emphasis>Chryseobacterium meningosepticum</emphasis></citetitle>) infections in children. <citetitle><emphasis>Int J Pediatr</emphasis></citetitle> <emphasis role="strong">2011:</emphasis>215237.</para>
          </listitem>
          <listitem id="ch0064s000000li0324" role="bibliographyEntry">
            <para>324.<emphasis role="strong">Lin PY, Chu C, Su LH, Huang CT, Chang WY, Chiu CH.</emphasis> 2004. Clinical and microbiological analysis of bloodstream infections caused by <citetitle><emphasis>Chryseobacterium meningosepticum</emphasis></citetitle> in nonneonatal patients. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>3353–3355.</para>
          </listitem>
          <listitem id="ch0064s000000li0325" role="bibliographyEntry">
            <para>325.<emphasis role="strong">Breurec S, Criscuolo A, Diancourt L, Rendueles O, Vandenbogaert M, Passet V, Caro V, Rocha EP, Touchon M, Brisse S.</emphasis> 2016. Genomic epidemiology and global diversity of the emerging bacterial pathogen <citetitle><emphasis>Elizabethkingia anophelis. Sci Rep</emphasis></citetitle> <emphasis role="strong">6:</emphasis>30379.</para>
          </listitem>
          <listitem id="ch0064s000000li0326" role="bibliographyEntry">
            <para>326.<emphasis role="strong">Ratnamani MS, Rao R.</emphasis> 2013. <citetitle><emphasis>Elizabethkingia meningoseptica</emphasis></citetitle>: emerging nosocomial pathogen in bedside hemodialysis patients. <citetitle><emphasis>Indian J Crit Care Med</emphasis></citetitle> <emphasis role="strong">17:</emphasis>304–307.</para>
          </listitem>
          <listitem id="ch0064s000000li0327" role="bibliographyEntry">
            <para>327.<emphasis role="strong">Jean SS, Lee WS, Chen FL, Ou TY, Hsueh PR.</emphasis> 2014. <citetitle><emphasis>Elizabethkingia meningoseptica</emphasis></citetitle>: an important emerging pathogen causing healthcare-associated infections. <citetitle><emphasis>J Hosp Infect</emphasis></citetitle> <emphasis role="strong">86:</emphasis>244–249.</para>
          </listitem>
          <listitem id="ch0064s000000li0328" role="bibliographyEntry">
            <anchor id="ch0064s000000a0147"/>
            <para>328.<emphasis role="strong">Li Y, Kawamura Y, Fujiwara N, Naka T, Liu H, Huang X, Kobayashi K, Ezaki T.</emphasis> 2003. <citetitle><emphasis>Chryseobacterium miricola</emphasis></citetitle> sp. nov., a novel species isolated from condensation water of space station Mir. <citetitle><emphasis>Syst Appl Microbiol</emphasis></citetitle> <emphasis role="strong">26:</emphasis>523–528.</para>
          </listitem>
          <listitem id="ch0064s000000li0329" role="bibliographyEntry">
            <para>329.<emphasis role="strong">Green O, Murray P, Gea-Banacloche JC.</emphasis> 2008. Sepsis caused by <citetitle><emphasis>Elizabethkingia miricola</emphasis></citetitle> successfully treated with tigecycline and levofloxacin. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">62:</emphasis>430–432.</para>
          </listitem>
          <listitem id="ch0064s000000li0330" role="bibliographyEntry">
            <para>330.<emphasis role="strong">Gupta P, Zaman K, Mohan B, Taneja N.</emphasis> 2017. <citetitle><emphasis>Elizabethkingia miricola</emphasis></citetitle>: a rare non-fermenter causing urinary tract infection. <citetitle><emphasis>World J Clin Cases</emphasis></citetitle> <emphasis role="strong">5:</emphasis>187–190.</para>
          </listitem>
          <listitem id="ch0064s000000li0331" role="bibliographyEntry">
            <para>331.<emphasis role="strong">Zdziarski P, Paściak M, Rogala K, Korzeniowska-Kowal A, Gamian A.</emphasis> 2017. <citetitle><emphasis>Elizabethkingia miricola</emphasis></citetitle> as an opportunistic oral pathogen associated with superinfectious complications in humoral immunodeficiency: a case report. <citetitle><emphasis>BMC Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>763.</para>
          </listitem>
          <listitem id="ch0064s000000li0332" role="bibliographyEntry">
            <para>332.<emphasis role="strong">Kenna DTD, Fuller A, Martin K, Perry C, Pike R, Burns PJ, Narayan O, Wilkinson S, Hill R, Woodford N, Logan JMJ, Turton JF.</emphasis> 2018. <citetitle><emphasis>rpoB</emphasis></citetitle> gene sequencing highlights the prevalence of an <citetitle><emphasis>E. miricola</emphasis></citetitle> cluster over other <citetitle><emphasis>Elizabethkingia</emphasis></citetitle> species among UK cystic fibrosis patients. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">90:</emphasis>109–114.</para>
          </listitem>
          <listitem id="ch0064s000000li0333" role="bibliographyEntry">
            <para>333.<emphasis role="strong">Kämpfer P, Busse HJ, McInroy JA, Glaeser SP.</emphasis> 2015. Elizabethkingia endophytica sp. nov., isolated from <citetitle><emphasis>Zea mays</emphasis></citetitle> and emended description of <citetitle><emphasis>Elizabethkingia anophelis</emphasis></citetitle> Kämpfer et al. 2011. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">65:</emphasis>2187–2193.</para>
          </listitem>
          <listitem id="ch0064s000000li0334" role="bibliographyEntry">
            <para>334.<emphasis role="strong">Lau SK, Wu AK, Teng JL, Tse H, Curreem SO, Tsui SK, Huang Y, Chen JH, Lee RA, Yuen KY, Woo PC.</emphasis> 2015. Evidence for <citetitle><emphasis>Elizabethkingia anophelis</emphasis></citetitle> transmission from mother to infant, Hong Kong. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">21:</emphasis>232–241.</para>
          </listitem>
          <listitem id="ch0064s000000li0335" role="bibliographyEntry">
            <para>335.<emphasis role="strong">Nicholson AC, Whitney AM, Emery BD, Bell ME, Gartin JT, Humrighouse BW, Loparev VN, Batra D, Sheth M, Rowe LA, Juieng P, Knipe K, Gulvik C, McQuiston JR.</emphasis> 2016. Complete genome sequences of four strains from the 2015-2016 <citetitle><emphasis>Elizabethkingia anophelis</emphasis></citetitle> outbreak. <citetitle><emphasis>Genome Announc</emphasis></citetitle> <emphasis role="strong">4:</emphasis>e00563–e16.</para>
          </listitem>
          <listitem id="ch0064s000000li0336" role="bibliographyEntry">
            <para>336.<emphasis role="strong">Hu S, Jiang T, Zhang X, Zhou Y, Yi Z, Wang Y, Zhao S, Wang M, Ming D, Chen S.</emphasis> 2017. <citetitle><emphasis>Elizabethkingia anophelis</emphasis></citetitle> isolated from patients with multiple organ dysfunction syndrome and lower respiratory tract infection: report of two cases and literature review. <citetitle><emphasis>Front Microbiol</emphasis></citetitle> <emphasis role="strong">8:</emphasis>382.</para>
          </listitem>
          <listitem id="ch0064s000000li0337" role="bibliographyEntry">
            <para>337.<emphasis role="strong">Janda JM, Lopez DL.</emphasis> 2017. Mini review: new pathogen profiles: <citetitle><emphasis>Elizabethkingia anophelis. Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">88:</emphasis>201–205.</para>
          </listitem>
          <listitem id="ch0064s000000li0338" role="bibliographyEntry">
            <para>338.<emphasis role="strong">Nicholson AC, Bernardet J, Kämpfer P.</emphasis> 2021. Elizabethkingia. <citetitle><emphasis>In</emphasis></citetitle> Trujillo ME, Dedysh S, DeVos P, Hedlund B, Kämpfer P, Rainey FA, Whitman WB (ed), <citetitle><emphasis>Bergey’s Manual of Systematics of Archaea and Bacteria.</emphasis></citetitle> Wiley, Hoboken, NJ.</para>
          </listitem>
          <listitem id="ch0064s000000li0339" role="bibliographyEntry">
            <para>339.<emphasis role="strong">Chang JC, Hsueh PR, Wu JJ, Ho SW, Hsieh WC, Luh KT.</emphasis> 1997. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">41:</emphasis>1301–1306.</para>
          </listitem>
          <listitem id="ch0064s000000li0340" role="bibliographyEntry">
            <para>340.<emphasis role="strong">Vandamme P, Bernardet JF, Segers P, Kersters K, Holmes B.</emphasis> 1994. New perspectives in the classification of the flavobacteria: description of <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> gen. nov., <citetitle><emphasis>Bergeyella</emphasis></citetitle> gen. nov., and <citetitle><emphasis>Empedobacter</emphasis></citetitle> nom. rev. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">44:</emphasis>827–831.</para>
          </listitem>
          <listitem id="ch0064s000000li0341" role="bibliographyEntry">
            <para>341.<emphasis role="strong">Bokhari S, Abbas N, Singh M, Cindrich RB, Zeana C.</emphasis> 2015. <citetitle><emphasis>Empedobacter brevis</emphasis></citetitle> bacteremia in a patient infected with HIV: case report and review of literature. <citetitle><emphasis>Case Rep Infect Dis</emphasis></citetitle> <emphasis role="strong">2015:</emphasis>813528.</para>
          </listitem>
          <listitem id="ch0064s000000li0342" role="bibliographyEntry">
            <para>342.<emphasis role="strong">Sharma B, Nagpal K, Handa R, Dubey P.</emphasis> 2013. Combination of AIDP and pyramidal signs associated with antecedent hepatitis A infection: a rare (co)occurrence. <citetitle><emphasis>BMJ Case Rep</emphasis></citetitle> <emphasis role="strong">2013</emphasis>(jun12_1)<emphasis role="strong">:</emphasis>bcr2013009530.</para>
          </listitem>
          <listitem id="ch0064s000000li0343" role="bibliographyEntry">
            <para>343.<emphasis role="strong">Zhang RG, Tan X, Liang Y, Meng TY, Liang HZ, Lv J.</emphasis> 2014. Description of <citetitle><emphasis>Chishuiella changwenlii</emphasis></citetitle> gen. nov., sp. nov., isolated from freshwater, and transfer of <citetitle><emphasis>Wautersiella falsenii</emphasis></citetitle> to the genus <citetitle><emphasis>Empedobacter</emphasis></citetitle> as <citetitle><emphasis>Empedobacter falsenii</emphasis></citetitle> comb. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">64:</emphasis>2723–2728.</para>
          </listitem>
          <listitem id="ch0064s000000li0344" role="bibliographyEntry">
            <para>344.<emphasis role="strong">Kämpfer P, Avesani V, Janssens M, Charlier J, De Baere T, Vaneechoutte M.</emphasis> 2006. Description of <citetitle><emphasis>Wautersiella falsenii</emphasis></citetitle> gen. nov., sp. nov., to accommodate clinical isolates phenotypically resembling members of the genera <citetitle><emphasis>Chryseobacterium</emphasis></citetitle> and <citetitle><emphasis>Empedobacter. Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">56:</emphasis>2323–2329.</para>
          </listitem>
          <listitem id="ch0064s000000li0345" role="bibliographyEntry">
            <para>345.<emphasis role="strong">Giordano C, Falleni M, Capria AL, Caracciolo F, Petrini M, Barnini S.</emphasis> 2016. First report of <citetitle><emphasis>Wautersiella falsenii</emphasis></citetitle> genomovar 2 isolated from the respiratory tract of an immunosuppressed man. <citetitle><emphasis>IDCases</emphasis></citetitle> <emphasis role="strong">4:</emphasis>27–29.</para>
          </listitem>
          <listitem id="ch0064s000000li0346" role="bibliographyEntry">
            <para>346.<emphasis role="strong">Traglia GM, Dixon C, Chiem K, Almuzara M, Barberis C, Montaña S, Merino C, Mussi MA, Tolmasky ME, Iriarte A, Vay C, Ramírez MS.</emphasis> 2015. Draft genome sequence of <citetitle><emphasis>Empedobacter</emphasis></citetitle> (formerly <citetitle><emphasis>Wautersiella) falsenii</emphasis></citetitle> comb. nov. Wf282, a strain isolated from a cervical neck abscess. <citetitle><emphasis>Genome Announc</emphasis></citetitle> <emphasis role="strong">3:</emphasis>e00235–e15.</para>
          </listitem>
          <listitem id="ch0064s000000li0347" role="bibliographyEntry">
            <para>347.<emphasis role="strong">van der Velden LB, de Jong AS, de Jong H, de Gier RP, Rentenaar RJ.</emphasis> 2012. First report of a <citetitle><emphasis>Wautersiella falsenii</emphasis></citetitle> isolated from the urine of an infant with pyelonephritis. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">74:</emphasis>404–405.</para>
          </listitem>
          <listitem id="ch0064s000000li0348" role="bibliographyEntry">
            <para>348.<emphasis role="strong">Ademhan Tural D, Dogru Ersöz D, Emiralioglu N, Ozsezen B, Hazirolan G, Sunman B, Yalcin E, Özçelik U, Kiper N.</emphasis> 2021. <citetitle><emphasis>Clinical Characteristics of Children with Cystic Fibrosis Infected with Unusual Bacteria.</emphasis></citetitle> Minerva Pediatr, Torino, Italy.</para>
          </listitem>
          <listitem id="ch0064s000000li0349" role="bibliographyEntry">
            <para>349.<emphasis role="strong">Collins C, Almuzara M, Saigo M, Montaña S, Chiem K, Traglia G, Mussi MA, Tolmasky M, Iriarte A, Vay C, Ramirez MS.</emphasis> 2018. Whole-genome analysis of an extensively drug-resistant <citetitle><emphasis>Empedobacter falsenii</emphasis></citetitle> strain reveals distinct features and the presence of a novel metallo-β-lactamase (EBR-2). <citetitle><emphasis>Curr Microbiol</emphasis></citetitle> <emphasis role="strong">75:</emphasis>1084–1089.</para>
          </listitem>
          <listitem id="ch0064s000000li0350" role="bibliographyEntry">
            <para>350.<emphasis role="strong">Zeng Y, Dong N, Zhang R, Liu C, Sun Q, Lu J, Shu L, Cheng Q, Chan EW, Chen S.</emphasis> 2020. Emergence of an <citetitle><emphasis>Empedobacter falsenii</emphasis></citetitle> strain harbouring a tet(X)-variant-bearing novel plasmid conferring resistance to tigecycline. <citetitle><emphasis>J Antimicrob Chemother</emphasis></citetitle> <emphasis role="strong">75:</emphasis>531–536.</para>
          </listitem>
          <listitem id="ch0064s000000li0351" role="bibliographyEntry">
            <para>351.<emphasis role="strong">Olowo-Okere A, Ibrahim YKE, Olayinka BO, Mohammed Y, Nabti LZ, Lupande-Mwenebitu D, Rolain JM, Diene SM.</emphasis> 2022. Genomic features of an isolate of Empedobacter falsenii harbouring a novel variant of metallo-β-lactamase, bla<subscript>EBR-4</subscript> gene. <citetitle><emphasis>Infect Genet Evol</emphasis></citetitle> <emphasis role="strong">98:</emphasis>105234.</para>
          </listitem>
          <listitem id="ch0064s000000li0352" role="bibliographyEntry">
            <para>352.<emphasis role="strong">Holmes BWR, Steigerwalt AG, Brenner DJ.</emphasis> 1988. A taxonomic study of <citetitle><emphasis>Flavobacterium spiritivorum</emphasis></citetitle> and <citetitle><emphasis>Sphingobacterium mizutae</emphasis></citetitle>: proposal of <citetitle><emphasis>Flavobacterium yabuuchiae</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Flavobacterium mizutaii</emphasis></citetitle> comb. nov. <citetitle><emphasis>Int J Syst Evol Microbiol</emphasis></citetitle> <emphasis role="strong">38:</emphasis>348–353.</para>
          </listitem>
          <listitem id="ch0064s000000li0353" role="bibliographyEntry">
            <para>353.<emphasis role="strong">Boixeda D, de Luis DA, Meseguer MA, Aller R, Martin de Argila C, Lopez Sanroman A.</emphasis> 1998. A case of spontaneous peritonitis caused by <citetitle><emphasis>Weeksella virosa. Eur J Gastroenterol Hepatol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>897–898.</para>
          </listitem>
          <listitem id="ch0064s000000li0354" role="bibliographyEntry">
            <para>354.<emphasis role="strong">Slenker AK, Hess BD, Jungkind DL, DeSimone JA.</emphasis> 2012. Fatal case of <citetitle><emphasis>Weeksella virosa</emphasis></citetitle> sepsis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>4166–4167.</para>
          </listitem>
          <listitem id="ch0064s000000li0355" role="bibliographyEntry">
            <para>355.<emphasis role="strong">Toescu SM, Lacey S, Low HL.</emphasis> 2017. First report of postoperative intracranial <citetitle><emphasis>Weeksella virosa</emphasis></citetitle> infection. <citetitle><emphasis>Acta Neurochir (Wien)</emphasis></citetitle> <emphasis role="strong">159:</emphasis>2235–2238.</para>
          </listitem>
          <listitem id="ch0064s000000li0356" role="bibliographyEntry">
            <para>356.<emphasis role="strong">Sankar SA, Lo CI, Fall B, Sambe-Ba B, Mediannikov O, Diallo I, Labas N, Faye N, Wade B, Raoult D, Fournier PE, Fenollar F.</emphasis> 2015. Noncontiguous finished genome sequence and description of <citetitle><emphasis>Weeksella massiliensis</emphasis></citetitle> sp. nov. <citetitle><emphasis>New Microbes New Infect</emphasis></citetitle> <emphasis role="strong">8:</emphasis>89–98.</para>
          </listitem>
          <listitem id="ch0064s000000li0357" role="bibliographyEntry">
            <para>357.<emphasis role="strong">Snyder RW, Ruhe J, Kobrin S, Wasserstein A, Doline C, Nachamkin I, Lipschutz JH.</emphasis> 2004. <citetitle><emphasis>Asaia bogorensis</emphasis></citetitle> peritonitis identified by 16S ribosomal RNA sequence analysis in a patient receiving peritoneal dialysis. <citetitle><emphasis>Am J Kidney Dis</emphasis></citetitle> <emphasis role="strong">44:</emphasis>e15–e17.</para>
          </listitem>
          <listitem id="ch0064s000000li0358" role="bibliographyEntry">
            <para>358.<emphasis role="strong">Tuuminen T, Heinäsmäki T, Kerttula T.</emphasis> 2006. First report of bacteremia by <citetitle><emphasis>Asaia bogorensis</emphasis></citetitle>, in a patient with a history of intravenous-drug abuse. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">44:</emphasis>3048–3050.</para>
          </listitem>
          <listitem id="ch0064s000000li0359" role="bibliographyEntry">
            <para>359.<emphasis role="strong">Juretschko S, Beavers-May TK, Stovall SH.</emphasis> 2010. Nosocomial infection with <citetitle><emphasis>Asaia lannensis</emphasis></citetitle> in two paediatric patients with idiopathic dilated cardiomyopathy. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">59:</emphasis>848–852.</para>
          </listitem>
          <listitem id="ch0064s000000li0360" role="bibliographyEntry">
            <para>360.<emphasis role="strong">Carretto E, Visiello R, Bardaro M, Schivazappa S, Vailati F, Farina C, Barbarini D.</emphasis> 2016. <citetitle><emphasis>Asaia lannensis</emphasis></citetitle> bacteremia in a ‘needle freak’ patient. <citetitle><emphasis>Future Microbiol</emphasis></citetitle> <emphasis role="strong">11:</emphasis>23–29.</para>
          </listitem>
          <listitem id="ch0064s000000li0361" role="bibliographyEntry">
            <para>361.<emphasis role="strong">Moore JE, McCalmont M, Xu J, Millar BC, Heaney N.</emphasis> 2002. <citetitle><emphasis>Asaia</emphasis></citetitle> sp., an unusual spoilage organism of fruit-flavored bottled water. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">68:</emphasis>4130–4131.</para>
          </listitem>
          <listitem id="ch0064s000000li0362" role="bibliographyEntry">
            <anchor id="ch0064s000000a0148"/>
            <para>362.<emphasis role="strong">Han XY, Pham AS, Tarrand JJ, Rolston KV, Helsel LO, Levett PN.</emphasis> 2003. Bacteriologic characterization of 36 strains of <citetitle><emphasis>Roseomonas</emphasis></citetitle> species and proposal of <citetitle><emphasis>Roseomonas mucosa</emphasis></citetitle> sp. nov. and <citetitle><emphasis>Roseomonas gilardii</emphasis></citetitle> subsp. <citetitle><emphasis>rosea</emphasis></citetitle> subsp. nov. <citetitle><emphasis>Am J Clin Pathol</emphasis></citetitle> <emphasis role="strong">120:</emphasis>256–264.</para>
          </listitem>
          <listitem id="ch0064s000000li0363" role="bibliographyEntry">
            <para>363.<emphasis role="strong">Rihs JD, Brenner DJ, Weaver RE, Steigerwalt AG, Hollis DG, Yu VL.</emphasis> 1993. <citetitle><emphasis>Roseomonas</emphasis></citetitle>, a new genus associated with bacteremia and other human infections. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">31:</emphasis>3275–3283.</para>
          </listitem>
          <listitem id="ch0064s000000li0364" role="bibliographyEntry">
            <para>364.<emphasis role="strong">Kovaleva J, Degener JE, van der Mei HC.</emphasis> 2014. <citetitle><emphasis>Methylobacterium</emphasis></citetitle> and its role in health care-associated infection. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>1317–1321.</para>
          </listitem>
          <listitem id="ch0064s000000li0365" role="bibliographyEntry">
            <para>365.<emphasis role="strong">Patt TE, Hanson RS.</emphasis> 1978. Intracytoplasmic membrane, phospholipid, and sterol content of <citetitle><emphasis>Methylobacterium organophilum</emphasis></citetitle> cells grown under different conditions. <citetitle><emphasis>J Bacteriol</emphasis></citetitle> <emphasis role="strong">134:</emphasis>636–644.</para>
          </listitem>
          <listitem id="ch0064s000000li0366" role="bibliographyEntry">
            <para>366.<emphasis role="strong">Engler C, Norton R.</emphasis> 2001. Recurrent <citetitle><emphasis>Methylobacterium mesophilicum</emphasis></citetitle> sepsis associated with haemodialysis. <citetitle><emphasis>Pathology</emphasis></citetitle> <emphasis role="strong">33:</emphasis>536–537.</para>
          </listitem>
          <listitem id="ch0064s000000li0367" role="bibliographyEntry">
            <para>367.<emphasis role="strong">Hornei B, Lüneberg E, Schmidt-Rotte H, Maass M, Weber K, Heits F, Frosch M, Solbach W.</emphasis> 1999. Systemic infection of an immunocompromised patient with <citetitle><emphasis>Methylobacterium zatmanii. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">37:</emphasis>248–250.</para>
          </listitem>
          <listitem id="ch0064s000000li0368" role="bibliographyEntry">
            <para>368.<emphasis role="strong">Kaye KM, Macone A, Kazanjian PH.</emphasis> 1992. Catheter infection caused by <citetitle><emphasis>Methylobacterium</emphasis></citetitle> in immunocompromised hosts: report of three cases and review of the literature. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">14:</emphasis>1010–1014.</para>
          </listitem>
          <listitem id="ch0064s000000li0369" role="bibliographyEntry">
            <para>369.<emphasis role="strong">Simon A, Völz S, Reiffert SM, Bölefahr H, Marklein G, Büttner R, Hepping N, Bode U, Fleischhack G.</emphasis> 2007. Protracted cervical lymphadenitis with <citetitle><emphasis>Mycobacterium avium</emphasis></citetitle> and <citetitle><emphasis>Methylobacterium mesophilicum. Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">26:</emphasis>971.</para>
          </listitem>
          <listitem id="ch0064s000000li0370" role="bibliographyEntry">
            <para>370.<emphasis role="strong">Lai CC, Cheng A, Liu WL, Tan CK, Huang YT, Chung KP, Lee MR, Hsueh PR.</emphasis> 2011. Infections caused by unusual <citetitle><emphasis>Methylobacterium</emphasis></citetitle> species. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>3329–3331.</para>
          </listitem>
          <listitem id="ch0064s000000li0371" role="bibliographyEntry">
            <para>371.<emphasis role="strong">Tang W, Desai A, Desai K.</emphasis> 2021. A case report of <citetitle><emphasis>Methylobacterium radiotolerans</emphasis></citetitle> bacteremia and brain abscesses. <citetitle><emphasis>Infect Microbes Dis</emphasis></citetitle> <emphasis role="strong">3:</emphasis>112–114.</para>
          </listitem>
          <listitem id="ch0064s000000li0372" role="bibliographyEntry">
            <para>372.<emphasis role="strong">Brown WJ, Sautter RL, Crist AE Jr.</emphasis> 1992. Susceptibility testing of clinical isolates of <citetitle><emphasis>Methylobacterium</emphasis></citetitle> species. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">36:</emphasis>1635–1638.</para>
          </listitem>
          <listitem id="ch0064s000000li0373" role="bibliographyEntry">
            <para>373.<emphasis role="strong">Dé I, Rolston KV, Han XY.</emphasis> 2004. Clinical significance of <citetitle><emphasis>Roseomonas</emphasis></citetitle> species isolated from catheter and blood samples: analysis of 36 cases in patients with cancer. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">38:</emphasis>1579–1584.</para>
          </listitem>
          <listitem id="ch0064s000000li0374" role="bibliographyEntry">
            <para>374.<emphasis role="strong">Shokar NK, Shokar GS, Islam J, Cass AR.</emphasis> 2002. <citetitle><emphasis>Roseomonas gilardii</emphasis></citetitle> infection: case report and review. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>4789–4791.</para>
          </listitem>
          <listitem id="ch0064s000000li0375" role="bibliographyEntry">
            <para>375.<emphasis role="strong">Struthers M, Wong J, Janda JM.</emphasis> 1996. An initial appraisal of the clinical significance of <citetitle><emphasis>Roseomonas</emphasis></citetitle> species associated with human infections. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">23:</emphasis>729–733.</para>
          </listitem>
          <listitem id="ch0064s000000li0376" role="bibliographyEntry">
            <para>376.<emphasis role="strong">Wang CM, Lai CC, Tan CK, Huang YC, Chung KP, Lee MR, Hwang KP, Hsueh PR.</emphasis> 2012. Clinical characteristics of infections caused by <citetitle><emphasis>Roseomonas</emphasis></citetitle> species and antimicrobial susceptibilities of the isolates. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">72:</emphasis>199–203.</para>
          </listitem>
          <listitem id="ch0064s000000li0377" role="bibliographyEntry">
            <para>377.<emphasis role="strong">Kim YK, Moon JS, Song KE, Lee WK.</emphasis> 2016. Two cases of bacteremia due to <citetitle><emphasis>Roseomonas mucosa. Ann Lab Med</emphasis></citetitle> <emphasis role="strong">36:</emphasis>367–370.</para>
          </listitem>
        </itemizedlist>
        <anchor id="ch0064s000000a0139"/>
        <beginpage pagenum="934"/>
        <anchor id="ch0064s000000a0140"/>
        <beginpage pagenum="935"/>
        <anchor id="ch0064s000000a0141"/>
        <beginpage pagenum="936"/>
        <anchor id="ch0064s000000a0142"/>
        <beginpage pagenum="937"/>
        <anchor id="ch0064s000000a0143"/>
        <beginpage pagenum="938"/>
        <anchor id="ch0064s000000a0144"/>
        <beginpage pagenum="939"/>
        <anchor id="ch0064s000000a0145"/>
        <beginpage pagenum="940"/>
        <orderedlist role="notesList">
          <listitem role="noteEntry">
            <para><anchor id="ch0064s000000a0149"/><link linkend="ch0064s000000a0001">*</link>This chapter contains contributions from Mario Vaneechoutte and Georges Wauters, coauthors of this chapter in previous versions of this <emphasis>Manual</emphasis>.</para>
          </listitem>
        </orderedlist>
      </sect2>
    </sect1>
  </chapter>
